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Abstract 
The transmission of the malaria parasite (Plasmodium spp) is effected by a small 
proportion of the population that commit to sexual development forming either 
male or female gametocytes. Currently front-line anti-malarials are developed 
to treat the asexual life stage parasitising mature erythrocytes. While circulating 
mature erythrocytes form a relatively homogenous population, it has been 
recently established that Plasmodium spp can colonise progenitor cells in the 
erythroid lineage. I hypothesised that these tissue-resident erythroid precursors 
may form a niche for preferential development of gametocytes, and therefore 
developed a quantitative approach to enumerate Plasmodium-infected 
erythropoietic intermediate cells in haematopoietic tissues. We demonstrate 
that within erythropoietic tissues, early reticulocytes preferentially drive 
commitment to gametocytogenesis, with the splenic niche contributing the 
quantifiable majority of gametocytes.  Furthermore, this same erythropoetic 
niche offers the parasite protection against antimalarial drug treatment and, as 
such, may serve as origins of recrudescent infection and continuing transmission. 
My data therefore demonstrate that host cell phenotype and location play an 
active role in determining the developmental fate of malaria parasites and 
furthermore suggests a mechanism for the persistence of malaria parasites. 	
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Introduction	 	 		 1	
1 Introduction 	
1.1  Introduction Outline 	
This introduction will address the structure and function of the Plasmodium 
parasite’s sexual and asexual forms in the context of both immature erythroid cell 
infection and the perpetuation of disease. Moreover, the case for the development 
of a murine model of tissue resident erythroid infection and its subsequent 
combination with a quantitative analytical approach will be made. 
The first two sections (sections 1.2 & 1.3) will provide a comprehensive overview of 
the background literature needed in order to contextualise the third section 
(section 1.4).  
1.2 Malaria and Plasmodium spp     
The key points in this section are: 
• Features defining a parasite’s cellular tropism.  
• Features defining a host cell’s susceptibility to Plasmodium. 
• Environmental and parasite cues facilitate gametocyte commitment. 
• Immature gametocytes develop out of circulation.  
• The gametocyte ultra-structure and motility.  
• Drug resistance and recrudescence highlight the need to fully understand the 
temporal and dynamics of infection.  
• The use of a murine model organism to advance the study of multiple aspects 
of Plasmodium biology and malaria pathology.  
 
The conclusions to these points are reviewed in the summary: section 1.2.37. 	
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1.2.2  Malaria  
Malaria is a mosquito-borne infectious disease that The World Health Organization 
(The WHO) describes as an acute febrile illness ranging in severity from mild chills 
and headaches through to respiratory disease and cerebral malarial (The WHO, 
2017). It is endemic within a global band of tropical and sub-tropical countries 
(Figure 1.1). Consequently, the international strategies for control and elimination 
of the disease transcend geographical boundaries. Nonetheless the political, social 
and economic stability of endemic countries influence the current rate of local 
progress. There has been a 37% decrease in reported global disease incidences 
between the years 2000 and 2015. Despite this, 3.2 billion people remain at risk, 
with 214 million incidences and 400,000 deaths reported in 2015 alone.  The sheer 
scale of eradication challenges are directly and indirectly highlighted by the 
recently adopted WHO-led 15 year strategy that estimates the need for a $8.7 
billion annual spend by 2030 (WHO, 2015).  
 																	 				
Figure 1.1 Global distribution of malaria (WHO, 2015). 	
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1.2.3 Plasmodium spp  
The causative agent of malaria is the unicellular, eukaryotic Apicomplexa parasite, 
Plasmodium. There are five human infective species of Plasmodium that cause 
malaria: P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. The 
species that cause the greatest mortality and morbidity are P. falciparum and P. 
vivax, respectively (Figure 1.2). As such, current research in the field, from basic 
through to clinical, has focused on the prevention and cure of disease caused by 
these two particular species.  
 
 
Figure 1.2 Global distribution of A. P. vivax and B. P. falciparum (MAP, 2015). Key 
displays the estimated percentage of the population (country) infected at any given time 
during 2010.  
A. 
B. 
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1.2.4 Plasmodium Life Cycle Overview 
All Plasmodium parasites have a life cycle split between a vertebrate host and a 
female Anopheles mosquito (the vector). Host to vector transmission events are 
flanked by the survival and proliferation of Plasmodium spp within two different 
host environments. Reflecting this, the parasite undergoes a sequential transition 
between morphologies (Figure 1.3), with specialised invasive forms facilitating the 
parasite’s establishment of infection within the host. There are three invasive 
forms of Plasmodium: the sporozoite (Figure 1.3 A), the merozoite (Figure 1.3 B & Ci) 
and the ookinete (Figure 1.3 F3).  
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A.	B.	
C.i.	
D.	
F.	
C.ii.	
1.	 2.	 3.	
4.	5.	
Figure 1.3 Life cycle of Plasmodium (Rosenthal, 2008). A. The host is infected with 
sporozoites during a blood meal. B. The sporozoites rapidly translocate to the liver and 
undergo multiple rounds of asexual reproduction within hepatocytes. C.i. The released 
merozoites invade circulating erythroid cells and undergo asexual reproduction. C.ii. 
Erythrocytes containing mature asexual forms of certain Plasmodium spp cytoadhere to 
the endothelium lining of blood vessels and uninfected erythrocytes. D. A number of 
parasites commit themselves to a parallel developmental pathway that generates sexual 
cells called gametocytes.  F. The gametocytes are taken up in the blood meal; activate (1) 
and fertilize (2) in the insect’s midgut forming a zygote that matures into an ookinete (3). 
This stage translocates the midgut wall and develops into oocyst that contains 
sporozoites (4), and ruptures (5) releasing sporozoites that migrate to the insect’s salivary 
glands. 
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1.2.5 Plasmodium spp and Evolutionary Distance 
Gathering in vivo data for human parasites is ethically restricted, therefore making 
the investigation of parasite dynamics during infection difficult. As such, murine 
infective species have been used as model organisms to supplement the study of 
the Plasmodium life cycle within the host. There are four species of murine 
infective Plasmodium: P. chabaudi, P. vinckei, P. berghei and P. yoelii (Wykes and 
Good, 2009). The relevance of animal models to key features of human malaria will 
be reviewed in Section 1.2.36. Nonetheless, it is important at this point to address 
the phylogenetic groupings (Figure 1.4) within the Plasmodium genus in order to 
provide clear context to the contrasts between species biology.  
 
 
Figure 1.4 Evolutionary relationships between Plasmodium spp (Loy et al., 2016). 
Human (red), chimpanzee (blue) and gorilla (green) infective species. The scale bar indicates 
0.03 substitutions per site. Phylogeny was estimated by maximum likelihood analysis on 
2.4kb mitochondrial genome. 
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Following the sequencing and annotation of DNA from ape-infective Plasmodium 
species it became clear that P. falciparum arose via a zoonotic infection from 
African gorillas around 10,000 years ago, rather than the previous theory of cross 
infection from chimpanzees (Loy et al., 2016). The evolutionarily closest relative of 
P. falciparum is a gorilla-infective Plasmodium, P.  praefalciparum. Both species 
are grouped within the Laverania clade of the Plasmodium phylogenetic tree, which 
was generated based on the nucleotide sequences of the mitochondrial genome. 
This clade is distinct from the other human and murine infective Plasmodium spp 
which cluster within the subgenus of Plasmodium (Duval et al., 2010).  
 
The four rodent infective Plasmodium species were isolated between 1948 and 1974 
from Africa (Perkins et al., 2007). The WHO registry of standard malaria parasites 
contains 70 field isolates of rodent malaria parasites and these isolates are 
classified into subspecies (Ramiro et al., 2012). Recent work into comparing the 
polymorphisms at 11 nuclear gene loci suggested that the subspecies are 
independently evolving and should in fact be consisted distinct species, therefore 
potentially drastically expanding the number of rodent malaria parasites (Ramiro et 
al., 2012). A phylogenetic study using the apicoplast genome noted an evolutionary 
closeness between the rodent malaria clade and human infective P. ovale, leading 
the authors to hypothesise a host switch event between rodents and humans 
reflective of the gorilla to human event giving rise to P. falciparum (Arisue et al., 
2012). This clade arrangement is not reflected in Figure 1.4, which was generated 
by Loy et al (2016), but it is supported by recent work using a manually curated 
genome for P. ovale (Rutledge et al., 2017). The manual annotation protocol 
allowed for the novel analysis and comparison of differently distributed 
pseudogenes between Plasmodium genomes (Rutledge et al., 2017). It also allowed 
the authors to highlight that the disparities observed within the phylogenetic 
groupings of Plasmodium is due in part to the low quality reference genomes 
available for the less studied species (Rutledge et al., 2017).  
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1.2.6 The Merozoite   
Due to the early establishment of continuous in vitro culturing conditions for P. 
falciparum (Trager and Jensen, 1976) and the continuing relative lack of protocols 
for robustly propagating P. vivax, much merozoite structural biology has conducted 
using the Laverania Plasmodium species (Mons, 1990; Trager and Jensen, 1976). 
Despite the species divergence there is speculation that the overarching features of 
their biology is shared (Hanssen et al., 2013).  	
The merozoites of Plasmodium spp have a highly polarised morphology that is 
defined by the apical complex (Figure 1.5). Recently, high definition electron 
tomography has confirmed historical observations that the apical complex of P. 
falciparum consists of an arrangement of three dense proteinaceous rings. These 
anchor the microtubule filaments that run longitudinally under the plasma 
membrane (Hanssen et al., 2013; Langreth et al., 1978). The plasma membrane 
encapsulates the vital eukaryotic organelles required for physiology and metabolic 
function. The cell also contains the Apicomplexa-specific metabolic organelle, the 
apicoplast, alongside the characteristic apical structures: the rhoptries, 
micronemes and dense granules (Hanssen et al., 2013).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.5 Merozoite structure (Gaur et al., 2016) 
Introduction	 	 		 9	
The cytoskeleton of the merozoite is composed of three elements: the 
microtubules, actin microfilaments and intermediate filaments known as the 
subpellicular network (SPN) (Etienne-Manneville, 2004). The SPN supports the 
cytoplasmic side of the double membrane layer named the inner membrane 
complex (IMC) (Tremp et al., 2014). The IMC structure is further supported by the 
microtubules, a polarised network facilitating protein distribution throughout the 
cell. The actin filaments of most eukaryotic cells exert protrusive and contractile 
forces to facilitate cellular motility, this does not occur in Plasmodium as the 
parasite does not modify its shape in order to gain motility (Etienne-Manneville, 
2004; Ménard, 2001). Nonetheless, the motility that Apicomplexa parasites do 
display, gliding (sporozoites) and cell invasion (all zoites), is sensitive to blocking 
the polymerisation of actin with drugs such as cytochalasin B (Miller et al., 1979; 
Russell and Sinden, 1981). Plasmodium contains two variants of actin: actin I and 
actin II, with the filaments of the actin 1 forming a scaffold for the myosin class of 
mechanochemical enzymes (ATPases). Myosin A (MyoA) is the motor of a structure 
collectively known as the glideosome (Figure 1.6), in which MyoA pulls on the actin 
1 filament generating force through the hydrolysis of ATP (Ménard, 2001; Kumpula 
and Kursula, 2015; Etienne-Manneville, 2004). This complex was initially believe to 
interact with an aldolase tetramer (Starnes et al., 2009; Jewett and Sibley, 2003), 
which was proposed to act as a bridging protein connecting the actin filaments to 
the C- terminal tails of extracellular parasite ligands (Starnes et al., 2009; Jewett 
and Sibley, 2003). Directed point mutations in the aldolase putative binding site 
disrupted the interaction between the enzyme and the adesin protein as judged by 
in vitro pull down assays (Buscaglia et al., 2004; Starnes et al., 2009). Moreover, 
conditional aldolase knockout (cKO) parasites had a attenuated growth phenotype 
(Starnes et al., 2009). Nonetheless, a later study that cultured aldolase cKO 
parasites in glucose rich media attributed the attenuated growth phenotype to 
decreased enzymatic activity of aldolase rather than the dysfunction of the 
glideosome, as such the authors concluded that aldolase is dispensable in parasite 
motility (Shen and Sibley, 2014).  
 
The parasite surface adhesions bind to their respective receptors and are 
translocated to the posterior pole of the parasite; thus binding to a fixed ligand 
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would lead to a forward motion, be it gliding forward or penetration into a host cell 
(Hanssen et al., 2013; Koch and Baum, 2015).   
 
 
1.2.7 Host Cell Preference: The Invasion of Erythrocytes or Reticulocytes 
The preferential and restricted invasion of particular erythrocyte age classes in the 
host peripheral blood is characteristic of some Plasmodium spp. P. falciparum is 
capable of invading all erythroid cells in the peripheral blood, whereas P. vivax and 
P. berghei demonstrate preferential invasion of younger red blood cells 
(reticulocytes).   
 
The reticulocyte population within the peripheral blood is a small heterogeneous 
subset of enucleated erythroid cells containing vestigial reticular network ribosomal 
RNA that is lost during maturation into erythrocytes (Motoi Ishidate, 1990). The 
restrictive tropism P. vivax has for this erythroid subset was described almost 80 
	Figure 1.6 The location of the IMC and glideosome within the merozoite and 
sporozoite (Bargieri et al., 2014).	Associated with the IMC are the proteins associated with 
the glideosome complex. The direction of gliding is indicated. PPM; parasite plasma 
membrane.  
Adhesin	
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years ago (Hegner, 1938). However, P. vivax exhibits high genetic diversity between 
geographical isolates. Moreover, cellular tropism differs greatly between P. vivax 
isolates from ethically different patients, for example patients in Thailand and 
India (Lim et al., 2016). This suggests that the parasite invasion preference is 
influenced by both the parasite and the host genetic background.  	
1.2.8 Merozoite Invasion 
The ability of a free merozoite to invade a host cell is a prerequisite for the 
parasite intra erythrocyte life cycle. Thus, in order to understand the parameters 
that restrict Plasmodium to a particular erythroid age class it is essential to discuss 
the requirements for merozoite invasion. This section will therefore be a discussion 
concerning ligand receptor interactions that facilitate erythroid cell invasion in the 
peripheral blood, with note of interactions that restrict the parasites to 
reticulocyte invasion.  
 
The merozoite is the only extracellular stage of the erythrocytic asexual life cycle, 
having been released from the host cell via parasite-mediated egress. It is 
molecularly primed for re-invasion from this point due to the exocytosis of the 
micronemes. The release of these proteins has been linked to merozoite exposure 
to the low potassium ion concentration in the blood, an event that is speculated to 
trigger the successive activation of protein kinase G (PKG) and the phospholipase C 
(PLC) pathway, resulting in the release of calcium from internal parasite store 
(Taylor et al., 2010; Singh et al., 2010; Farrell et al., 2012; Brochet and Billker, 
2016). However, the contribution of environmental potassium concentrations to this 
model has recently been re-evaluated as evidence exists suggesting that merozoites 
can also invade in high ion concentrations (Badalà et al., 2008).  
 
Merozoite invasion of host cells, first described in the monkey-infective parasite P. 
knowlesi using light microscopy and rudimentary time lapse imaging, is broken 
down into four distinct phases: initial attachment, apical re-orientation, formation 
of the tight/-moving junction and sealing of the parasitophorous vacuole (PV) 
(Figure 1.7) (Hanssen et al., 2013; Dvorak et al., 1975). This process of invasion 
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takes approximately 1 minute from the point of egress and broadly, many of the 
key events and checkpoints are be similar throughout the Plasmodium genius 
(Yahata et al., 2012; Gilson and Crabb, 2009).  
 
 
 
1.2.9 Low Affinity Initial Attachment   
Early electron microscopy studies observed that the merozoite fibrillar coat consists 
of surface proteins (Ladda et al., 1969). Many of these are 
glycosylphosphatidylinositol (GPI) anchored proteins, but a small proportion are 
integral membrane and peripherally associated surface proteins (Figure 1.8 & Table 
1.1). P. falciparum merozoite surface protein 1 (MSP-1) was the first of these 
proteins to be characterised (Perkins and Rocco, 1988) and orthologs have been 
subsequently identified in P. vivax and P. berghei (del Portillo et al., 1991; Babon 
et al., 2007; Jennings et al., 1998).  MSP-1 is expressed during late schizogony as an 
~190 kDa precursor protein. It is initially cleaved into four fragments, through a 
sequence of proteolytic events mediated by the subtilisin- like protease SUB1, 
which remain bound in a non-covalent complex to the parasite surface. Presumably 
this processing event conveys a functional change to the protein that is now 
displayed on the surface of the free merozoite and binds Band 3 on the host 
erythrocyte (Goel et al., 2003). At the point of merozoite invasion the MSP-142 
fragment is cleaved by SUB2 into two additional fragments, the smaller of which 
Figure 1.7 Merozoite invasion is rapid and involves many ligands (adapted from Weiss 
et al., 2016). 1. Initial low affinity attachment. 2a and b. High affinity binding and reorientation. 
3. Formation of the tight junction. 4. The moving junction. 5. Sealing of the PV.			
1. 2a. 2b. 3. 4. 5. 
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(MSP-119) is retained on the parasite surface (Seong-kyun et al., 2016; Holder et al., 
1985; Babon et al., 2007; Holder, 2009).   
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	 					 19 kDa 83 kDa 30 kDa 38 kDa 33 kDa 
42 kDa 
Figure 1.8 Structural domains of merozoite surface proteins (MSP, adapted from Gaur et al., 
2016). MSP-1 is the largest of the MSPs and is proteolytically processed. The first four fragments 
are 83kDa (MSP-183: derived from the N-terminus of the full MSP-1 molecule), 38kDa, 30kDa 
(MSP-138 and MSP-130: central regions) and 42kDa. The latter fragment is then cleaved into 
33kDa and 19kDa (MSP-133 and MSP-119: C-terminus). MSP-119 contains two EGF-like domains 
all except one (MSP-119) is shed during entry into the host cell. A signal peptide is a short 
sequence at the N-terminus that directs the protein towards the secretory pathway. An epidermal 
growth factor domain (EGF) is a secondary amino acid structure and includes 6 cysteine 
residues that form 3 disulfide bonds. The main structure is a two-stranded beta-sheet followed by 
a loop. Tandem repeats typically fold to form a single solenoid domain. A 
glycosylphosphatidylinositol (GPI) domain at the C-terminus acts to anchor proteins to the cell 
surface (Gaur et al., 2016).  
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P. falciparum 
gene 
RBC binding in 
P. falciparum  
Protein function and 
characteristics in P. 
falciparum  
Homolog in P. vivax Homolog in P. berghei  
msp-1 
(Perkins and 
Rocco, 1988) 
Yes. Receptor 
is Band 3.  
(Goel et al., 
2003). 
MSP-1/6/7 binds MSPDBL-
1/2 (Carlton et al., 2008). As 
a complex binds to host 
glycophorin A (Baldwin et 
al., 2015). 
Contains GPI anchor. Two 
EGF domains (del Portillo 
et al., 1991; Babon et al., 
2007). Novel MSP1P 
paralog (Cheng et al., 
2013). 
Contains GPI anchor. Two EGF domains 
(Jennings et al., 1998) 
msp-2 (Clark 
et al., 1989) 
Unknown* Essential, cannot be KO. 
(Cowman et al., 2015; 
Sanders et al., 2006).  
Homolog not present at 
corresponding loci (Black 
et al., 2002). 
Homolog not present at corresponding loci 
(Kedzierski et al., 2000) 
msp-3 
(McColl et 
al., 1994; 
Oeuvray et 
al., 1994) 
Unknown* Mutigene family; 8 paralogs, 
including MSPDBL-1 & 2, 
H101 & 3. Non-essential 
(study didn’t state which 
paralog targeted) (Mills et 
al., 2002). 
multi-gene family. Two 
paralogs;. Lacks GPI 
anchor, alanine-rich 
heptads, leucine-zipper, 
DBL domain (Galinski et 
al., 2001; Jiang et al., 
2013). 
Putative ortholog (Rice et al., 2014). 
msp-4 
(Marshall et 
al., 1997) 
 
Unknown* Non-essential (Sanders et 
al., 2006).  
Surface membrane GPI 
anchored. Single EGF 
domain (Black et al., 
2002). 
A single protein homology to both MSP-4 and 
MSP-5 (Kedzierski et al., 2000). 
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P. 
falciparum 
gene 
RBC binding in P. 
falciparum  
Protein function and 
characteristics in P. 
falciparum  
Homolog in P. vivax Homolog in P. berghei  
msp-5 
(Marshall 
et al., 
1998) 
Unknown* Non-essential (Sanders et 
al., 2006).  
Associated with the 
micronemes.  Single EGF 
domain (Black et al., 
2002).  
A single protein homology to both MSP-4 and 
MSP-5 (Kedzierski et al., 2000) 
msp-6 
(Singh et 
al., 2009) 
Unknown* Member of MSP-3 family. 
Non-covalently binds with 
MSP-1 and MSP-7. 
(Carlton et al., 2008). KO 
studies not published. 
No homolog (Carlton et 
al., 2008) 
Unknown*. Work on MSP-7 KO did not 
investigate relationship (Tewari et al., 2005).  
msp-7 
(Stafford 
et al., 
1996) 
Unknown. Binding 
observed to non-
RBC ligand P-
Selection (Perrin et 
al., 2015) 
Forms a complex with 
MSP-1 and MSP-6 Multi-
gene family. Includes 
MSRP genes 
(Kadekoppala et al., 2010) 
Multi-gene family. No 
reported EGF domains 
(Castillo et al., 2017) 
KO: invasion attenuated. Impaired invasion of 
erythrocytes but not reticulocytes (Tewari et 
al., 2005).  
 
msp-8 
(RMP-1) 
(Black et 
al., 2001) 
Unknown* Not present on the 
merozoite surface.  
Expressed during ring 
stage. Non-essential. 
(Black et al., 2001). 
Surface membrane GPI 
anchored. Smaller protein 
then in P. falciparum 
(Fearon et al., 2015).  
Surface membrane GPI anchored. KO:  Non-
essential.  Highly conserved EGF domains 
between P. falciparum and P. vivax (de 
Koning-Ward et al., 2008; Fearon et al., 
2015). 
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P. falciparum 
gene 
RBC binding in 
P. falciparum  
Protein function and 
characteristics in P. 
falciparum  
Homolog in P. vivax Homolog in P. berghei  
msp-10 
(Black et al., 
2003) 
Unknown* Esential (Sanders et al., 
2006). 
Surface membrane GPI 
anchored. Smaller protein 
then in P. falciparum. Two 
EGF domains (Fearon et 
al., 2015). 
Surface membrane GPI anchored. KO:  
Non-essential   Relatively highly conserved 
EGF domains between P. falciparum and P. 
vivax (Fearon et al., 2015). 
 pf38 
(Sanders et 
al., 2005) 
Unknown* GPI-anchored.  6-cys 
domain (Feller et al., 
2013). 
Located on merozoite 
surface (Mongui et al., 
2008). 
Non-essential (Van Dijk et al., 2010). 
pf92 
(Sanders et 
al., 2007) 
Unknown* 6-cys domain. Essential 
(Sanders et al., 2006).  
Highly conversed N- 
terminal cysteine residues 
(Seong-kyun et al., 2016) 
Unknown* 
 pf41 
(Sanders et 
al., 2005) 
Unknown* Two tandem 6-cys 
domains (Parker et al., 
2015) 
Two s45/48 domains. 6-cys 
domain (Angel et al., 2008) 
Syntenic with P. falciparum (Thompson et 
al., 2001a). 
Stevor 
(Blythe et al., 
2008) 
Glycophorin C 
(Niang et al., 
2014) 
Multi variant gene family  Unknown* Unknown*  
Table 1.1 Characteristic features of parasite ligands that facilitate initial low affinity binding. Asterisk (*) denotes where literature 
could not be found.    
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The refractory nature of pfmsp1 to genetic disruption highlights its essential role 
in host cell invasion (Sanders et al., 2006). Thus it is unsurprising that despite 
being under selection pressures from the host antibody response, the genetic 
sequence of pfmsp-1 contains regions of highly conversed sequence, in particular 
the region containing MSP-119 (Takala and Plowe, 2009). Predictably, many 
invasion inhibiting antibodies bind to MSP-119, with the abundance of anti- MSP-
119 antibodies correlating strongly with P. falciparum malaria resistance in West 
African countries (Branch et al., 1998). Consequently, this fragment has become 
a vaccine target (Ockenhouse et al., 2006).  
 
Additional surface proteins localising to the merozoite surface have been 
identified in P. falciparum, including a number of MSPs, some of which also 
undergo proteolytic-processing and form complexes with MSP-1 (MSP-6&7, MSP-
9)(Baldwin et al., 2015). Many of these identified proteins have homologs in both 
P. vivax and P. berghei. Nonetheless there are structural differences between 
corresponding MSPs homologs indicative of functional differences (Table 1.1). 
This could be a mechanism for the divergent tropisms between the parasite 
species, with the P. vivax and P. berghei MSP homologs binding reticulocytes 
preferentially. Moreover, the corresponding host receptor for the vast number of 
surface proteins has not been identified. As such, the role initial binding plays in 
restricting the parasite to a particular host cell lineage and maturation point are 
under-investigated.  
 
 
1.2.10 High Affinity Binding 
After initial low affinity attachment, the merozoite must re-orientate to bring 
its apical end in contact with the host cell plasma membrane. Live cell imaging 
of merozoites treated with a drug inhibiting the actin-myosin (glideosome) 
motor showed that the motor is not required for apical reorientation (Weiss et 
al., 2015). However, the GPI-anchored merozoite surface coat proteins are only 
attached to the outer leaflet of the parasite plasma membrane. Reorientation 
requires ligands that can span the whole plasma membrane and can associate 
with the parasite cytoskeleton (Weiss et al., 2016).  
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High affinity binding between the apical end of P. falciparum merozoites and 
the host cell is mediated by proteins from two families: the erythrocyte-binding 
antigens (EBA) [also known as erythrocyte-binding ligands: EBL] and the 
reticulocyte-binding protein homologues (PfRH family). The availability of the 
complete P. falciparum genome has indicated that EBA family consists of the 
functional proteins: EBA-175, EBA-181 (as known as JESEBEL), EBA-140 (BAEBL) 
and EBA-1 (Figure 1.9). The PfRH family consists of the functional proteins: 
PfRH1, PfRH2a, PfRH2b, PfRH4 and PfRH5 (Figure 1.10). Singh et al (2010) 
observed that the binding of an EBA (EBA-175) protein to its corresponding host 
receptor restores the cytosolic calcium levels to basal levels, triggering the 
release of PfRH proteins from the rhoptry neck (Weiss et al., 2016). Nonetheless, 
there is evidence that the release of the rhoptry neck proteins occur in a more 
staggered and sequence manner. Antibodies against PfRH1 block the surface 
localisation of EBA-175 and subsequent invasion, thus indicating that at least one 
PfRH protein is released prior to EBA-175 binding (Gao et al., 2013).  
 
	
Figure 1.9 Secondary domains of EBA proteins (Howell et al., 2006).  F1 and F2 are 
the two Duffy binding like (DBL) domains. This domain derives its name from its homology 
to the domains of the P. vivax ligand that binds the Duffy antigen receptor. TM is the trans 
membrane domain; c-cys is the C terminal cysteine rich domain; sig is the signal 
sequence.  		
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The irreversible, stable binding mediated by the EBA and PfRh proteins indicates 
that the attachment of these adhesins to their erythrocyte receptors commits 
the merozoite to invasion (Figure 1.11). Evidence has also been presented that 
indicates apical adhesin binding is somewhat of a ‘starting pistol’ for erythrocyte 
invasion and the sequential downstream events take place without any further 
checkpoints ensuring co-ordination or successful execution (Riglar et al., 2011, 
2015). Secretion of rhoptry bulb proteins has been observed during the inhibition 
of moving junction formation leading to the organelles contents being 
erroneously discharged onto the erythrocyte surface (Treeck et al., 2009).  
 
c 	c 	
Figure 1.10 Secondary domains of PfRH proteins (Gaur et al., 2016). Orange are the 
erythrocyte binding domains (EBD). This domain contains a high alpha helical content 
reflective of DBL domains. Not marked here are the nucleotide binding region that is in close 
proximity to the EBD (Grüber et al., 2011).  The C-terminus is on the right hand side; the N-
terminus is on the left. The former contains a trans-membrane domain and the latter a signal 
peptide. Pfrh5 does not have a transmembrane domain, instead it is held at the merozoite 
surface by PfRipr. Yellow and red are the sequence difference between PfRH2a/b. Green 
are EGF domains (Weiss et al., 2016). 
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1.2.11 Transcriptional Regulation  
Transcriptomics and proteomics investigations have observed differential 
patterns of expression for the functional members of the eba and pfrh gene 
families between laboratory strains originally isolated from different global 
locations (Gaur and Chitnis, 2011). The first evidence for variegated expression 
in P. falciparum was obtained from two studies which identified that pfrh2a and 
pfrh2b were transcriptionally silent in certain long term clonal culture adapted 
parasite lines, but not in others despite all strains containing both genes intact 
within their genome (Taylor et al., 2002). The cohort of ligands expressed 
together defines what is called the parasite’s ‘invasion pathway’.  
 
The invasion pathways have been characterised based on the chemical 
properties of the host receptors required to achieve invasion (Figure 1.11).  The 
‘invasion pathway’ of a particular parasite can be phenotyped as either sialic 
acid dependent or independent through the use of erythrocytes which are 
BSG	Band	4.1
	
Figure 1.11 Ligand receptor binding (Tham et al., 2012). Resistance (R) or sensitivity (S) of 
a ligand-receptor interaction to enzyme treatment (neuraminidase; chymotrypsin; trypsin) is 
indicated in the bottom part of the diagram. EBA-175 and EBA-140 bind to Glycophorins A 
and C respectively in what is considered a sialic acid-dependent manner due to the sialic acid 
residues attached to the O-linked oligosaccharides. Likewise, EBA-181 (receptor band 4.1), 
EBA-1 (binding Glycophorin B), PfRH2a/b (binding Receptor Z), and PfRH1 (unknown 
receptor Y) all bind to the erythrocyte in a sialic acid-dependent manner. PfRH4 (binding CR1) 
and PfRH5 (binding BSG; Basigin) both bind to the host cell in a manner considered to be 
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depleted of certain classes of host receptors. Classically this has been achieved 
through treatment of the host cells with particular enzymes. The three most 
common treatments use the enzymes neuraminidase (removes sialic acid from 
glycophorins), trypsin (cleaves glycophorin A and glycophorin C) and 
chymotrypsin (cleave glycophorin B). Such experiments classify a parasites 
invasion pathway broadly as either sensitive (cannot invade) or resistant (can 
invade). Sensitivity to neuraminidase characterises a parasite strain’s invasion 
pathway as sialic acid-dependent, whereas, resistance to this treatment 
indicates a sialic acid-independent invasion pathway. (Cortés, 2008; Tham et al., 
2012).  
 
The variant expression patterns of eba and pfrh have hallmarks of epigenetic 
regulation, a bistable and consequently reversible mechanism that governs 
phenotypes without genomic editing. The P. falciparum genome is 22.9 Mb in 
size and organised across 14 chromosomes (Gardner et al., 2013) with a high 
proportion maintained as euchromatin (open/ accessible chromatin). However, 
regions of heterochromatin (inaccessible chromatin) have been reported to 
stretch from telomeres to subtelomeric domains, which, incidentally are the 
location of the eba and pfrh genes (Weber and Henikoff, 2014; Duffy et al., 
2014; Gardner et al., 2002). The heterochromatin maintains clusters of silenced 
genes through an increased presence of histone-packed nucleosomes governed 
by associated post-translation modifications and histone tail binding proteins 
such as canonical heterochromatin protein 1 (HP1) (Weber and Henikoff, 2014; 
Duffy et al., 2014; Flueck et al., 2009). Various histone tail modifications have 
been identified in the parasite, with 88 of them being unique to Plasmodium 
(Saraf et al., 2016). Various epigenetic modulators catalysing the removal or 
addition of histone tail marks also have been identified in Plasmodium (Volz et 
al., 2010). Plasmodium contains only a single HP1 protein that localises primarily 
to the trimethylation lysine 9 of histone 3 (H3k9me3) mark and in turn recruits 
methyltransferases that modify adjacent nucleosomes, thus self-perpetuating 
heterochromatin spread (Lomberk et al., 2006).   
  
Alongside the four canonical histones (H1-4) Plasmodium also expresses four 
variants: PfCenH3, PfH3.3, PfH2A.z and PfH2B.z (Duffy et al., 2014). These 
variants presumably have evolved to provide unique transcription regulation that 
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facilitates the transient and temporal expression of all stage specific open 
reading frames throughout the parasite life cycle. Supporting this, the PfH2A.z 
and PfH2B.z variants are enriched at the 5’ UTRs of genes expressed during the 
blood stage development (Bártfai et al., 2010; Hoeijmakers et al., 2013). The 
covalent modification of histone protein tails is a stable mechanism of heritable 
epigenetic transcriptional regulation. The histone tails undergo a number of 
posttranslational modifications that interact with DNA cytosine (me5C) 
methylation, which, by broad definition, regulate the bistable compact structure 
of chromatin, thus controlling the physical accessibility of DNA to transcriptional 
regulators (Jin et al., 2011). A chromatin immunoprecipitation (ChIP) study on a 
parasite line that expresses pfrh4 during merozoite invasion showed that the 
transcriptional regulation of this gene is sequentially controlled by the removal 
of the silencing H3k9me3 mark and the addition of the activating acetylation 
during schizont maturation (H3K9ac) (Jiang et al., 2010). The low GC content of 
the Plasmodium genome was an impediment to early investigations into the 
parasite me5C content. Nonetheless, a recent study coupling the bisulfite 
conversion of unmethylated cytosines with high throughput sequencing 
generated a genome wide map of P. falciparum me5C (Ponts et al., 2013).  
 
As discussed, the malaria parasite nucleus is a heterogeneous organelle 
containing multiple active and silent chromatin domains. Studies of the 
incorporation of 5-bromo-uridine 5’-triphospate (BrUTP) in mammalian cells 
showed that transcription occurs at discrete foci throughout the nucleus (Iborra 
et al., 1996). The same is true for Plasmodium. Active genes are preferentially 
localised to transcriptionally permissive regions containing the histone tail-
modifying enzymes and DNA methylases, whereas silent genes group outwith this 
region in perinuclear repressive subtelomeric clusters (Coleman et al., 2012). 
The telomeric sequences tether chromosomes to the perinuclear region in these 
clusters through interactions between telomere-associated repeat elements 
(TAREs) and additional uncharacterised proteins (Duffy et al., 2016). Coleman et 
al (2012) showed that pfrh4 clusters within the repressive perinuclear regions 
within clonal parasites that do not express it. Activation of pfrh4 could be 
forced in these parasites by the expression of an adjacent transgene, thus 
forcing recruitment of this chromosomal region to an active site.  For a silenced 
gene to be activated it could either leave the subtelomeric cluster and move to 
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the active site as a solitary chromosome (Mok et al., 2008), or form an active 
site in situ (Marty et al., 2006), evidence exits to supporting both theories 
(Figure 1.12). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.2.12 Functional Redundancy  
Genetic disruption studies have shown the variantly expressed invasion ligands 
are largely functionally redundant, with the loss of any given ligand being 
compensated by transcription and utilisation of an alternative ligand-receptor 
interaction (Duraisingh et al., 2003; Gunalan et al., 2011). It has been observed 
that high pfrh1 expression negatively correlated with the expression of pfrh2a/b 
implying overlapping function in invasion and consequently, functional 
Subtelomeric	gene		
Figure 1.12 Subtelomeric multi gene family silencing and activation (Ralph et al., 2005). 
Inactive genes cluster within subtelomeric clusters (left hand side; silent) associated with the 
nuclear membrane. Circles associated with the nuclear membrane represent telomere ends. 
Rectangles represent subtelomeric genes; lines protruding from rectangles represent the rest 
of the chromosome. Red rectangle represents subtelomeric gene about to be/ being 
transcribed.  Several mechanisms of activation have been proposed. A. in situ recruitment of 
machinery for activation (red) telomeric gene.  B and C activation of (red) gene after moving 
from the cluster. This can either be away from the nuclear membrane periphery (B) or 
remaining at the nuclear periphery but disassociating from the cluster (C). 
Nuclear	membrane	
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redundancy within the PfRh family (Duraisingh et al., 2003; Nery et al., 2006). 
Moreover, overlapping function does not exclusively reside within a gene family; 
there is evidence to indicate functional compensation between eba and pfrh 
genes (Stubbs et al., 2005). Stubbs et al (2005) observed an increased expression 
pattern for PfRH4 when eba-175 was genetically disrupted. Interestingly, PfRH5 
is not only structurally distinct from the other proteins in its family, it is also 
ubiquitously expressed and functionally essential among all laboratory strains 
(Weiss et al., 2016). 
 
Interestingly, simultaneous genetic disruption of the three genes eba-175, pfrh4 
and pfrh2b produces a nonviable parasite line in any laboratory parasite strain 
tested. The refractory nature of the triple knockout is highly indicative of a 
minimal requirement in ligand-receptor complement for invasion (Tham et al., 
2012). Moreover, antibodies reactive with specific EBA and PfRH proteins inhibit 
invasion, thus indicating that each specific ligand in any given cohort of 
temporally expressed ligands is essential for invasion (Table 1.2).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ligand Genetic disruption  	
EBL-175 (Lee et al., 
1990) 
KO. Non essential 
(Lopaticki et al., 2011) 
	
EBL-1 (Peterson 
and Wellems, 2000) 
Not expressed in some 
clonal lines (Lopaticki et 
al., 2011) 
	
EBA-140 
(Thompson et al., 
2001b) 
KO. Non essential 
(Lopaticki et al., 2011) 
	
EBA-181 (Gilberger 
et al., 2003) 
KO. Non essential 
(Lopaticki et al., 2011) 
	
PfRH 1 (Rayner et 
al., 2001) 
KO. Non essential (Gao et 
al., 2008) 
	
PfRH 2a (Rayner et 
al., 2000) 
KO. Non essential 
(Duraisingh et al., 2003) 
	
PfRH 2b (Rayner et 
al., 2000) 
KO. Non essential 
(Duraisingh et al., 2003) 
	
PfRH 4 (Kaneko et 
al., 2002) 
KO. Non essential (Reiling 
et al., 2012) 
	
PfRH 5 (Kaneko et 
al., 2002) 
Cannot be disrupted 
(Baum et al., 2008)  
	
Table 1.2 Genetic disruption of EBA and PfRH proteins  
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1.2.13 P. vivax Alternative Invasion Pathways  
Whilst the literature is conspicuously silent in terms of studies on P. berghei 
merozoite invasion ligands, a protein (PBANKA_1332700) was identified in a 
proteomic and transcriptomic study containing a Duffy binding domain (Hall et 
al., 2005). In contrast, P. vivax has been highly characterised as containing the 
Duffy binding protein (DBP) paralogs and the reticulocyte-binding proteins (RBPs) 
(Menard et al., 2013; de Sousa et al., 2014). The formation of irreversible 
merozoite attachment is mediated by PvDBP, a microneme protein that is 
related to P. falciparum EBA protein family, binding to the Duffy blood group 
antigen (Figure 1.13). As such, Duffy binding was believed to be essential for P. 
vivax invasion. This was supported by the discovery of a second Duffy-dependent 
ligand, antigenically distinct from PvDBP, the erythrocyte binding protein (EBP2) 
that binds exclusively to reticulocytes (Ntumngia et al., 2016). Moreover, studies 
in the monkey-infective parasite P. knowlesi, showed that genetic disruption of 
the PvDBP homolog prevented merozoite invasion (Singh et al., 2005). This 
species is evolutionarily related to P. vivax and relies exclusively on the Duffy 
receptor for invasion of human erythrocytes in vitro. However, P. knowlesi can 
invade rhesus monkey erythrocytes in a Duffy-independent manner (Paul et al., 
2016). Recent work has identified that the PvRBP family contains 11 paralogs, 
two of which (PvRBP1a and PvRBP2a) can also bind independently of the Duffy 
antigen (Figure 1.14) (Li and Han, 2012; Galinski et al., 1992; Han et al., 2016). 
Moreover, the qPCR analysis of different P. vivax Thailand isolates demonstrated 
a high variation in PvRBP expression (Hietanen et al., 2016). Taken together this 
suggests that additional Plasmodium species can achieve invasion via an 
alternative pathway reflective of the multiple invasion pathways exhibited by P. 
falciparum 
 
 
Figure 1.13 Secondary domains of DBP proteins (Howell et al., 2006). DBL is the Duffy 
binding like domains. TM is the trans membrane domain; c-cys is the C terminal cysteine 
rich domain; sig is the signal sequence. Note the difference between P. falciparum EBA 
and this DBP: this protein contains only one DBL domain.  
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Figure 1.14 Secondary domains of the PvRBP proteins (Li and Han, 2012). White 
region; signal peptide. Dark blue region; trans membrane domain. Light blue region; 
internal repeat region. Pink domain; reticulocyte binding domains. Green region: 
ribosomal protein S1-like RNA-binding domain.  	
1.2.14 Confining P. vivax to Reticulocytes  
Although P. vivax lacks an obvious homolog to the essential and ubiquitous PfRH5 
ligand, analysis of the PvRBP2a crystal structure showed structural conservation 
with that of the PfRH5 scaffold (Gruszczyk et al., 2016).  Although the invasion 
pathway of PvRBP2a was characterised as different to the host receptor of 
PfRH5, the authors noted that PvRBP2a could bind equally to erythrocytes and 
reticulocytes (Gruszczyk et al., 2016). The erythrocyte-binding domain of 
PvRBP1a has been identified as a homologous region to PfRH4, suggesting that 
they may share a common host receptor, the complement receptor 1 (CR1) (Han 
et al., 2016). CR1 is present on both erythrocytes and reticulocytes (Gruszczyk 
et al., 2016), nonetheless, Han et al (2016) observed a significantly higher 
binding activity of PvRBP1a to reticulocytes compared with erythrocytes. 
However, Han et al (2016) based their assessments on the expression of only the 
putative functional domain of PvRBP1a, whereas a contemporary study that 
attributed significant erythrocyte binding to PvRBP1a used the whole protein 
(Franca et al., 2016). The Duffy binding protein PvDBP, has been identified as 
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having a significant reticulocyte binding preference (Han et al., 2016). This may 
be reflective of the decrease in Duffy abundance during reticulocyte to 
erythrocyte maturation (Liu et al., 2010). Taken together, it can be suggested 
that the P. vivax expressed cohort of invasion ligands defines parasite cellular 
tropism. However, it could also be suggested that the phenotype of the host cell 
supplies a selection pressure in terms of the cohort of invasion ligands the 
parasite expresses.   
 
1.2.15 Host Genotype Influencing the Tropism of P. vivax   
Efforts to identify host determinants for Plasmodium invasion have been 
hindered by the absence of a nucleus in peripheral blood erythrocytes and 
reticulocytes. This precludes direct genetic manipulation of these maturation 
stages. Nonetheless, aberrant erythrocyte receptor phenotypes and additional 
polymorphisms that confer resistance to malaria have been identified through 
epidemiological studies (Network, 2015). For example, the West African centric 
polymorphisms in the Duffy blood group antigen overlaps with the geographical 
low prevalence of P. vivax (Gething et al., 2012). The monogenic Duffy antigen 
(FY) exhibits two main co-dominant alleles known as Fya and Fyb, the result of a 
single point mutation swapping glycine to asparagine within the protein. These 
alleles combine as four erythrocyte phenotypes; Fya+b+, Fya-b+, Fya+b-, Fya-b-. 
The latter phenotype is the result of disruption within the Fy promoter region 
thus preventing transcription (Howes et al., 2011). Recent mapping of the global 
distribution of the mutated promoter revealed a 90% fixation of this allele within 
sub-Saharan Africa, with a 98-100% frequency of the homozygous Duffy negative 
phenotype (Figure 1.15) (Howes et al., 2011).  
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Figure 1.15 Global distribution of homozygous Duffy negative phenotype (MAP, 
2015). Key displays the estimated percentage of the population (country) effected at any 
given time during 2010.  
 
Unsurprisingly, due to the previous discussion concerning alternative invasion 
pathways, Duffy negative individuals have been observed to be infected with P. 
vivax in Africa. What is surprising though, is that genetic screens have attributed 
this parasite invasion phenotype to copy number variations in the PvDBP 
(Gunalan et al., 2016; Pearson et al., 2016; Hostetler et al., 2016), paralogs that 
were later shown to bind in only a Duffy-dependent manner (Gunalan et al., 
2016). The absence of transcriptional studies on these isolates is probably the 
reason that their Duffy negative invasion phenotype has not been discussed in 
the context of the variant expression of the PvRBP family (Gunalan et al., 2016; 
Pearson et al., 2016; Hostetler et al., 2016). Exasperatingly the reports also lack 
a description of whether these parasites are invading reticulocytes or 
erythrocytes.  
 
Nevertheless, studies investigating the reticulocyte preference of P. vivax 
isolates from India noted high erythrocyte invasion (Lim et al., 2016). The most 
frequent Fy allele in this region is Fya (Howes et al., 2011). The homozygous 
expression of Fya has been observed to decrease P. vivax binding by 50% 
compared to Fyb (King et al., 2011). Thus it is tempting to conclude that the 
host FY phenotype is exerting a selection pressure on the parasite to invade 
using a PvRBP pathway, which culminates in parasitisation of erythrocytes.  
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1.2.16 Host Genotype and P. falciparum Invasion  
Naturally occurring host receptor polymorphisms, such as Basigin Ok(a-) variants 
and glycoprotein null cells, have also been used to determine the specificity of 
ligand binding and how essential particular interactions are to invasion by P. 
falciparum (Bei and Duraisingh, 2012). However, unlike the FY phenotypes, such 
polymorphisms are rare and are as such unlikely to be under balancing selection 
by regional Plasmodium infection rates. A recent large scale knockdown study 
genetically manipulated the nucleated erythrocyte precursor cells of human 
blood in vitro and identified the glycophorin proteins as non-essential for P. 
falciparum invasion (Egan et al., 2015). As such, there would be no selective 
advantage for the glycophorin null cell phenotypes in malaria endemic regions. 
During this large scale knockdown, Egan et al (2015) also identified a host 
receptor that had not previously been implicated in P. falciparum invasion. The 
screen observed that multiple laboratory strains and field isolations could not 
infect CD55-/- cells, nonetheless, the corresponding parasite ligand is yet to be 
identified (Egan et al., 2015).  
 
Intriguingly, it has been shown in P. falciparum that the EBA and PfRH proteins 
mediating attachment of merozoites to an erythrocyte induce the local 
phosphorylation of the host cell cytoskeleton (Zuccala et al., 2016). In 
circulation, the host erythrocyte is subjected to large shearing forces, and as 
such, the cell has unrestricted deformability in order to prevent structural 
damage. The biochemical dimerisation and disassembly of spectrin, a protein 
that lies under the plasma membrane, facilitates cellular distortion (An et al., 
2002). Antibodies targeting the EBA-175 receptor GPA have been shown to 
decrease the erythroid cells deformability due to increased cross-linking 
between the cytoskeleton and the receptor cytoplasmic tail (Chais et al., 2011; 
Koch and Baum, 2015). In stark contrast, PfRH4 binding to the CR1 receptor 
triggers phosphorylation of spectrin decreasing membrane stability (Glodek et 
al., 2010). Although it remains unclear how changes to the spectrin cytoskeleton 
that increase rigidity would facilitate invasion, it is clear that surface ligand-
receptor interactions trigger internal processes in the host cell altering its 
biophysical architecture (Koch and Baum, 2015).  
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1.2.17 Moving Tight Junction 
Once apical re-orientation is complete (Figure 1.16), the rhoptry neck (RON) 
protein complex is discharged and implanted into the erythrocyte so that apical 
membrane antigen 1 (AMA1) can lock with it and form a tight junction. The tight 
junction is a ring of direct association between the invading parasite and host 
membrane. There is evidence that the trigger for RON secretion is PfRh5 binding 
in P. falciparum. Antibodies against this parasite ligand block invasion at a point 
after apical reorientation (Weiss et al., 2015).  
 
Although it is possible that the RON complex proteins associate with a host cell 
receptor to provide anchorage, this has not been shown experimentally. 
However, there is indirect evidence that AMA1 forms an association with the 
host’s Kx protein (Kato et al., 2005). Kato et al (2005) showed that 
recombinantly expressed AMA1 could bind wild type erythrocytes but not Kx -/- 
cells. This interaction may define the localisation of the tight junction on the 
erythrocyte surface (Satchwell, 2016).  Nonetheless, there is strong but 
controversial evidence that the AMA1 interaction with the RON complex is not 
essential for tight junction formation and that this complex, when formed, is not 
involved in transduction of the force generated by the glideosome (Bargieri et 
al., 2013). In contrast, the microneme-secreted merozoite thrombospondin-
related anonymous protein (MTRAP), a transmembrane protein, has been 
identified as an essential bridge between the actin-myosin motor and the 
extracellular surface. The mtrap gene is conserved and syntenic among 
Plasmodium species (Baum et al., 2006). Its essential contribution to merozoite 
invasion was illustrated by unsuccessful attempts to genetically disrupt it (Baum 
et al., 2006). The host receptor for MTRAP is believed to be Semaphorin 7a 
(Bartholdson et al., 2012) 
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Figure 1.16 Formation of the tight and moving junction (Ahouidi et al., 2016). A. 
Merozoite re-orientation is associated with ligand-receptor binding. B. The secretion of 
MTRAP, a protein associated to the glideosome, and its binding to its host receptor allows 
the parasite to move into the host cell.  
 
1.2.18 The Parasitophorous Vacuole 
The invasion event places the parasite within a parasitophorous vacuole (PV), 
the membrane of which (PVM) is derived from the host plasma membrane. 
(Dluzewski et al., 1992). The PVM forms a significant barrier to the uptake of 
nutrients or the export of parasite-derived proteins, although one parasite 
protein EXP2, is thought to be involved in both processes. This protein was 
initially characterised as localising to the PVM and being expressed throughout 
the entire intra-erythrocytic lifecycle (Fischer et al., 1998). Genetic disruption 
experiments in the Apicomplexa parasite, Toxoplasma gondii, targeting the EXP2 
ortholog, GRA17, showed that the PV of GRA17 null parasite was impermeable to 
fluorescent solutes that can diffuse into the PV of wild type parasite (Gold et 
al., 2016). This suggested a role for EXP2 in forming a pore in the PVM (Figure 
1.17). In contrast to nutrient uptake, export of parasite derived proteins is 
mediated by a protein complex called the Plasmodium translocon of exported 
proteins (PTEX)(Sherling and van Ooij, 2016). Recent work has shown that 
improperly folded exported proteins jam EXP2 suggesting that this protein is the 
central translocation channel for exported proteins (Mesen-Ramirez et al., 
2016). Interestingly, data exists suggesting that the localisation of the PTEX to 
the PVM varies according to host cell. The PTEX and EXP2 of P. falciparum and 
P. berghei parasitised reticulocytes were partially located outside of the PVM in 
vesicles (Meibalan et al., 2015). Although these structures have been linked to 
A. B. 
Introduction	 	 		 33	
the relatively heightened nutrient contents of the reticulocyte compared to 
erythrocytes, a functional role in parasite metabolism has yet to be assigned to 
them.   
 
 
 
 
 
 
 
 
Figure 1.17 The EXP2 pore in the PVM. Simplified schematic of the proposed 
mechanism of PTEX mediated protein export and nutrient uptake. After being desposited 
into the PV, proteins destined for export cross the PVM via the EXP2 channel in 
association with the PTEX complex (Sherling and van Ooij, 2016).   
 
1.2.19 Intracellular Life Cycle  
The asexual life cycle of both P. falciparum and P. vivax is completed in 48 
hours (hrs) from the point of invasion to the point of egress, whereas, murine 
infective P. berghei has a life cycle duration of 22-24 hrs. Initially, within the 
erythrocyte, the parasite takes on a flattened ring morphology, before morphing 
into an engorged, rounded trophozoite after which the multiply-nucleated 
schizont breaches the host cell releasing invasive merozoites (Bannister et al., 
2000).  
 
During development, the parasite exports 8% of its predicted proteome (400 
proteins) to the host cell, 25% of which are essential to parasite survival (de 
Koning-Ward et al., 2016). Proteins such as the ring-infected erythrocyte surface 
antigen (RESA) become associated with the host’s cytoskeleton and others, such 
as the P. falciparum erythrocyte membrane protein 1 (PfEMP1) protein family, 
are inserted into the host cell plasma membrane (Da Silva et al., 1994; Kriek et 
al., 2003). These proteins are tracked through the PTEX via the inclusion of the 
pentameric Plasmodium export element (PEXEL) (Mesen-Ramirez et al., 2016). 
Nonetheless, a number of exported proteins, such as the PfEMP1, are PEXEL 
Erythrocyte cytosol PV PVM 
Protein export. 
Nutrients uptake 
EXP2 
PTEX 
complex 
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negative and instead contain an internal transmembrane segment or N-terminal 
signal sequence that functions as an endoplasmic reticulum target and license 
for export (de Koning-Ward et al., 2016). A prominent feature of parasite 
protein export is the creation of an exomembrane, a system strongly 
characterised by the Maurer’s clefts. These structures are closed cisternal 
compartments that are formed by the parasite within the host cytosol soon after 
invasion. Maurer’s clefts are believed to act as a depot and chaperone for 
parasite proteins that are exported to the host membrane (Lanzer et al., 2006; 
de Koning-Ward et al., 2016). The structure is also associated with resident 
proteins, such as the PfEMP1 trafficking protein 1 (PTP1). During P. falciparum 
asexual development, the host erythrocyte membrane also becomes distorted 
with knob-like protrusions (Rug et al., 2014). These structures are created by 
the exported knob-associated histidine-rich protein (KAHRP) forming links with 
the erythrocyte cytoskeleton (Watermeyer et al., 2016). Host membrane 
remodeling decreases the deformability of the erythrocyte. Additional structural 
modifications have also been implicated in decreased deformability. Atomic 
force microscopy observed that the host’s erythrocyte spectrin-actin 
cytoskeleton expands as the asexual parasite matures (Shi et al., 2013; 
Millholland et al., 2011). The parasite also seems to mine the host actin from 
the erythrocyte cytoskeleton junction points, redistributing it between the 
Maurer’s cleft and the knob structures (Zhang et al., 2015). Moreover, 
Plasmodium conveys novel channel activity to the infected cell through 
formation of new permeation pathways that increase membrane conductance 
and induce uptake of small molecules, such as sugars and amino acids, used by 
the parasite for rapidly generating biomass (Decherf et al., 2004). Currently, the 
only characterised component of this pathway is cytoadherence-linked asexual 
gene 3 (CLAG3) (de Koning-Ward et al., 2016).  
 
Interestingly, P. falciparum can establish infection within erythrocytes with 
mutations that reduce the host cells basal deformability (Boctor and Dorion, 
2008; Muley et al., 2011; Makani et al., 2017). A comparison of P. falciparum in 
vitro growth within erythrocyte with the sickle cell or the wild type phenotype 
concluded that proliferation is dependent on oxygen availability rather than host 
cell rigidity (Orjih, 2005). It should be noted that the sickle cell mutation 
prevents the parasite actin remodeling of the host cell, thus preventing P. 
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falciparum displaying its adhesion proteins (Cyrklaff et al., 2010). Taken 
together, it would seem that the parasite growth and intra-erythrocyte survival 
is not dependent on initial erythroid cell deformability.  
 
The parasite genome encodes for a complete de novo heme biosynthesis 
pathway (Sigala et al., 2015). However, genetic knock-out studies have shown 
the pathway is redundant during blood-stage infection, suggesting that the 
parasite can adequately scavenge host heme (Ke et al., 2014). From later ring 
stages, the parasite endocytoses large quantities of the host cell cytosol in order 
to digest the erythrocyte haemoglobin in an acidic compartment called the 
digestive vacuole. Excess heme, which is toxic to the parasite, is biomineralised 
into non-toxic hemozoin  (Figure 1.18). Nonetheless, the fact that the pathway 
is essential for all other parasite life stages (Ke et al., 2014) highlights three 
things: firstly, the pathway is truly functional; secondly, heme is essential to 
metabolism at all stages; and thirdly, as the parasite can synthesise heme de 
novo, developing within a cell expressing hemoglobin is not a prerequisite to 
survival. This is interesting in the context of recent work that suggested that 
asexual blood stage Plasmodium could replicate within dendritic cells (Wykes 
and Horne-Debets, 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.18  Heme metabolism (Sigala et al., 2012). Intra-erythrocyte parasite (white) 
generates heme by either degradation of host hemoglobin in the food vacuole (digestive 
vacuole), or by de novo biosynthesis co-ordinated between the mitochondria, apicoplast 
and cytosol. The mitochondria and the apicoplast are both symbiogenic organelles, with 
the apicoplast defining the phylum of Apicomplexa.  
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1.2.20 Sequestration of Plasmodium 
Maturing trophozoites are the point in the parasite life cycle that the 
pathogenesis of P. vivax and P. falciparum malaria was classically believed to 
diverge. From this stage onwards P. falciparum is absent from peripheral blood 
(Carvalho et al., 2010). This is attributed to the ability of the parasite to 
sequester in the small blood vessels of organs. This is a cellular characteristic 
shared with P. berghei schizonts, although in this species the parasite-expressed 
proteins mediating cytoadherance remain undefined (Franke-Fayard et al., 2010, 
2005). Recently, the low prevalence of circulating P. vivax schizonts lead 
researchers to postulate that this species also sequesters (Lim et al., 2016).  
 
By the 1980’s the proteins from the P. falciparum erythrocyte membrane protein 
1 (PfEMP1) family were described to mediate the sequestering of the parasite by 
binding to multiple host receptors (Berendt et al., 1989; Udeinya et al., 1983). 
These parasite ligands are encoded by the diverse var multigene family that are 
mutually exclusively expressed (Baruch et al., 1995; Smith et al., 1995). There is 
some evidence that more than one var gene can be expressed at one time in a 
single cell (Joergensen et al., 2010). The same var gene(s) is transcribed from 
the immature trophozoite over many generations, but the parasite can switch to 
expression of a different var gene(s) therefore altering binding specificity and 
causing clonal antigenic variation (Duffy et al., 2016).  
 
1.2.21 Epigenetic Expression of var Genes 
The expression of var genes, like the invasion ligands, is regulated by epigenetic 
mechanisms. Silencing is associated with the enrichment of H3K9me3 and 
subteleomeric clustering at peri-nuclear locations, whilst enrichment in H3K9ac 
at 5’UTR is associated with transcriptional activation (Duffy et al., 2016). 
Moreover, the active var gene is transiently repressed in the mature 
trophozoite, an event associated with enrichment in H3K4me2 at the 5’UTR. This 
histone modification has been linked to epigenetic memory as the transiently 
repressed var gene is activated in the subsequent life cycle (Lopez-rubio et al., 
2007; Duffy et al., 2016).    
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1.2.22 Diversity in the Genetic Sequence and Primary Structure  
The var genes (approx. 60 prologs within the P. falciparum 3D7 genome) are 
divided into groups based on chromosomal location, upstream promoter 
sequence and transcriptional direction (Rovira-Vallbona et al., 2011).  Group A, 
Group B and chimeric Group B/A var genes are located at subtelomeric regions 
of all chromosomes, but are transcribed in opposite directions (Claessens et al., 
2014). Group C and chimeric Group B/C genes are found typically at internal 
regions on chromosomes 4, 7, 8 and 12 (Claessens et al., 2014). There is a single 
member of Group E vars called var2csa (Rovira-Vallbona et al., 2011).  
 
The var genes contain two exons. Exon 1 encodes the extracellular part of the 
protein, whilst exon 2 encodes the trans membrane and intra-cellular segment. 
Exon 1, in contrast to Exon 2, is very genetically diverse leading to high inter 
and intra clonal variability between PfEMP1 protein primary structures (Rovira-
Vallbona et al., 2011). Claessens et al (2014) was the first to show, using genetic 
crosses and whole genome sequencing of the cloned parental and prodigy lines, 
that var genes within groups B and C undergo ectopic recombination at a higher 
rate than any other region in the P. falciparum genome. The authors also 
observed that the greatest rates of recombination occurred during asexual 
mitosis. As such, they proposed a model whereby var gene diversity is generated 
during the asexual life cycle, while later meiosis events generate a new, 
although similar, repertoire of var genes derived from both parents (Claessens et 
al., 2014). Recombining var genes have low levels of sequence homology, thus 
the process is unlikely to be controlled by homologous recombination. Instead, 
subtelomeric clustering has been proposed as a mechanism of co-localising var 
genes from different regions in order to facilitate ectopic recombination 
(Claessens et al., 2014).  
 
1.2.23 Conserved Secondary Domain Cassettes 
The first exon of the var genes encodes a secondary structure containing a N- 
terminal segment followed by a succession of DBL and cysteine rich inter-domain 
regions (CIDR) domains (Claessens et al., 2014). The DBL and CIDR domains are 
subdivided into six and four major classes, receptively (Figure 1.19) (Smith et 
al., 2000). The architecture of these domains is preserved during the ectopic 
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recombination between subtelomeric var genes that fuels inter and intra clonal 
diversity (Claessens et al., 2014).  
 
The different domain cassettes bind to different host receptors within a limited 
pool of specificity (Figure 1.19). All parasites seem to have the same 
fundamental repertoire of host receptor specificities (Mkumbaye et al., 2017).  
The group E VAR2CSA protein binds to placental chondroitin sulfate on 
chondroitin sulfate proteoglycans in the placenta syncytium. There is a clear link 
between this sequestration pattern and placental malaria in pregnant women 
(Pereira et al., 2016). As such, a number of studies have sought to correlate 
additional parasite sequestration patterns with disease outcome in paediatric 
malaria (Janes et al., 2011). While observations indicate that severe malaria 
pathology is associated with a limited number of antigen variants, this still 
remains relatively less established compared with pregnancy related malaria. 
(Janes et al., 2011; Nielsen et al., 2002). This may reflect acquisition of  
immunity to severe malaria following infection by a limited range of antigen 
variants associated with severe disease (Gupta et al., 1999). Moreover, sero-
epidemological and var transcriptional studies have suggested that group A 
variants are more represented in isolates taken from African patients with 
severe malaria (Janes et al., 2011).  
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To date most P. falciparum sequestration studies have focused on PfEMP1, 
however the gene families of repetitive interspersed family (rif) and the 
subtelomeric variant open reading frame (stevor) proteins also play a role. The 
rif genes encode the second largest variant surface antigen protein family in the 
P. falciparum genome (Goel et al., 2015). These proteins are expressed on the 
surface of asexual infected erythrocytes and mediate PfEMP1 independent 
rosetting, thus contributing to microvascular obstruction (Goel et al., 2015). The 
rif proteins (RIFIN), like PFEMP1 and STEVOR proteins are localised to Maurer’s 
Figure 1.19 PfEMP1 structure and var gene groupings (Claessens et al., 2014; 
Hviid and Jensen, 2015). A. schematic of var gene, exon 1 translated as PfEMP1 with 
different domain classes and further groupings. B. Tandem domain arrangements in 
the different var gene groups and the adhesion phenotypes. 
A. 
B. 
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clefts (Wang and Hviid, 2015; Goel et al., 2015). Recent work has shown that 
STEVOR proteins can directly mediate binding to glycophorin C, thus mediating 
rosetting (Niang et al., 2014).   
 
The adverse consequences of parasite sequestration, which has been well-
characterised in P. falciparum, remains controversial for P. vivax. Rosetting 
(Marín-Menéndez et al., 2013; Chotivanich et al., 2012), placental mono 
infections (Mayor et al., 2012) and lack of schizonts within peripheral blood have 
all been reported during P. vivax infections (Lim et al., 2016). Genomic analysis 
of P. vivax has identified a subtelomeric, multigene family called vir, which 
encodes immunovariant proteins (del Portillo et al., 2001) that have been 
implicated in parasite adherence to spleen and lung tissue (Carvalho et al., 
2010; del Portillo et al., 2001). Two endothelium expressed receptors, CD36 and 
ICAM-1, implicated in P. falciparum binding have been shown to interact, 
although to a lesser extent, with P. vivax infected erythrocytes (Carvalho et al., 
2010; Bernabeu et al., 2012). However, it is important to note that vir genes, 
unlike var genes, do not undergo clonal variant expression (Fernandez-Becerra 
et al., 2005). 
 
P. berghei also has the ability to sequester, however, unlike P. falciparum, 
whole body bioluminescence imaging of schizont sequestration in CD36-/- mice 
indicated that this host receptor is the only one utilised by the parasite. 
(Franke-Fayard et al., 2005; El-Assaad et al., 2013). Nevertheless, it could be 
postulated that the sequestration patterns of P. berghei are reflective of group 
B and C PfEMP1 structures that are characterised as binding to CD36 (Figure 
1.19). Through genetic disruption, a small single gene protein, schizont 
membrane associated cytoadherence protein (SMAC) has been implicated in P. 
berghei binding to CD36 (Fonager et al., 2012). Nonetheless SMAC null in P. 
berghei retain the ability to sequester, although to a greatly reduced extent 
compared to the wild type phenotype, suggesting additional redundant proteins 
can mediate CD36 binding (Fonager et al., 2012).   
 
The intra-erythrocytic life cycle results in the release of multiple invasive 
merozoites. Interestingly, the localisation of GFP-tagged GAP50 has implied that 
the parasite glideosome is unassembled during ring to mid-trophozoite stage 
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parasites. It is not until late schizogony that the protein localises into distinct 
foci at the periphery of the parasite, probably to ensure its later distribution 
around the periphery of and act as a architectural scaffold for the daughter 
merozoites (Yeoman et al., 2011). 
 
1.2.24 Commitment to Gametocytogenesis  
In parallel to the asexual cycle, a flexible number of parasites commit 
themselves to a developmental pathway that generates (pre-) sexual cells called 
gametocytes (Smalley et al., 1981b). These cells are the only transmission 
competent form within the host and as such, must be taken up within the  blood 
meal of the vector to continue the Plasmodium life cycle. Gametocytes are cell 
cycle arrested, thus do not multiply by mitotic division.  
 
The continuous culture of P. falciparum has implied that asexual development is 
the default pathway. Nonetheless, the decision to undergo gametocytogenesis is 
still largely, from a spectator’s point of view, a stochastic one. Identifying the 
physiological mechanism that influences parasite metamorphosis has proven 
challenging in the absence of an extreme environmental change.  	
1.2.25 Gametocytogenesis: Metabolism and Host Environment 
Structurally, the metabolic organelles undergo divergent development during 
gametocytogenesis. The mitochondrion enlarges throughout gametocyte 
maturation, whereas, in contrast the apicoplast remains relatively small and 
closely associated with the nucleus (Sinden, 2015). As with asexual blood stages, 
the de novo heme biosynthesis pathway is redundant in maturing gametocytes, 
suggesting they also scavenge host heme (Ke et al., 2014). Nonetheless, a recent 
metabolomic study of in vitro P. falciparum gametocytes observed oxidative 
metabolism differs significantly from asexual parasites (Lamour et al., 2014). 
Intriguingly, there are differences between the glucose consumption pathways 
used by sexual and asexual parasites to generate energy, and inferences can be 
drawn from this in regards to gametocyte commitment in ‘nutrient deprived’ 
environments. During asexual proliferation the parasite relies heavily on 
relatively rapid aerobic fermentation glycolysis and glutaminolysis (with a low 
flux TCA cycle) to convert scavenged glucose and glutamine into biomass and 
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energy (Salcedo-Sora et al., 2014). Traditionally fermentative glycolysis was 
considered a feature exclusive to anaerobic metabolism, nonetheless it has 
become widely described under aerobic conditions in rapidly proliferating cancer 
cells (Warburg, 1959). Under these conditions the asexual parasite scavenges 
purine precursors, amino acids and fatty acids from the host (Salcedo-Sora et 
al., 2014).  Interestingly, during gametocytogenesis (non-proliferating 
development) energy production shifts towards the less rapid oxidation of 
glucose in the mitochondria via the canonical tricarboxylic acid cycle (TCA) 
(Figure 1.20). Significantly, the in vitro methodologies used to enhance the 
gametocytogenesis of P. falciparum are all centered around nutrient deprivation 
(Salcedo-Sora et al., 2014). Moreover, transcriptional analysis of P. falciparum 
gametocytes observed an up-regulation of the type II fatty acid synthesis 
pathway compared with asexual development (Young et al., 2005). This suggests 
that gametocyte-specific metabolic pathways are a reaction to development 
within a nutrient deficient environment in which Plasmodium cannot readily 
scavenge abundant metabolites, such as the hypoglycemia observed in severe 
malaria and patients with hyperparasitaemia (Binh et al., 1997).  
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Figure 1.20 Schematic of major energy- producing metabolic pathways. Glucose and 
Glutamine contribute to energy production. After transport into the parasite, glucose gives 
rise to glucose-6-phosphate (G6P). Under anaerobic or aerobic fermentation, glucose is 
rapidly metabolised to lactate and other byproducts in the cytoplasm. A high flux 
glycolysis maintains metabolic intermediates that support nucleotide and lipid 
biosynthesis. Anaerobic glycolysis generates a net energy production of 2 ATP molecules 
per glucose. Pyruvate can be metabolised in the mitochondrion, replenishing the 
tricarboxylic acid (TCA) cycle. Nutrients in the TCA undergo oxidative phosphorylation 
(OXPHOS) at the mitochondria membrane to generate ATP (Oburoglu et al., 2016).   	
The conversion of the human infective eukaryotic parasite Trypanosoma brucei 
to its quiescent transmission competent form has been described as being 
triggered by parasite derived cell to cell signaling mediated in order control 
parasite density (Seed and Wenck, 2003). There has been an observed positive 
correlation between hyperparasitaemia and P. falciparum gametocyte carriage 
in patients (Nacher et al., 2002). Moreover there is in vitro evidence that 
Plasmodium gametocyte conversion is influenced by secreted parasite factors, 
however the authors did not comment on a correlation between parasite density 
and secretion (Mantel et al., 2013; Regev-Rudzki et al., 2013). Additionally high 
gametocyte carriage has also been observed within asymptomatic P. falciparum 
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and P. vivax infected patients, thus suggesting there is not a link between 
parasite density and gametocyte formation (Degefa et al., 2016). 
 
Recently, two studies have observed extracellular vesicles (EVs) secreted from 
P. falciparum (PfEVs) (Mantel et al., 2013; Regev-Rudzki et al., 2013). 
Eukaryotic EVs are used by cells to shuttle functional cargo, such as mRNA and 
proteins, between each other. Both Mantel et al (2013) and Regev-Ridzki et al 
(2013) independently described the parasite-infected erythrocyte derived PfEVs 
as being formed from the Maurer’s cleft and containing the Maurer’s cleft 
resident protein PTP2. Moreover, Mantel et al (2013) demonstrated that the 
PfEVs carry host derived microRNA and functional Argonaute 2 complexes (RNA 
interference protein). Phagocytosis of infected erythrocyte derived PfEVs 
induces inflammatory responses from macrophages (Mantel et al., 2013). The 
PfEVs can also be internalised by infected erythrocytes in culture and a positive 
correlation was observed between PfEVs uptake and gametocyte formation, 
although the signaling pathways they manipulate and the trigger for their 
release have yet to be identified (Mantel et al., 2013; Regev-Rudzki et al., 
2013). It should be noted that EV have only been investigated and observed in P. 
falciparum cultures and due to the architectural involvement of the Maurer’s 
cleft, it could be postulated that EV could be restricted to species that display 
such structures.  	
1.2.26 Gametocytogenesis: AP2G 
The parasite symbiogenic genomes, located in the apicoplast and the 
mitochondria, only encode a combined total of 33 proteins, all of which are 
involved in metabolic-related activities (Gardner et al., 2002; Hikosaka et al., 
2011). The nuclear karyotype of Plasmodium contains 14 chromosomes, all of 
which are autosomal (Gardner et al., 2002). Therefore, gametogenesis-related 
transcriptional changes must be both distributed throughout the nuclear genome 
and regulated on an epigenetic and post-transcriptional level.  
 
A transcription factor, AP2-G, has recently been identified in both P. falciparum 
and P. berghei as the master regulator of gametocyte-specific transcription 
(Sinha et al., 2014; Kafsack et al., 2014).  AP2-G, which is believed to facilitate 
its own positive feedback regulation, is also enriched at its locus for the 
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epigenetic silencing factor HP1(Rovira-Graells et al., 2012; Josling and Llinás, 
2015). The depletion of HP1 in P. falciparum leads to the derepression of ap2-g 
and a subsequent increase in gametocyte conversion (Brancucci et al., 2014), 
thus implying that the epigenetic regulation of ap2-g contributes to sexual 
commitment. Posttranscriptional regulation also plays a role, although 
functionally undefined, in gametocyte commitment. The deletion of one of two 
P. falciparum RNA-binding proteins, PfPuf1, results in a decrease in gametocyte 
production (Josling and Llinás, 2015).  
 
The onset of AP2-G expression has yet to be defined in the literature, however 
commitment to gametocytogenesis is widely believed to take place at the ‘ring 
stage’ of the preceding erythrocyte cycle, thus producing schizonts containing 
exclusively sexually committed merozoites that are restricted to one gender 
(Bruce et al., 1990; Salcedo-Sora et al., 2014). However, there is conflicting 
evidence that suggests that the invading merozoite remains plastic in terms of 
its commitment to gametocytogenesis (Mons et al., 1985). Nevertheless, it is 
likely that commitment takes places whilst the parasite genome is in a state 
amenable to high gene expression. The ring stages of P. falciparum have been 
observed to contain relatively less compact centromeric histone cores than later 
stages, a chromatin conformation generally linked to transcriptional regulation 
(Hoeijmakers et al., 2012). However, parallel studies by other authors have 
observed the highest level of nucleosome depletion, and thus gene expression, 
in the trophozoite stage (Bunnik et al., 2014; Ponts et al., 2010). Ultimately, it 
is likely that a combination of parasite signaling and metabolic cues influence 
upstream events of AP2-G, thus driving gametocyte commitment.  	
1.2.27 Female and Male Gametocytes  
Superimposed onto sexual development, the haploid parasite becomes either a 
female or a male gametocyte. Within the vector mid-gut, the quiescent mature 
gametocytes activate to form gametes and rapidly emerge from the erythrocyte. 
For the male, this process comes after 3 rounds of DNA replication and axoneme 
assembly, resulting in the release of <8 motile gametes, a process called 
exflagellation. The single female gamete is fertilised by a single male gamete 
forming a zygote.  
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The sex ratio of Plasmodium, like gametocyte conversion rates, is plastic and as 
such can be considered an adaptive phenotype.  Considering gender allocation 
within the evolutionary principles that govern most eukaryotes, there are two 
complementary forces influencing the sex ratio of Plasmodium. Firstly, ensuring 
successful fertilisation, particularly within a clonal low gametocyte density 
infection, the sex ratio generally skews towards a positive female bias, thereby 
promoting random mating. Secondly, there is evidence that a long-term 
genetically diverse infection applies a selection pressure to deviate from random 
mating and thus promote genetic inbreeding (Talman et al., 2004; Nee et al., 
2002).  
 
Unsurprisingly, proteomic studies have highlighted a dramatic divergence 
between the genders and also asexual stages of Plasmodium (Khan et al., 2005; 
Lasonder et al., 2002). Following male activation, DNA replication and axoneme 
assembly are initiated through calcium dependent kinase activity (Khan et al., 
2005).  Gene-deletion studies in P. berghei have shown that exflagellation is 
reliant on numerous protein kinases and protein phosphatases, whose functions 
seem to be unnecessary or redundant in the asexual stage (Guttery et al., 2015). 
Moreover, the disruption of the cell division cycle 20 (CDC20) protein generates 
parasites with a functional asexual cycle and subsequent multiple fission, 
however, the male gametes fail to undergo mitotic separation after DNA 
replication (Guttery et al., 2012). On the completion of male DNA replication, 
the basal bodies of the axonemes egress to form flagella (Guttery et al., 2015). 
From this point fertility is dependent on fusion with the female gamete, a 
process mediated by the 6-cys proteins P48/45, P230 and P47 and the plant-
sterility gene hap2/gcs1 (Van Dijk et al., 2001; Liu et al., 2008; Laurentino et 
al., 2011). Disruption of P48/45 or P230 in P. berghei produces male gametes 
that cannot attach to female gamete through a multi protein interaction 
believed to involve P47 (Van Dijk et al., 2010). Observations made using a P. 
falciparum P230 mutant indicated this protein might also have a role in the 
interaction between the male gamete and erythrocytes (Eksi et al., 2006). 
Nonetheless this function of P230 may not be conversed across Plasmodium 
species, as it was not observed in P. berghei (Van Dijk et al., 2010). Male 
gametes lacking hap2/gcs1 do attach to females but do not fuse (Liu et al., 
2008). 
Introduction	 	 		 47	
 
Initial post-fertilisation development in metazoans relies on mRNAs supplied by 
the oocyst in translationally quiescent cytoplasmic processing bodies (P bodies) 
and stored in particles known as P granules.  The translation of these pools of 
mRNA is triggered by fertilisation and occurs prior to the transition to 
transcription of the zygotic genome (Stitzel and Seydoux, 2008). Within 
Plasmodium, translationally quiescent mRNA are found within the cytoplasm of 
female gametocytes associated with the DEAD-box RNA helicase DOZI and the 
Sm-like factor CITH, which together define a protozoan maternal P granule (Mair 
et al., 2010, 2006). Gene deletions of either DOZI or CITH in P. berghei results in 
zygotes that do not develop into ookinetes (Mair et al., 2010). Through liquid 
chromatography-mass spectrometry Mair et al (2010) identified 16 proteins 
associated with DOZI and CITH with roles in rapid recruitment of ribosomes, post 
translation repression and glycolysis. Notably the authors observed an absence of 
proteins involved in RNA degradation, thus emphasising that the Plasmoidum P 
granules are a site of mRNA storage. Moreover, a recent study has demonstrated 
that the stored mRNA is only involved in parasite growth up to the post-
fertilisation development of the zygote. Using alpha-amanitin to inhibit de novo 
transcription in in vitro ookinete cultures the authors observed a lack of 
maturing ookinetes (Guerreiro et al., 2014).  
 
1.2.28 Immature Gametocytes of P. falciparum are not in Circulation 
The developing gametocytes of P. falciparum display different characteristics 
compared with P. vivax and the murine Plasmodium spp (Figure 1.21). The 
development of P. falciparum is highly protracted relative to both its asexual 
cycle and the maturation of other Plasmodium spp gametocytes (Table 1.3). 
Uniquely, the morphological transitions P. falciparum undergoes across the 10-
12 day development period can be divided into five discrete stages (stages I-V). 
Although it should be noted that initially after invasion the gametocyte takes on 
a ring like morphology (<30 hrs post-invasion) and cannot be distinguished 
morphologically from asexual parasites until >30 hrs post-invasion. The immature 
stages (stages I-IV) are undetectable in samples taken from peripheral blood, 
although recent transcriptional profiling of ex vivo samples indicated that 
gametocytes circulate within peripheral blood up to 20hrs post-invasion (Pelle et 
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al., 2015). As such, features of P. falciparum gametocyte development must 
both necessitate and facilitate the parasites transient removal from circulation.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1.3 Asexual and gametocyte maturation time frames  
Species  Subgenus  Asexual cycle 
duration  
Gametocyte 
maturation  
P. falciparum  Laverania 48 hrs  10- 12 days 
P. vivax Plasmodium  48 hrs  48 hrs 
P. berghei  Plasmodium 22-24 hrs  30-48 hrs 
A. 
B. 
Figure 1.21 Gametocyte morphology (Josling and Llinás, 2015). A. Rounded 
morphology of P. vivax mature gametocytes on a Giemsa stained blood smear and 
viewed under light microscopy. B. The five stages of P. falciparum gametocyte 
morphology; a. Giemsa stained and viewed under light microscope, b. schematic of 
microtubules and IMC.     
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As discussed above, the major P. falciparum ligand defining the infected 
erythrocyte’s cytoadherence phenotype is PfEMP1. Interestingly, an early 
proteomic overview detected var gene expression in stage IV gametocytes 
(Florens et al., 2002). Nonetheless, this finding was starkly contradicted by a 
later proteomic study that noted an absence of proteins involved in PFEMP1 
processing and export (Silvestrini et al., 2010). This is in agreement with the 
consistent observation that the var gene family is down-regulated at the onset 
of gametocyte development (Duffy and Tham, 2007; Sharp et al., 2006; Tibúrcio 
et al., 2013). However, antibodies in the plasma of malaria patients have 
indicated the existence and immune recognition of gametocyte specific antigens 
(Dinko et al., 2012; Saeed et al., 2008). The parasite switch to sex exclusive 
ligands correlates with the reports that gametocytes bind to host receptors 
displayed on bone marrow derived endothelial cells that have not previously 
been implicated in Plasmodium asexual cytoadhesion (Rogers et al., 2000). 
Nonetheless, the early reports of gametocyte cytoadherence lacked biological 
relevance in terms of binding frequency and strength (Rogers et al., 2000; Day et 
al., 1998). As such, a later assay concluded that immature gametocytes of both 
a reference clone and a field isolate lacked a biologically relevant binding 
affinity to bone marrow endothelium (Silvestrini et al., 2012). Consequently, 
these results, coupled with the observations that stage I-IV gametocytes lack 
adhesive knob like structures (Crabb et al., 1997; Sinden, 1982), point to 
immature gametocytes being unable to undergo ligand-receptor mediated 
cytoadhesion.  
 
The need of asexual parasites to sequester is a reaction to the decrease in the 
cells deformability and, as such, its inability to circulate through splenic 
sinusoids (Glenister et al., 2002; Tibúrcio et al., 2015b).  3D imaging 
experiments have determined that, despite the extensive morphological change 
P. falciparum gametocytes undergo, there is no significant increase in surface 
area or volume of the host cell (Aingaran et al., 2012). Nonetheless, measuring 
the shear modulus of infected erythrocytes has revealed a systematic decrease 
in host cell membrane deformability in immature gametocytes compared to 
stage V mature gametocytes (Aingaran et al., 2012). Computer modeling has 
indicated that the physical parameters of immature gametocytes would prevent 
passage through splenic slits (Aingaran et al., 2012). This data was consistent 
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with results from ektacytometry and microsphiltration studies showing that 
immature P. falciparum gametocytes are less deformable than stage V 
gametocytes (Dearnley et al., 2012; Tibúrcio et al., 2012).   
 
Surface remodeling of infected erythrocytes through the export of parasite 
derived proteins, such as the variant STEVOR ligands, and the mechanical re-
structuring of the intracellular parasite have been implicated in the decreased 
deformability of mature asexual P. falciparum (Glenister et al., 2002; Nunes et 
al., 2007). STEVOR proteins are also highly expressed and associated with the 
erythrocyte membrane in stages III-IV gametocytes but not in stage V. It has 
been shown, through the overexpression of STEVORs in stage V gametocytes, 
that these proteins have a direct link with the cells decreased deformability 
(McRobert et al., 2004; Tibúrcio et al., 2012). This combined with the 
disassembly of the microtubule subpellicular network are likely the reason for 
the sharp drop off in rigidity in stage V gametocytes (Dearnley et al., 2012; 
Tibúrcio et al., 2015a). It can therefore be speculated that the systematic 
increase in gametocyte deformability, may play a role in retaining immature 
sexual cells within specific anatomical foci.  
 
Currently, the removal of immature gametocytes from circulation has not been 
observed in species within the Plasmodium subgenera. This is predominately due 
to gametocytes being indistinguishable from asexual parasites prior to full 
maturation. A recent microarray comparison between the transcriptome of a P. 
berghei ap2-g null line with wild type was performed to identify early-
transcribed genes downstream of PbAP2-G. The dynamics of 18 promoters with 
PbAP2-G binding motifs identified from this screen were investigated. From this 
pool, the promoter of PBANKA_101870 was identified as being transcribed pan 
sexually and relatively early in gametocyte maturation (Sinha et al., 2014).  
 
1.2.29 The Gametocyte Glideosome 
Plasmodium gametocytes contain a ‘subpellicular membrane complex’, which 
has been shown to be analogous to the IMC of the motile zoite stages. It is 
speculated that this membrane structure serves a purely structural role as the 
gametocyte (stages I-IV) elongates by establishing a cytoskeleton of 
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microtubules beneath the IMC. Intriguingly even though the gametocyte has no 
reported motile ability, the integral proteins of the glideosome, such as Gap-50 
and actin, are expressed and localise correctly in the gametocyte (Poulin et al., 
2013; Hliscs et al., 2015; Dearnley et al., 2012). Thus, this stage possesses the 
parasite machinery that enables both gliding and cell invasion.  
 
1.2.30 Malaria: Treatment Failure 	
The treatment of malaria is an arms race; efforts to control the disease have 
been hampered by the widespread and rapid emergence of parasite resistance 
to, and treatment failure of front-line anti-malarial drugs (Table 1.4). For 
example, in 1993 Malawi had to replace its front line use of chloroquine (CQ) to 
treat P. falciparum malaria with the combination therapy sulphadoxine-
pyrimethamine (SP) due to high levels of treatment failure caused by drug 
resistance. By 2007, SP resistance had emerged and treatment efficiency had 
fallen in Malawi from 100% to 61-73% (Nkhoma et al., 2007). The WHO defines 
drug resistance as “the ability of a parasite strain to survive or multiply despite 
the administration…. of drug given in doses equal to or higher 
than…recommended” (WHO, 2010).  The drive towards drug resistance occurs in 
two phases. Firstly, a spontaneous genetic event occurs producing a drug 
resistant parasite. Secondly, under drug selection pressure the mutation is 
selected for and spreads throughout the population.  																			
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Table 1.4 Anti malarials (WHO, 2010). Generic name and chemical family of approved 
anti malarials.   
 
1.2.31 Mutation for CQ Resistance  
The intrinsic mutation rate of Plasmodium is assumed to be very low, ~ 10-9 (the 
probability that a unit of DNA mutates with time), and it is only mutations within 
a drug target or drug transporter that will convey resistance (Su et al., 1999; 
Hastings, 2011). Interestingly, epidemiological studies have suggested that the 
resistance of P. falciparum to CQ is not the result of a single genetic mutation 
event, but rather resistance emerged independently within a number of 
geographical foci (WHO, 2010). CQ, in its uncharged form, diffuses across 
membranes and in drug sensitive parasites it accumulates in the acidic digestive 
vacuole, where the now protonated drug is trapped. The drug is believed to 
combine with the toxic byproduct of heme digestion, thereby interfering with 
the parasite endogenous detoxification processes. CQ resistant parasites carry 
synonymous mutations within a digestive vacuole transporter protein, P. 
falciparum chloroquine resistance transporter (PfCRT) that facilitates drug 
export; three mutually exclusive changes in the amino acid sequence have been 
identified in the field (Chinappi et al., 2010). The pfmdr1 gene also encodes a 
transporter associated with chloroquine resistance in P. falciparum (Pisciotta et 
al., 2017). However, the mechanism of chloroquine resistance in P. vivax and P. 
berghei is not understood. Mutations in pvmdr1 have been reported to play a 
Chemical Family  Drugs 
4-Aminoquinolines Chloroquine. Amodiaquine, piperaquine 
Amino-alcohols 
Quinine, quinidine, mefloquine, halofantrine, 
lumefantrine 
Dulfonamides and 
sulfones Sulfadoxine, sulfalene, dapsone 
Biguanides Proguanil, chlorproguanil 
Diaminopyrimidine Pyrimethamine 
8-Aminoquinoline Primaquine 
Sesquiterpene 
lactones 
Artemisinin, arteether, artemether, artesunate, 
dihydroartemisinin 
Naphthoquinene Atovaquone 
Antibiotics doxycyline, tetracycline 
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role in chloroquine resistance, although there is evidence that the global pattern 
of mutation doesn’t directly correlate with chloroquin resistance (Pisciotta et 
al., 2017; Melo et al., 2014).  
1.2.32 Mutation for ART Resistance  
The prominent use of CQ was replaced by alternative synthetic antimalarials, 
which in turn fueled treatment specific failure. The global use of ARTs began in 
the 1990s. Artemisinin (ART) and its derivatives (ARTs) contain a 1,2,4- trioxane 
core containing an endoperoxide ring (Table 1.4) and become widely used as 
front line antimalarials in the 1990s (Lin, 2011).  The mechanism(s) of action of 
ARTs is/are still unclear but are likely to involve activation of the pro-drug 
within the body by cleavage of its endoperoxide ring, resulting in the release of 
free radicals (Klonis et al., 2013a). Interestingly, parasite sensitivity to ARTs 
positively correlates with its progression through the asexual cycle. In a tightly 
synchronised in vitro culture, ring parasites were less sensitive to the drug than 
later stages (Klonis et al., 2013b). This suggests that ART activation, and 
therefore potency, is driven by the accumulation of end products of the 
parasite’s own metabolism. Indeed, in vitro and in vivo studies have both 
suggested that the end products of hemoglobin digestion, heme and ferrous iron, 
are the activators of ART (Klonis et al., 2013a). Recent biochemical and cellular 
evidence has linked ART sensitivity to decreased phosphatidylinositol-3-
phosphate (PI3P) abundance, an endoplasmic reticulum export protein, as a 
result of the direct inhibition of P. falciparum phosphatidylinositol-3-kinase 
(PfP13K) in early ring stages (Mbengue et al., 2015).  
Although ART monotherapy has been reported to clear initial blood stage 
infection rapidly (Nguyen Duy Sy et al., 1993) currently, WHO advocates 
Artemisinin Combination Therapies  (ACTs) as the front line treatment against all 
species of malaria parasite (WHO, 2015) (Table 1.5). The rationale for ACT 
(Table 1.5) is simple; firstly, ARTs are rapidly cleared from the body, therefore 
are co-dosed with a prolonged-acting drug. Secondly, if the drugs each have a 
target encoded by a different gene the likelihood of parasites containing a 
spontaneous resistance to treatment is halved. As a result, the use of ACT was 
designed to delay the spread of resistance for the highly potent ART and stems 
the spread of resistance against the older secondary drug.  
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ART resistance was first described in Cambodia in 2008 and as of 2014 it was 
well established within South East Asia with ACT failure also becoming widely 
reported in the region (Anderson et al., 2014). Resistance to other antimalarial 
drugs, such as CQ, is described in terms of recrudescence of infection; however, 
due to the fast clearance of parasites, ART resistance is described in terms of a 
protected parasite clearance time. Crudely this is measured as the proportion of 
patients exhibiting stage blood infections at day 3 after treatment (Baumgärtner 
et al., 2017). There is strong evidence that the ART resistance phenotype has a 
genetic linkage to single nucleotide polymorphisms (SNP) in a region of P. 
falciparum chromosome 13 encoding the propeller region of a kelch protein, 
kelch13 (Anderson et al., 2014; Takala-harrison et al., 2015). Nonetheless, 
genome-wide association studies have indicated that the genetic basis for ART 
resistance is complex (Fairlamb et al., 2016). Nonsynonymous mutations on 
chromosomes 10, 13 and 14, which lie in or near genes involved in post-
replication DNA repair, are at high frequency in ART resistant P. falciparum 
populations (Takala-harrison et al., 2013; Cheeseman et al., 2012). As such, it 
has been postulated that these genetic markers are indicative of genomes in 
which ART resistant conferring kelch 13 mutations can occur (Fairlamb et al., 
2016).  
 
Despite the recent evidence that ART targets and inhibits PfP13K, 
polymorphisms in the gene are not detectible in all resistant strains, however, 
decreased ubiquitination of PfP13K was consistently observed in ART resistant P. 
falciparum (Mbengue et al., 2015). Mbengue et al (2015) observed that ART 
resistant associated mutations in kelch 13 reduced the binding of PfPI3K to the 
its propeller domain, this in turn reduced PfP13K ubiquitination increasing its 
stability and leading to an increase in downstream PI3P levels. The authors 
suggested that increased PI3P levels may be involved in a downstream cascade 
influencing transcriptional and DNA repair pathways (Mbengue et al., 2015). The 
20 or so kelch 13 mutations are associated with ring-stage parasites entering a 
quiescent state during exposure to ART (Baumgärtner et al., 2017). 
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1.2.33 Selection Pressure for Resistance: Ineffective Treatment 
In the simplest terms, two aspects of a drug define its function: 
pharmacodynamics and pharmacokinetics. The former is the mechanism of drug 
action. The latter, on the other hand, is a description of what the drug does in 
the body. This includes the mechanisms of drug absorption, bioavailability, 
metabolism and excretion. Pharmacokinetics also takes into account the drug’s 
distribution within tissue, which is dependent on blood perfusion, tissue mass, 
regional pH and the partition characteristic between the blood and tissue (such 
as cell membrane permeability).  
 
Classically, the treatment outcome of malaria is believed to be determined by 
the concentration of active drug in the blood stream (White, 2013). As such, 
drug pharmacokinetics need to be taken into account when administering 
antimalarials to ensure the dose translates directly to the optimal drug 
concentration in the blood. If this is not taken into consideration, there is a risk 
that the patient will receive a dose that equates to sub optimal concentrations 
in the blood.  
 
It is well established that resistance can be selected for in vivo when the 
parasite is exposed to sub-optimal concentrations of antimalarials. This ties into 
the epidemiological observations that low transmission areas are the epicenter 
of emerging drug resistance. The level of an individual’s acquired immunity to 
malaria is a function of the regional intensity of transmission, within high 
transmission areas partially immune individuals can experience asymptomatic 
malaria infection, thus these individuals do not seek therapeutic treatment 
(WHO, 2010). Moreover, many of the front-line drugs currently used were 
ARTs Combination drug  
Artesunate Amodiaquine 
Artesunate Mefloquine 
Dihydroartemisinin Piperaquine 
Artemether Lumefantrine  
Artesunate SP 
Table 1.5 ACT combinations 
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initially prescribed at sub-optimal levels. For example, the optimal dose for SP 
in children was extrapolated only from pharmacokinetic studies carried out in 
adults and as such led to treatment failure in children (Barnes et al., 2006). In 
parallel, there is a wide distribution and self-prescription of counterfeit and 
poor-quality antimalarial drugs within endemic regions (Nayyar et al., 2012). The 
spread of resistance is dependent on the transmission of the mutant from the 
initial host to the susceptible population. This is therefore contingent on the 
mutant generating a recrudescent infection in the initial host, producing 
gametocytes and infecting a vector.  
1.2.34 Recrudescence of ART Sensitive Parasites  
Interestingly, treatment failure for ART monotherapy administered at reported 
curative concentration was due to infection recrudescence after complete 
clearance from the peripheral blood (Cheng et al., 2012; Looareesuwan et al., 
1997; Ittarat et al., 2003). As such, these reported recrudescent events have 
distinct infection dynamics compared with treatment failure due to ART 
resistance. Moreover, multiple reports have stated that the parasites 
contributing to the recrudescing infection post ART treatment are not resistant 
to ART in vitro and re-administration of ART to patients is effective in clearing 
the recrudesced infection (Cheng et al., 2012; Looareesuwan et al., 1997; Ittarat 
et al., 2003). Recrudescence after ART treatment, like ART resistance, has been 
linked to drug induced dormancy of ring stage parasites (Cheng et al., 2012). 
Evidence has been generated from both in vitro cultures and in vivo infected 
using ART sensitive parasite lines of a number of Plasmodium species that ART 
treatment results in a populations of morphologically distinct dormant ring stage 
parasites (LaCrue et al., 2011; Teuscher et al., 2010). Teuscher et al. 2010 
observed that approx. 2 % of an in vitro culture of drug sensitive P. falciparum 
entered dormancy under various concentrations of ART (200, 500 and 20 ng/mL). 
Within 5-9 days post treatment 50% of the dormant parasites had recovered and 
re-entered the growth cycle. Nonetheless, it remains to be seen whether 
dormancy observed in ART resistant and ART sensitive parasites are governed by 
genetic and mechanistic similarities.  
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1.2.35 Post Artesunates Delayed Hemolysis 
Post artesunates delayed hemolysis (PADH), marked by high lactate 
dehydrogenase (LDH) and low haptoglobin plasma levels well after the complete 
clearance of parasites, has been reported in both adults and children after both 
parenteral and oral administration of chemotherapy.  As such, it would seem 
that PADH is not the result of the incorrect extrapolation of dosing 
concentrations from pharmacokinetic studies carried out on adults, as was the 
case for the sub-optimal dosing of SP (Barnes et al., 2006). Host genetic markers 
for the prediction of immune-mediated or drug induced hemolysis, such as 
glucose-6-phosphate dehydrogenase deficiency or the ‘direct antiglobulin test’ 
have yet to be conclusively identified. Moreover, there remains inconsistency 
within field reports as to whether hemolysis is occurring in a predominately 
intravascular manner via complement fixation or by extravascular removal of 
erythrocytes by splenic phagocytes. Recent work favoring the extravascular 
hemolytic explanation for PADH has linked ART induced expulsion of dead 
parasites from circulating erythroid cells (‘pitting’) and the subsequent later, 
but premature, clearance of these pitted cells by the spleen (Jaureguiberry et 
al., 2014).  
 
1.2.36 P. berghei: a Model Organism  
As mentioned previously, there are ethical barriers to studying the spatial and 
temporal dynamics of human infective Plasmodium in vivo. To overcome this 
barrier, researchers have used murine Plasmodium infections of laboratory 
rodents as a model for malaria.  
 
Although P. chabaudi provides insight into chronic infection and self-resolving 
infection (therefore host immunity), the availability of efficient genetic 
technologies for P. yoelii and particularly P. berghei have made these two 
species the predominant models for gene function (Janse et al., 2011).  The 
genomes of human and murine infective Plasmodium are highly conserved with 
approximately 80% of the open reading frames being orthologous (Janse et al., 
2011).   
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The work in this thesis is focused on the blood stage infection of Plasmodium. P. 
berghei can mimic a number of severe human malaria pathologies in several 
strains of mice, such as cerebral complication, pregnancy-associated pathology 
and acute lung injury (Franke-Fayard et al., 2010). However, the extent to 
which these pathologies, especially experimental cerebral malaria (ECM), are 
representative of human disease is hotly contested in the literature (Craig et al., 
2012). Nonetheless, the use of P. berghei to investigate host immunopathology 
has fueled the genetic manipulation of the species; there are now numerous 
clonal lines expressing either fluorescent or bioluminescent markers (Janse et 
al., 2006; Franke-Fayard et al., 2005). The use of these transgenic P. berghei 
lines facilitates the imaging of parasites within host tissue either in vivo or ex 
vivo (Franke-Fayard et al., 2005; Claser et al., 2014). Moreover, the use of 
rodents allows for the host genetic background to be controlled.  
 
The long-standing investment in technologies and methodologies has made P. 
berghei an obvious choice for visualising and analysing host-parasite 
interactions. Nonetheless, the divergences between human and murine infective 
Plasmodium must be taken into account when translating laboratory findings to 
a clinical setting. It is thus important that there is cross talk between 
experimental and field studies, therefore enabling the use of the developmental 
murine models to temporally and spatially study host-parasite phenotypes that 
human field samples have shown light on.  
1.2.37 Summary  
The key points in this section were: 
• The expression of host receptors defines a host cell’s susceptibility to 
Plasmodium (section 1.2.15 page 27). 
• Immature gametocytes develop out of circulation (section 1.2.28; page 
47).  
• The gametocyte has a fully assembled glideosome (section 1.2.29; page 
50).  
• The temporal and spatial dynamics of infection influences drug 
pharmacology (section 1.2.33; page 55). 
• P. berghei is a valuable model organism (section 1.2.36; page 57). 
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1.3 Structure and Function of the Bone Marrow and Spleen 
The key points in this section are: 	
• Where stress and homeostatic erythropoiesis occurs in mice and humans.  
• Whether erythroid progenitors have the ligands and cytoskeleton allowing 
for Plasmodium invasion. 
•  Whether there is a metabolic advantage to invading erythroblasts.  
• The effect malaria has on erythropoiesis. 
The conclusions to these points are reviewed in the summary: section 1.3.14. 
1.3.1 Bone Marrow Structure and Function: Mice and Human 
In both mice and humans, the bone marrow is the viscous tissue found within the 
cavities of the axial and long bones. It is the major source of hematopoietic 
stem cells (HSCs), the multipotent, self-renewing progenitors that give rise to all 
cellular elements in the blood (both myeloid and lymphoid) and immune system, 
thus making it a primary immunological organ (Figure 1.22).  Adult bone marrow 
also contains mesenchymal stem cells (MSCs), the progenitors of the cellular 
components of tissues (Travlos, 2006; Gurkan and Akkus, 2008). Structurally, the 
marrow supports the proliferation of its stem cells in a highly organised stroma, 
which is composed of reticular cells that form a spongy scaffold.  
 
 
 
 
 
 
 
Figure 1.22 HSC differentiation pathways (Haggstrom, 2009).  Schematic showing 
development of myeloid and lymphoid lineages from Hematopoetic Stem Cell 
precursors.  
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The diaphysis portion (Figure 1.23) of adult long bones consists largely of 
mesenchymal cells and adipose tissue (yellow marrow). At birth, the entire 
skeleton is filled with active hematopoietic tissue (red marrow), from this point 
onwards red marrow is steadily converted into yellow marrow. Conversion is 
finite, with an end point in early adulthood. At this point red marrow is 
restricted to the axial skeleton and the epiphysis/metaphysis of the humeral and 
femoral bones (Małkiewicz and Dziedzic, 2012). Nonetheless, a recent deep 
imaging study of murine adult long bones observed the highest frequency of 
HSCs were located in the diaphysis compared to the metaphysis and epiphysis 
(Acar et al., 2015).  
 
 
 
 
Blood is delivered to the bone marrow by the nutrient artery, which splits into 
ascending and descending branches that run along the longitudinal axis of the 
tissue. These branches then spilt into small radial arterioles and capillaries that 
extend towards the cortical bone. Near the bone, the vessels become venous 
sinusoids that drain via the central sinus and the collecting venules back into the 
centre vein and away from the marrow through the nutrient vein. This structure 
makes the bone marrow a highly vascularised tissue (Figure 1.24). The bone 
marrow does not have draining lymphatic vessels (Travlos, 2006; Gurkan and 
Akkus, 2008). 
Diaphysis	
v	 v	Metaphysis	Metaphysis	
Epiphysis	Epiphysis	
Figure 1.23 Structure of the long bones (Nrpt.co.uk, 2017)   
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Sinusoidal walls, which consist of a single layer of endothelial cells, are 
fenestrated, not supported by a complete basement membrane and are in direct 
contact with parenchymal (extra vascular) cells. This lack of regular vessel wall 
structures allows for a high level of permeability (Kopp et al., 2005; Itkin et al., 
2016), allowing the mature cells arising from the HSCs to migrate out of the 
tissue into the blood stream.  
The maturation and commitment of lineage-negative HSCs to the wide variety of 
blood cell lineages is called Hematopoiesis. The maturation of the discrete cell 
lineages is a compartmentalised process within the hematopoietic tissue. 
Osteoblasts and other mesenchymal stromal cells construct a supportive niche 
for quiescent HSC within the deep peri-sinusoidal regions (Acar et al., 2015; 
Kaplan et al., 2007). The bone marrow sinusoidal endothelium creates a second 
scaffold structure, forming the vascular HSC niche where differentiation occurs 
(Kaplan et al., 2007).  
1.3.2 Cellular Transmigration into Tissue   
The process of extravasation through the endothelium into a tissue is termed 
diapedesis (Schmidt et al., 2011). The vascular endothelium has an active role in 
diapedesis through its reorganisation of its cytoskeleton and membrane. 
Currently, there are two identified routes of diapedesis for leukocytes 
c	 Venous	sinusoids	
Figure 1.24 Bone marrow is a highly vascularised tissue (adapted 
from Travlos, 2006) 
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migration: between endothelial cells (paracellular) or through individual 
endothelial cells (transcellular), both of which occur during inflammation and 
immune responses (Schmidt et al., 2011). The leukocytes choice of the 
transcellular pathway is regulated by the relative stiffness of endothelial cell 
and the tightness of the endothelial cell junction, with high endothelial rigidity 
promoting this pathway (Martinelli et al., 2014; Schaefer et al., 2014). Within 
the bone marrow endothelial cells exhibit prominently different functions in 
different vascular beds, with arterial and sinusoidal endothelial cells displaying 
different anatomical, hemodynamic, molecular and metabolic signatures (Itkin 
et al., 2016). Evidence exists showing that the permeable fenestrated sinusoids 
are the preferential site of leukocyte trafficking (Itkin et al., 2016), thus 
suggesting that paracellular migration is the predominant route to access the 
bone marrow tissue.  
 
Both migratory pathways are highly regulated through sequential ligand-receptor 
interactions between the migrating cell and the endothelium, including, for 
example, binding of selectins, integrins and intercellular adhesion molecules 
(ICAM) (Filippi, 2016). Alongside promoting cellular adhesion, these binding 
interactions also instigate bidirectional signaling between the leukocyte to the 
endothelial cells that establish leukocyte polarity, crawling, and loosening of the 
endothelial cell junctions (Filippi, 2016).  
Under inflammatory conditions, endothelial cells express vascular cell adhesion 
protein endothelial (E)- and platelet (P)- selectin. These receptors capture 
leukocytes through binding to an array of sialylated carbohydrate ligands and P- 
selectin glycoprotein ligand 1 (Muller, 2013). The subsequent leukocyte rolling is 
controlled by adhesion between class dependent leukocyte integrins 
(lymphocyte function-associated antigen 1; CD11a/CD18), Mac-1 (macrophage-1 
antigen; CD11b/CD18) and Very late antigen -4 (VLA-4) which bind to their 
corresponding endothelial ligands ICAM-1 and VCAM -1, respectively (Nourshargh 
and Alon, 2014). The leukocyte binding to ICAM-1 and VCAM-1 triggers internal 
endothelial signalling leading to the formation of ICAM-1 and VCAM-1 clusters 
supported by actin thus enhancing leukocyte binding (Vestweber, 2015). 
Moreover, the binding of leukocytes to these ligands triggers additional internal 
endothelial signals, such as transient Ca2+ signals that stimulates the active 
opening of the endothelial cell junction through actinomyosin filament mediated 
Introduction	 	 		 63	
contraction and the production of reactive oxygen species that triggers the 
dissociation of endothelial cell junction cadherin proteins (Vestweber, 2015). 
Consequently, the process of diapedesis is restricted to cells that have the 
capability to undergo these complex and sequential interactions.  
A novel mechanism of extravasation of intravascular non-leukocyte cells has 
been reported and termed angiopellosis (Allen et al., 2017). Allen et al (2017) 
used intravital microscopy to visualise the dynamics of injected cardiac stem 
cells in transgenic zebrafish embryos. The authors reported that angiopellosis 
differs both morphologically and temporally from diapedesis. The former process 
took significantly longer to occur, the stem cells retained their shape opposed to 
undergoing deformable morphological changes and the endothelial cells actively 
remodeled to form pockets in order to accommodate the transmigrating cell. 
Moreover, through inhibiting a characterised cell endothelial receptor (CD11a; a 
member of the β2 integrin complex lymphocyte function-associated antigen 1) 
used during leukocyte diapedesis the authors showed that the cardiac stem cells 
were utilising unique and likely β2 integrin independent ligand-receptor 
interactions to achieve angiopellosis (Allen et al., 2017). This therefore opens 
the possibility for other mechanisms of transmigration to exist for cells that have 
the ability to adhere to endothelial receptors, such as ICAM, but have no 
characterised integrin expression, such as Plasmodium-infected erythrocytes.  
1.3.3 Spleen Structure and Function 
The human and mouse spleen consists of distinct micro-anatomical zones: the 
white pulp and the red pulp. Although there are a great number of similarities 
between the spleens of the two species, there are also some structural 
differences. Both of which will be highlighted in this section.    
Electron microscopy has shown that the white pulp is composed of lymphocytes, 
phagocytes and blood vessels arranged in a reticular framework (Saito et al., 
1988). The white pulp makes the spleen a secondary immunological organ and in 
both species it can be sub-categorised into three compartments: the 
periarteriolar lymphoid sheath (PALS), the follicles and the marginal zone 
(Cesta, 2006a). T-cells dominate the PALS that surround the arterioles that enter 
the parenchymal tissue of the spleen. The follicles are continuous with the PALS 
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but are areas of B cell prevalence. Both the PALS and the follicles are 
surrounded by the marginal zone. The correct organisation and maintenance of 
these structures is controlled by specific chemokines (Mebius and Kraal, 2005). 
In rodents the marginal sinus, which forms a border between the PALS/follicles 
and the marginal zone, mediates lymphocyte re-circulation via endothelial 
transmigration (Ferrer et al., 2014). A relatively recent immunohistological 
study showed that this structure is not present in human spleen, however, a 
species-specific lymphoid-rich perifollicular zone was detected on the outer 
region of the marginal zone (Steiniger et al., 1997). The structural differences 
between human and mouse marginal zones indicates that there is divergence in 
patterns of lymphocyte recirculation, however the significance of this in terms 
of splenic immunological function remains undetermined (Steiniger et al., 2001). 
The red pulp is composed of a 3D meshwork of reticular fibres, myofibroblastic 
reticular cells and associated macrophages, all arranged into ‘splenic cords’. 
The reticular fibres are composed of collagenous and elastic fibres, basal 
laminae and unmyelinated adrenergic nerve fibres (Cesta, 2006b). Species-
specific differences in the red pulp remain poorly studied (Ferrer et al., 2014). 
The environment within the cords is believed to be acidotic and hypoxic (Cesta, 
2006b; Malley, 2007). 
The blood flow through the human microvasculature of the spleen is highly 
complex and somewhat controversial (Steiniger, 2015; Maxie, 2015; Ferrer et 
al., 2014; Steiniger et al., 2011). Historically this may be due to the 
misinterpretations of structures observed in post mortem corrosion casts and the 
over interpretation of non-human species-specific structures. Nonetheless, it is 
widely expected that a proportion of blood enters and filters through an ‘open 
circulatory system’, where it enters spaces not lined by endothelium or barrier-
forming cells (Steiniger et al., 2011). 
In the human spleen, blood (lymphocytes, erythroid cells and all other 
components) enters the spleen via the splenic artery, which then divides into 
the trabecular arteries within the splenic parenchyma. These blood vessels 
branch further into smaller arterioles, terminating at the perifollicular zone or 
in the red pulp. The blood from these arterioles either flows directly into 
adjacent venous sinuses via vascular conduits (closed circulation) or enters the 
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reticular meshwork of the red pulp (open circulation), where blood borne 
pathogens are cleared by the associated macrophages. The blood from the red 
pulp must re-enter closed circulation (Steiniger, 2015; Ferrer et al., 2014; 
Balogh, 2011; Cesta, 2006b). Transmission electron microscopy has shown that 
this is done by the erythrocytes transmigration through the sinusoidal walls of 
the venous sinuses within the red pulp (Figure 1.25) (Drenckhahn and Wagner, 
1986). Thus, erythrocytes re-entering closed circulation are subjected to a 
‘physical fitness test’, with cells displaying atypical geometry and deformability 
being excluded (Pivkin et al., 2016). This has led to the human spleen being 
classified as sinusoidal.  
Mice, like many domestic animals, have a spleen that is non-sinusoidal or 
‘reticular’. In this structure there is no closed circulation, arterioles empty 
entirely into the red pulp (Figure 1.25).  Nonetheless, the blood does not re-
enter the circulation via the walls of venous sinuses, instead it drains into open-
ended venules (Maxie, 2015). As such, re-entry into the vasculature does not 
require the erythrocytes to display the deformability range of healthy 
erythrocytes. Nonetheless, comparisons between the deformabilities of 
erythrocytes within the peripheral blood and erythrocytes retained within the 
spleen indicates that the mouse spleen has a method to exclude atypical cells 
from circulation (Huang et al., 2014).  
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Figure 1.25 Blood flow in non-sinusoidal and sinusoidal spleens (Maxie, 2015). 
Humans (sinusoidal) lack a marginal sinus, blood from the radial arteriole empties into 
the marginal zone and red pulp. Some arterioles are continuous with splenic 
sinusoids, creating the closed circulation where the (~90%) blood never leaves 
endothelial-lined vessels. The rest of the blood drains through the splenic cords 
entering the sinusoids through the endothelial slits. In mice, all blood is emptied into 
the red pulp or marginal sinus and drains through the red pulp into open-ended 
venous vessels.  
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1.3.4 Primary and Definitive Erythropoiesis 
It was observed as early as 1875 that the erythroid cells within the postnatal 
mammalian bloodstream lack a nucleus (Gulliver, 1875). This is in stark contrast 
to the bloodstream of mammalian embryos that contain two temporally 
overlapping erythroid populations, the first containing large nucleated cells and 
the second consisting of smaller enucleated cells (Palis, 2014). As such, the first 
wave of early fetal erythropoietic development is termed ‘primary’ 
erythropoiesis in order to distinguish it from ‘definitive’ erythropoiesis that 
generates enucleated cells from later fetal development onwards. HSCs arise in 
the fetal yolk sac and migrate to the fetal liver where they undergo expansion 
before reaching the bone marrow where postnatal definitive erythropoiesis 
occurs (Nandakumar et al., 2016).    	
1.3.5 Maturation of Definitive Erythroid Cells  
HSCs lack lineage specific cell markers, but within mice they express stem cell 
antigen 1 (Sca1) and the stem cell growth factor, c-Kit. For both mice and 
humans it is believed that under homeostatic conditions stem cells give rise to 
two non-identical daughter cells: one stem cell (for self-renewal) and one 
differentiating cell (Wilson and Trumpp, 2006). The earliest stage in cellular 
development where cells become restricted to the erythroid lineage is called the 
‘blast forming unit-erythroid’ (BFU-E). These cells respond to erythropoiesis 
stimulating factors and give rise to the rapidly proliferating ‘colony forming unit-
erythroid (CFU-E) (Barminko et al., 2016). Several studies have observed 
circadian oscillations in the colony-forming ability in the human and murine bone 
marrow, raising the possibility that homeostatic HSC proliferation and 
differentiation may follow circadian variations (Mendez-Ferrer et al., 2009; 
Abrahamsen et al., 1997; Bourin et al., 2009). Five subsequent discrete 
developmental stages separate CFU-E from terminally differentiated 
erythrocytes: pro-erythroblast, basophilic erythroblast, polychromatic 
erythroblast, orthochromatic erythroblast and reticulocyte (Figure 1. 26).  
 
The differentiation and proliferation of CFU-E are also regulated by 
erythropoiesis stimulating factors. The cell’s transition to pro-erythroblast is 
accompanied by the loss of c-Kit but the gain of the ubiquitous erythroid 
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marker, Ter119, a protein associated with glycophorin A (Barminko et al., 2016). 
The pro-erythroblasts proliferate and sequentially differentiate through the 
subsequent erythroid stages (Figure 1.26). Within both mice and humans, the 
pro-erythroblast undergoes 4 mitotic divisions, giving rise to a basophilic, 
polychromatic, orthochromatic ratio of 1:2:4:8 (Liu et al., 2013). Erythroblast 
development is accompanied a progressive decrease in cellular size, as well as 
condensation of the nucleus and an accumulation of cytoplasmic hemoglobin 
(Barminko et al., 2016). The former developmental characteristic has been 
linked to a successive shortening of the G1 phase (cell growth) between each 
division, thus also temporally shortening the cell cycle of each erythroblast 
stage (Dolznig et al., 1995). However, this observation was made in an avian 
model of erythropoiesis in which nuclear condensation is not associated with 
maturation, therefore it unlikely to be relevant to mammals. Moreover, in vitro 
culture systems with murine erythroblasts have reported progressive 
differentiation of subsequent stages at approximately twelve-hour intervals 
(Chen et al., 2009; Koury et al., 1984).  
 
At the orthochromatic stage, the erythroid cell has exited the cell cycle and the 
highly condensed nucleus and additional organelles are extruded, forming a 
reticulocyte. It has been hypothesised that enucleation occurs in order to 
prevent the dedifferentiation of erythrocytes during their exposure to external 
regulatory factors such as cytokines (Raess et al., 1985). Moreover, there is a 
direct link between enucleation and increases in cellular deformability; 
therefore erythroid cells may lose their nucleus in order to facilitate passage 
through narrow vessels such as capillaries (Gaehtgens et al., 1981; Barminko et 
al., 2016).  
 
The reticulocyte stage can be further sub-divided into four sub-categories 
(Heilmeyer stages I- IV) based on the gradual reduction in supravital staining 
patterns.  Stages I-II are confined to the bone marrow, whereas stages III-IV are 
observable within circulation where they mature into terminally differentiated 
erythrocytes (Malleret et al., 2015). The bone marrow restricted reticulocytes 
are endocytic and motile (Griffiths et al., 2012). The stage III cell egresses from 
the bone marrow parenchyma by diapedesis to the sinusoidal capillary lumen 
(Sage and Carman, 2012). Under homeostatic conditions it takes 2 – 3 days for 
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stage I reticulocytes to sequentially mature into erythrocytes (Raess et al., 
1985). In this work erythroblasts and stage I-II reticulocytes will be referred to 
as tissue resident erythroid cells. 
 
 
		
Figure 1.26 Schematic of erythroid cells and precursors.  CFU-E transform into A. 
pro-erythroblast, which then successively differentiate into B. basophilic erythroblast, C. 
polychromatic erythroblast and D. orthochromatic erythroblast. The orthochromatic stage 
enucleates to become an enucleated reticulocyte. The differentiation times in mice are 
marked above the cells (Chen et al., 2009; Filmanowicz and Gurney, 1961). E. Stage I-II 
reticulocytes mature within the tissue. F. Stage III-IV reticulocytes are within the 
circulation. The final differentiation stage is erythrocytes (RBC). From pro-erythroblasts 
the erythroid lineage expresses Ter119. This stage also expresses CD44 and CD71. The 
former is down-regulated systemically in relation to diapedesis.  
 
Flow cytometric approaches have recently been developed to identify the 
distinct stages of erythroid cells based on defined cellular characteristics. In the 
mouse, the transferrin receptor, CD71, is expressed highly in erythroid 
precursors and down-regulated during maturation (Lok and Ponka, 2000). This 
marker can be combined with Ter119 in order to identify CD71+ Ter119+ 
erythroblasts and CD71- Ter119+ erythrocytes (Socolovsky et al., 2001; Liu et al., 
2006). Recently, Chen et al (2009) have shown that the expression of the cell 
surface glycoprotein, CD44, is more systemically decreased during maturation 
than CD71, therefore allowing for a higher level of discrimination between the 
erythroblast stages. Using a combination of Ter119, CD44 and cell size, it is 
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possible to resolve all 6 stages from pro-erythroblast through to terminally 
differentiated erythrocytes (Table 1.6) (Chen et al., 2009; Liu et al., 2013).   
 
 
Cellular marker  Protein  Cell lineage  
Ter119 Associated with 
glycophorin A 
Erythroid lineage 
CD44 Glycoprotein involved in 
cell-cell interactions and 
diapedesis  
Leukocytes and erythroid 
cells 
CD45 Protein tyrosine 
phosphatase 
Pan leukocyte and early 
erythroblasts 
CD11b Subunit of integrin CR3 Myeloid and NK cells 
	
Table 1.6 Cellular markers used to resolve erythroid cells.	 
 
It is interesting to note that Chen et al (2009) also measured the protein 
abundance of three of the host receptors for Plasmodium invasion during 
erythroid maturation. Glycophorin A, the Duffy antigen and Band 3 are only 
detectible, at relatively low levels, from the basophilic erythroblast stage with 
abundance increasing through maturation (Chen et al., 2009).  It is also 
interesting to note that immature erythroid progentiors are positive for beta 2 
integrin, as judged by immunoadherence to a anti-cd18 coated plates 
(Papayannopoulou and Brice, 1992). This adhesion molecule is lost from the 
surface of erythroid cells as they mature to become CD18- cells 
(Papayannopoulou and Brice, 1992).  
 
1.3.6 Erythroblast Islands  
Within in vitro cultures, erythroblasts differentiate in the absence of other cell 
lineages. However, in vivo, erythropoiesis occurs within specialised multi-
lineage niches termed erythroblast islands. They comprise of a central ‘nurse’ 
macrophage, which engulfs the expelled erythroid nuclei, and erythroid cells at 
various stages of development (Chasis and Mohandas, 2009). Depletion studies in 
mice have shown that the central macrophages directly promote the retention 
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and maturation of the physically associated erythroid cells within hematopoietic 
tissue (Chow et al., 2011, 2013). The strength of the cellular adhesion between 
the central macrophage recedes prior to enucleation, thus allowing the 
subsequent reticulocyte to egress from the bone marrow (Toobiak et al., 2012). 	
1.3.7 Regulation of Steady State Definitive Erythropoiesis  
In mice and humans the hematopoietic tissue is located within the postnatal 
bone marrow.  Adult mouse splenic red pulp has also been recognised as a site of 
erythropoiesis (Sadahira et al., 1990). Under steady state conditions, 
erythrocyte production is regulated at the rapidly proliferating CFU-E population 
by the peptide hormone erythropoietin (EPO), which is synthesised primarily in 
the kidney by peritubular fibroblasts, and Stem cell factor (SCF) (Barminko et 
al., 2016). The epo locus contains an enhancer region that is regulated by 
hypoxia inducible transcription factors (Hifs) (Barminko et al., 2016). This 
permits transcriptional regulation in response to local oxygen levels in peripheral 
blood, which is an indirect measure of hematocrit. As such, hypoxic conditions in 
the blood leads to elevated levels of EPO in serum. Once hematocrit and 
consequently hemoglobin levels are restored, epo transcription returns to steady 
state levels (Barminko et al., 2016).  
 
Under steady state conditions, 10-20% and 40-60% of the CFU-Es undergo 
apoptosis in the murine bone marrow and spleen, respectively (Liu et al., 2006). 
CFU-E apoptosis also occurs in the human bone marrow under the same 
conditions (Muta and Krantz, 1993; Kelley et al., 1994). Increased EPO levels in 
both species stimulate CFU-E survival by increasing expression of cellular pro-
survival factors, such as BCL-XL, and down-regulation of pro-apoptotic factors 
(Koulnis et al., 2011, 2012). Moreover, the apoptotic signaling proteins, Fas and 
Fas-ligand, expressed by erythroblasts are down-regulated in the presence of 
EPO. It is interesting to note that splenic erythroblasts express a significantly 
higher Fas and Fas-ligand during basal state compared to their bone marrow 
counterparts (Liu et al., 2006). This homeostatic system compensates for minor 
fluctuations in hemoglobin levels without exhausting the slow dividing, earliest 
form of erythroid progenitor, the BFU-Es (Barminko et al., 2016).   	
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1.3.8 Definitive Erythropoiesis under Stress 
CFU-Es populations undergo 4 divisions before becoming terminally mature. As 
such, elevated EPO levels stimulated by minor hematocrit fluctuations can only 
regulate a limited increase in erythrocyte numbers. Therefore this mechanism 
cannot counteract erythrocyte deficiency under extreme conditions of hypoxic 
stress. As such, in these circumstances erythropoiesis is regulated at the BFU-E 
population level (Barminko et al., 2016).  
 
In both humans and mice, glucocorticoid (GC) nuclear hormone receptor 
signaling regulates stress erythropoiesis (Varricchio et al., 2012). GC signaling 
induces expression of a BFU-E hif (Hif-1 alpha) transcriptional regulator that 
promotes expansion of the BFU-E population (Flygare et al., 2011). Hif-1 alpha 
activation in turn synergises with GC signaling, thus suggesting that hypoxia 
(EPO) and stress signaling cooperate to restore erythrocyte numbers (Barminko 
et al., 2016). Interestingly, mice deficient in the GC receptor have an impaired 
phenotype that only manifests itself in the spleen under stress. The murine bone 
marrow does not exhibit GC receptor dependent regulation (Bauer et al., 1999; 
Reichardt et al., 1998). This therefore implicates the murine spleen as the 
predominant site of stress erythropoiesis.  
 
Both BMP4 and SCF also play significant roles in stress erythropoiesis (Barminko 
et al., 2016). The former signals through the Smad5 receptor of Sonic hedgehog 
primed BFU-Es in the murine spleen in order to regulate the erythroid response 
to anemia (Perry et al., 2009). Mice deficient in Smad5, although viable, fail to 
produce a compensatory erythroid response to anemia (Lenox et al., 2017; 
Barminko et al., 2016). The SCF and its signaling pathway work in synergy with 
the GC receptor; in the absence of SCF signaling the GC receptor cannot 
mediate prolonged BFU-E expansion (Lindern et al., 2017). Therefore, EPO, SCF, 
and BMP4 signaling synergise to increase proliferation. 
 
1.3.9 Extra Medulla and Stress Erythropoiesis in Humans 
The in vivo analysis and location of stress erythropoiesis in humans is difficult. 
Direct experiments examining the regulation of stress erythropoiesis are not 
possible and the analysis of erythropoiesis in patients with severe anemia is 
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complicated by the effects of pathology (Paulson et al., 2011). Nonetheless, 
extramedullary (outwith the bone marrow) erythropoiesis has been reported to 
occur when the bone marrow is compromised, such as in myeloproliferative 
disorders, lymphomas and leukaemias (Freedman and Saunders, 1981). 
Extramedullary erythropoiesis has also observed in the spleen and liver in 
patients without bone marrow dysfunction (Palitzsch et al., 1987; Deiwick, 
1992).  
 
Stutte et al (1986) speculated that murine and human splenic extramedullary 
erythropoiesis is fundamentally different. They proposed that murine splenic 
erythropoiesis involved endogenous splenic progenitors, whereas in humans they 
suspected that bone marrow endogenous erythroid cells migrated to the spleen 
(Stutte et al., 1986; Freedman and Saunders, 1981). However, this was directly 
contradicted by recent transplant experiments that observed the mobilisation of 
bone marrow HSCs to the murine spleen. This indirectly suggests that the 
establishment and replenishment of the murine splenic erythroid progenitor cells 
is dependent on bone marrow derived progenitors (Paulson et al., 2011; Perry et 
al., 2009). Interestingly, human bone marrow derived HSCs can also be mobilised 
(Broxmeyer et al., 2005) and their migratory pattern is controlled by the same 
chemokine as in mice, stromal cell derived factor 1 (SDF-1/ CXCL12) (Aiuti et 
al., 1997). This was confirmed by engraftment experiments where human HSCs 
homed to the spleen of irradiated mice in a SDF-1 dependent manner (Lapidot 
and Kollet, 2002). Interestingly, it should also be noted the stromal cells of the 
splenic red pulp in both species produce SDF-1 (Ellyard et al., 2005; Hargreaves 
et al., 2001).  
 
The investigation of mechanisms that regulate erythropoiesis in humans relies on 
in vitro culture systems and the non-invasive study of patients with various 
forms of anemia. The disease studies discussed above show that mechanistically, 
splenic erythropoiesis in humans is possible. Moreover, the Palizsch et al (1987) 
histological study of spleens harvested from deceased cirrhotic liver patients 
also reported splenic erythroblast islands within their ‘healthy’ control spleen 
samples, therefore providing evidence that the human spleen can be 
functionally permissive to erythropoiesis. However, it remains to be directly 
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investigated whether erythroid cells in the human spleen are regulated in a 
stress erythropoiesis manner similar to the mouse spleen.  	
1.3.10 The Cytoskeleton of Erythroblasts  
As discussed previously, terminally differentiated erythrocytes have a 
cytoskeleton assembly that facilitates high cellular deformability.  Protein 
expression profiling performed on highly synchronous erythroblast populations 
observed an increase in expression of all cytoskeletal proteins, except for actin, 
during maturation (Chen et al., 2009). The immunoblots of the skeletal proteins 
indicate that the earliest stage that all proteins are present at their maximum 
abundance is the polychromatic erythroblast. Therefore, it is likely that the 
complete assembly of a functional spectrin-based cytoskeletal network can only 
occur from this stage onwards (Chen et al., 2009). 
 
This is interesting in the context of Plasmodium invasion. As discussed previously 
it is believed that the parasite takes advantage of the deformable properties of 
erythrocyte cytoskeleton in order to gain entry to the cell (Zuccala et al., 2016).  	
1.3.11 The Metabolism of Erythroblasts  	
Intravital imaging of the murine bone marrow indicated there is a steep oxygen 
tension gradient across the tissue that forms relatively oxygen rich regions 
around the vasculature and hypoxic zones within the deep perisinusoidal regions 
(Spencer et al., 2014; Acar et al., 2015). Both regions are niches for HSCs. 
Hypoxic conditions disrupt the oxidative phosphorylation pathway leading to 
oxygen independent glycolysis (Solaini et al., 2010). Prolonged hypoxia leads to 
the stimulation of HIF transcription factors. It has been determined that HSCs 
undergo HIF dependent differentiation in the bone marrow (Oburoglu et al., 
2016; Mantel et al., 2010), thus establishing parenchymal lineage committed 
populations within the vascular niche. This niche is relatively less hypoxic, thus 
allowing restoration of oxidative phosphorylation (Oburoglu et al., 2016; Kaplan 
et al., 2007).  
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There has yet to be a metabolomics profile generated for the maturation stages 
of the erythroid lineage prior to diapedesis. As such, clear metabolic differences 
between the stages have yet to be identified. A recent comparison of 
reticulocytes (stage III &IV) with terminally mature erythrocytes observed that 
the former were more metabolically complex and rich in carbon metabolites 
(Srivastava et al., 2015). Mature erythrocytes do not contain mitochondria, thus 
the principal method of energy generation is via glycolysis. Within the 
reticulocyte the mitochondria is degraded, but Srivastava et al (2015) observed 
that this erythroid stage has a functional TCA cycle. Taking into account that 
erythroblasts undergo oxidative phosphorylation, it is likely they are more 
metabolically rich than reticulocytes. 
 
The metabolic environment of the erythroid cell is interesting when considered 
in the context of Plasmodium. As discussed previously parasite asexual 
proliferation is dependent on the availability of host-derived nutrients. 
Srivastava et al (2015) directly linked the nutrient rich environment of the 
reticulocyte to P. berghei tolerance of genetic disruption of parasite metabolic 
pathways. The metabolically active host cell made the parasite’s corresponding 
pathways redundant. Interestingly, when P. falciparum is cultured in mature 
erythrocytes, viability is lost when the parasite’s metabolic pathways are 
disrupted.  	
1.3.12 Erythropoiesis during Malaria  
Anemia is a common complication in patients presenting with malaria. The WHO 
defines anemia as hemoglobin levels <13.0 g/dL at sea level in adult men (WHO, 
2011). During the disease, the parasite lyses its host erythrocyte in order to gain 
entry to a new cell and the spleen removes both infected and uninfected 
erythrocytes from circulation (Safeukui et al., 2015). Nonetheless, the pathology 
of malaria-associated anemia is complex. As discussed above, a fluctuation in 
circulating hemoglobin levels would stimulate an increase in erythropoiesis. 
Malaria anemia is characterised by low reticulocytosis, and as such, it has been 
suggested that erythropoiesis is suppressed during infection (Pathak and Ghosh, 
2016). It has been observed in both human samples and murine models that 
malaria decreases the numbers of BFU-E and CFU-E in the bone marrow (Maggio-
Price et al., 1985; Wickramasinghe and Abdalla, 2000). This is not likely due to a 
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deficiency in the mechanism of homeostatic regulation, the evidence regarding 
the status of EPO production during malaria remains conflicted (Chang and 
Stevenson, 2004). Instead inadequate erythropoiesis is likely mediated by the 
inflammation within the erythropoietic tissue (Haldar and Mohandas, 2009).  
Malaria infection induces the release of high levels of inflammatory IFN-gamma 
and TNF-alpha over a short period (Wickramasinghe and Abdalla, 2000). While 
there have not been direct studies on erythroblast maturation in malaria 
infection, an in vivo study into Leishmania donovani induced anemia concluded 
that inflammatory cytokines mediated apoptosis of erythroblasts (Lafuse et al., 
2013). It is also interesting to note that pro-inflammatory cytokines can also 
induce the expression of hepcidin from hepatocytes, leading to a decrease in 
serum iron. As erythropoiesis dominates iron metabolism, there is a direct link 
between low circulating iron concentration and diserythropoiesis (Cavill, 2002). 
Therefore, the host’s immune response to infection probably makes a significant 
contribution to anemia.   
 
1.3.13 Organ Remodeling during Malaria 
 
Alongside diserythropoiesis, malaria causes architectural remodeling of the 
spleen and endothelial cell activation. Hyper-reactive malarial splenomegaly 
(HMS) is a leading cause of increased spleen weight in malaria endemic areas. It 
is caused by a aberrant immune response resulting from chronic antigenic 
stimulation and is distinct from splenomegaly that results directly from malaria 
parasitaemia (Leoni et al., 2015).  The latter pathophysiology is associated with 
the expansion of the red and white pulp, with the white pulp becoming markedly 
disorganised (Buffet et al., 2011).  
 
It is interesting to note that infected erythrocytes released extracellular vesicles 
have been reported to activate endothelial cells, up regulating the expression of 
ICAM-1 and CD36, thus exacerbating inflammation at the blood-brian barrier 
(Nantakomol et al., 2011; Campos et al., 2010; Combes et al., 2005).  	
1.3.14 Summary  
The key points in this section were: 
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• Erythroblasts are extravascular in the bone marrow but in open 
circulation in the spleen (sections 1.3.1 & 1.3.3; pages 59 & 63) 
• Extra medulla erythropoiesis occurs under stress in mice and has been 
observed in humans (section 1.3.9; pages 72).  
• Dyserythropoiesis during malaria contributes to anemia (section 1.3.12; 
pages 75).  
• Defined host invasion ligands are only expressed from the basophilic 
erythroblast stage (section 1.3.5; page 67). 
• Erythroid cytoskeletal proteins are only fully assembled from the 
polychromatic stage (section 1.3.10; page 74). 	
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1.4 Plasmodium within the Erythropoietic Organs of the Host 
The key points in this section are: 
• All stages of Plasmodium are present within the human bone marrow. 
• Plasmodium can invade erythroblasts.  
• There are two predominant models of in vivo extravascular infection. 
 
The conclusions to these points are reviewed in the summary: section 1.4.7 	
1.4.1 Evidence for Plasmodium in Human Bone Marrow  
Bone marrow aspirates from malaria patients infected with P. falciparum 
(Aguilar et al., 2014a; Abdulsalam et al., 2010; Smalley et al., 1981a; Aguilar et 
al., 2014b), P. vivax (Pothapregada and Kamalakannan, 2014; Imirzalioglu et al., 
2006; Yoeli et al., 1948; Tiab et al., 2000; Ru et al., 2009) or P. malariae 
(Imirzalioglu et al., 2006) have consistently contained detectible numbers of 
parasites. Taking into account the high density of tissue vasculature these 
observations are not surprising (section 1.3.1). However, many samples were 
obtained from patients presenting malaria-associated symptoms but with 
undetectable blood parasitaemia (Aguilar et al., 2014a; Abdulsalam et al., 2010; 
Aguilar et al., 2014b; Imirzalioglu et al., 2006; Ru et al., 2009). Aspirating and 
smearing bone marrow samples disturbs the endogenous tissue architecture, 
consequently studies using these techniques could not determine the location of 
parasites in relation to the vascular lumen or extravascular tissue. Nonetheless, 
these observations were the initial indication that the bone marrow is a site of 
parasite accumulation.   
Despite the observable presence of all stages of parasites, Smalley et al. (1981) 
were the first to note the enrichment of P. falciparum immature gametocytes 
within bone marrow aspirates compared with the peripheral blood. This was 
supported by a recent single patient study in which the authors performed 
histological analysis of bone marrow samples and reported high numbers of 
immature P. falciparum gametocytes compared with mature gametocytes 
(Farfour et al., 2012). Significantly, due to the study’s use of intact bone 
marrow sections, Farfour et al. (2012) were the first to report the presence of 
Plasmodium within the extravascular spaces of the bone marrow. The 
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observation that P. falciparum immature gametocytes localised within 
extravascular spaces offers an explanation for their conspicuous absence from 
peripheral blood (section 1.2.28). Nonetheless, the bone marrow was the only  
organ biopsied in this patient, and as such, the dynamics of extravascular 
infection throughout the host’s anatomy were not fully addressed in such 
studies.  
The first multi-organ, wide scale histology screen carried out on patient autopsy 
samples presented evidence that immature gametocytes of P. falciparum are 
over represented within the extra vascular spaces of the bone marrow compared 
with all other sampled organs (Joice et al., 2014). However, it should also be 
noted that the authors indirectly stated that ~55% of all parasites detected 
within extravascular bone marrow were asexual (Joice et al., 2014). Thus, 
despite immature gametocytes enrichment being the exciting observation, the 
evidence also interestingly indicates that the erythropoietic tissue may be an 
uninvestigated niche for both sexual and asexual development of Plasmodium.  
1.4.2 Invasion of Erythroblasts by Asexual Parasites 
The extravascular spaces of the bone marrow contain micro-environmental 
compartments in which immature erythroid cells proliferate and differentiate 
(section 1.3.5). Histological ex vivo studies of Plasmodium-infected bone marrow 
have not conclusively identified the maturation stage of the extravascular cells 
containing asexual parasites (Joice et al., 2014; Farfour et al., 2012). However, 
there is in vitro evidence that asexual P. falciparum (Peatey et al., 2013; Tamez 
et al., 2009, 2011; Joice et al., 2014) and P. vivax (Panichakul et al., 2007) can 
invade erythroblasts. This is supported by both an ex vivo flow cytometry-based 
study that reported schizont-like parasites of the murine parasite P. yoelii 
within nucleated Ter119+ cells (Imai et al., 2013) and an electron microscopy 
study that observed P. vivax in erythroblasts from bone marrow smears (Ru et 
al., 2009).  
 
1.4.3 The Two Models of Extravascular Gametocytaemia 
The studies discussed in section 1.4.1 (gametocytes within the extravascular 
spaces of the bone marrow) and those discussed in section 1.4.2 (erythroblast 
Introduction	 	 		 80	
susceptibility to asexual Plasmodium) are complimentary. Drawn together this 
evidence could support a hypothesis that merozoites establish an extravascular 
asexual micro-cycle that promotes the parallel development of gametocytes 
within immature tissue resident erythroid cells (erythroblasts and stage I-II 
reticulocytes) (Nilsson et al., 2015). However, confusion has arisen from the 
Joice et al. (2014) histological study where the majority of extravascular 
gametocytes were observed within cells that lacked markers associated with 
immature erythroid cells, therefore the authors considered these enucleated 
erythroid cells as ‘mature’ erythrocytes. As such, a second model has been 
proposed to address how Plasmodium establishes its extravascular 
gametocytaemia. This model hypothesises that immature gametocyte-infected 
erythrocytes actively ‘home’ to the extravascular spaces, transmigrating out of 
circulation into tissue (Figure 1.27) (Nilsson et al., 2015).  
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Figure 1. 27	 Establishing extravascular gametocytaemia. Two models predominate 
within the literature to explain the presence of gametocytes within erythropoietic tissue. 1. 
Merozoites enter the tissue through an unknown route or mechanism. These merozoites 
invade immature erythroid cells and form either asexual or sexual parasites. The asexual 
parasites can go on to seed further gametocyte infection within the tissue.  Immature 
gametocytes mature within the tissue in parallel with their host cell. Mature gametocytes 
emerge into circulation in enucleated erythroid cells. 2. Ring stage gametocyte-infected 
erythrocytes actively home to the erythropoietic tissue through an unknown mechanism. 
These cells translocate out of circulation into the tissue through an unknown mechanism 
and gametocyte maturation and decreases in cellular deformability occur here. Terminal 
gametocyte maturation results in an increase in deformability, which co-insides with the 
cell detection in peripheral blood.      
 
1.4.4 Gametocyte homing  
It is widely accepted that circulating maturing reticulocytes and terminally 
differentiated erythrocytes are non-motile. However, in vitro cultures of P. 
falciparum schizonts with human brain endothelium cell monolayers observed 
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formation of structures that resembled podosomes, which are involved in 
leukocyte transmigration (section 1.3.2) (Jambou et al., 2010). It is interesting 
to note that although erythrocytes do not express cd18 (section 1.3.5), infected 
erythrocytes display parasite derived ligands that can bind to endothelial cell 
receptor ICAM-1 and PECAM (section 1.2.23), both of which mediate steps in 
leukocytes transendothelial migration (section 1.3.2) and both of which are up 
regulated by endothelial cells during malaria infection (section 1.3.13). 
Nonetheless, it can be argued that the Jambou et al (2010) study was not 
biologically relevant as the monolayers were derived from an immortalised cell 
line and the parasitaemia was enriched to 90%. More recently, in vivo work from 
a humanised mouse model indirectly observed the migration of infected 
erythrocytes into the bone marrow parenchyma (Duffier et al., 2016). Yet, this 
work relied solely on histological detection of hemozoin within the parenchyma, 
and as such, conclusions cannot be made about the parasite life stage or 
viability. A contemporary intravital imaging study directly observed P. berghei 
gametocyte-infected erythrocytes translocating across bone marrow 
endothelium (De Niz, submitted; Marti Lab, Glasgow, 2016). Though, it should be 
noted that the authors relied on a constitutive fluorescent proxy and asexual 
parasite drug depletion in order to infer life cycle stage. Yet, this is the first 
direct evidence that gametocyte-infected erythrocytes may have the ability to 
actively and selectively migrate into tissue in vivo. Although gametocyte 
infected erythrocytes do not display parasite derived adhesion ligands (section 
1.2.28), it could be hypothesised that the parasite itself conveys motility to the 
infected cell and this can be tentatively linked to the fully assembled 
glideosome present within gametocytes during development. 
The gametocyte cytoskeleton has also been implicated in extravascular 
retention. Immature erythroid cells are retained within the erythropoietic tissue 
through their direct association with ‘nurse’ macrophages (section 1.3.6). Joice 
et al (2014) observed that the majority of extravascular gametocyte-infected 
‘mature’ erythroid cells were associated with erythroblastic islands. However, 
there is no direct evidence that stage III-IV reticulocytes or terminally 
differentiated erythrocytes can sustain a physical attachment to macrophages. 
This can largely be attributed to the fact that the adhesion ligands expressed on 
erythroblasts that are responsible for their attachment are absent from 
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circulating erythroid cells (Joneckis et al., 1993; Zennadi et al., 2012). It has 
therefore been suggested that the relatively decreased deformability of 
immature gametocytes promotes their retention within the extravascular 
erythropoietic tissue. Furthermore, the increase in deformability of maturing 
gametocytes mirrors their appearance in the peripheral blood, thus suggesting 
that the changes in gametocyte physicality is linked to translocation into 
circulation (Nilsson et al., 2015; Aingaran et al., 2012; Dearnley et al., 2012; 
Tibúrcio et al., 2012, 2015b).  
1.4.5 Model 1 and Model 2 May Coexist  
Sexual commitment has been observed to be enhanced when P. falciparum is 
cultured in early erythroid cells compared to terminally differentiated 
erythrocytes (Peatey et al., 2013; Joice et al., 2014). It has also been observed 
that erythroblasts are permissive to gametocyte development in vitro and 
infected erythroblasts in culture are able to develop to the point of enucleation 
(Peatey et al., 2013; Joice et al., 2014). Therefore, in vitro evidence suggests 
that gametocyte infection of erythroblasts is not a dead end and it can therefore 
be argued that the two models for establishing extravascular gametocytaemia 
are not mutually exclusive.  
1.4.6 Immunological Implications of Erythroblast Infection 
Erythroblasts express a high levels of MHC class I molecules and as such there 
are immunological implications of Plasmodium parasitising these cells (Imai et 
al., 2013). Consequently, there must be a trade off between developing within 
immature erythroid cells and the potential for killing via CD8+ cytotoxic T cells 
and subsequent clearance by phagocytic cells (Imai et al., 2015, 2013). 
However, the literature has not yet directly addressed ability of Plasmodium to 
establish a micro-environmental life cycle within immature erythroid cells, nor 
the implications this niche could have on malaria.  
1.4.7 The Need for a Murine Model of Immature Erythroid Infection  
Farfour et al. (2012) and Joice et al. (2014) were the first to comprehensively 
show Plasmodium has the ability to access the bone marrow extravascular niche. 
Nonetheless the use of human samples brings a number of limitations. 
Systematic analysis of the dynamics of infection cannot be performed. Ethically, 
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administration of chemotherapy cannot be withheld, therefore such studies 
cannot directly untangle the role chemotherapy plays in either the enrichment 
of immature gametocytes within the bone marrow or the overall dynamics of 
extravascular infection. Moreover, the use of frozen or formalin-fixed human 
samples restricted the authors to histological methodologies and precluded the 
use of flow cytometry. Only the latter can discretely identify the maturation 
stages of parasite-infected erythroblasts or early reticulocytes (stage I- II) using 
cellular markers (Joice et al., 2014; Farfour et al., 2012). 
Imai et al. (2013, 2015) and Ru et al (2009) presented ex vivo evidence that 
Plasmodium can invade nucleated non-circulating erythroid cells, however, the 
authors did not investigate the maturation stage of the parasitised erythroid cell 
stage, nor the enrichment of parasite life stages.  
Here we propose the development of a murine model of tissue resident erythroid 
infection. This will circumvent and control for the ethical requirement for use of 
chemotherapeutics. Moreover, this will also open the door to temporal studies 
that are impossible in humans. Another advantage of using a murine model is 
that, unlike field samples, the harvested tissue can be analysed rapidly, 
therefore making the use of flow cytometry a feasible option. The hematology 
literature has developed robust flow cytometry-based strategies to distinguish 
the maturing stages of immature erythroblasts in the murine bone marrow and 
spleen in order to study erythropoiesis (Chen et al., 2009; Liu et al., 2013, 
2006). These strategies, with limited modification, could be applied to the 
investigation of the maturation stages of Plasmodium infected immature 
erythroblasts.  
Calculating the parasitaemia of the different erythroid cell stages will reveal the 
parasite invasion preference, which in itself is interesting. However, as 
maturation along the erythroid lineage is accompanied by multiple rounds of cell 
division the cell numbers of different stages of immature erythroid cells are not 
equal (Liu et al., 2013). This is exacerbated during malaria by Plasmodium-
induced anemia (Chang et al., 2004; Villeval et al., 1990). As such, the 
quantifiable feature of flow cytometry will also allow us to identify the 
immature erythroid cell stage that contains the highest parasite burden, 
information that may prove biologically relevant to future chemotherapy trials.  
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Recently, the development of humanised mice models has allowed for the 
ethical manipulation of human Plasmodium infection in vivo (Duffier et al., 
2016; Moreno et al., 2006; Sabater et al., 2005). Nonetheless, there is a trade 
off with the use of such models. Murine host immunodeficiency is a prerequisite 
for human erythrocyte maintenance (Duffier et al., 2016; Moreno et al., 2006; 
Sabater et al., 2005). The NSG mouse strain used in such studies has a plethora 
of mutations that manifest as deficiencies in both the innate and adaptive 
immune systems (C.River, 2017). Considering that host erythropoietic tissue(s) 
are located within immunological organs, the depletion of the host immune 
system may have significant effects on erythropoiesis that cannot be 
experimentally controlled. Moreover, transferring infected human erythrocytes 
into a murine host precludes the investigation of immature erythroid cells 
infection. Human-infective Plasmodium cannot infect any stage of murine 
erythroid cells. Therefore in a humanised mouse model, merozoites will not be 
able to invade murine immature erythroid cells and establish a non-circulating 
infection. Taking this into account we have chosen to use a murine infective 
Plasmodium species, specifically P. berghei, to establish our model.  
1.4.8 Summary  
• There are two models of extravascular infection (section 1.4.3; page 79). 
• The literature has not yet directly addressed Plasmodium’s ability to 
establish a micro-environmental life cycle within immature erythroid 
cells, nor the implications this niche could have on malaria recrudescence 
(section 1.4.7; page 82).  																
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1.5. Conclusions  
Histological studies have observed Plasmodium within extravascular spaces of 
the bone marrow. Although there is evidence that Plasmodium can invade 
immature erythroid cells in vitro and in vivo, the temporal and spatial dynamics 
of extravascular infection has not been investigated. Due to the ethical and 
methodology restrictions imposed on the analyses of human field samples, we 
propose the development of a P. berghei model of immature erythroid infection.  
1.6 Aim and Hypothesis  
The hypotheses of this work are: 
• P. berghei invades immature erythroid cells in vivo. 
• A significant proportion of P. berghei parasites within immature erythroid 
cells undergo gametocytogenesis. 
• The immature erythroid cells offer a protective niche during drug 
administration; thus retaining a pool of parasites that could seed a 
recrudescent infection.  
 
In order to test the hypotheses, the overarching aim of this project is to 
establish a murine model of tissue resident erythroid infection. This will be 
compartmentalised into two questions (Figure 1.28): 
1. Does P. berghei parasitise tissue resident cells and is there enrichment 
for a particular life stage? 
2. Is erythropoietic tissue infection a source of recrudescence?  
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Figure 1.28. Project aim. Diagram depicting: the intra vascular (sinusoid) life cycle 
(blue arrows) of P. berghei; the immature erythroid cells (erythroblasts and early 
reticulocytes) within the erythropoietic tissue. It should be noted that this diagram is 
more representative of the endothelial lined bone marrow vessels rather than the open 
circulation of the splenic red pulp, nonetheless, the two questions being asked remain 
applicable for both tissues. The first question (1) asks whether a P. berghei merozoite 
can invade and replicate within erythroblasts and early reticulocytes. Dotted line and 
arrows associated with question 1 represent the migration of a parasite into the tissue 
and the parasite’s invasion of one of the age classes of erythroid cells.  The second 
question (2) asks whether a pool of infected immature erythroid cells remain after drug 
treatment (complete clearance of peripheral blood infection) and whether this pool 
could establish a recrudescent infection. The dotted lines and arrows associated with 
question 2 represent the migration of infected early reticulocytes into the peripheral 
circulation.  
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2. Materials and Methods 	
 
2.1 Mice 
All animal experiments were performed within the strict parameters defined by 
the Home Office and UK Animals (Scientific Procedures) Act 1986 and approved 
by the University of Glasgow Ethics Committee.  
Female BALB/c (Harlan) and NIH (Harlan) mice were age and weight matched. 
6-8 week old female outbred Theiler’s Original (TO) mice weighting 25-30 g were 
procured from Harlan Laboratories (Shardlow, England, UK) and used to maintain 
parasite stocks.  
 
2.2 P.berghei Parasite lines  
The characterised P. berghei- ANKA PbGFPko230p-SMCON (507 clone1) (Janse et 
al., 2006) was used to infect mice and as the parental line to P. berghei –ANKA 
PbGFPCON/RFPGAM line. The parasites were asynchronous in order to reflect the 
dynamics of a natural P. berghei infection. This was to reflect the presidence in 
the literature for observing parasite dynamics across seven days (Franke-Fayard 
et al., 2005, 2010) 
 
2.3 Statistics  
Graphs, means, SEM and SD were calculated from 3 experimental repeats in 
triplicate unless stated otherwise using Prism 6 (graphPad Software). Error bars 
are generated from SD unless stated otherwise. Normality was tested. p values 
were calculated using paired Student t test (comparisons of organs and erythroid 
compartments within a group), unpaired Student t test (comparisons between 
groups), one-way ANOVA in Prism 6 (graphPad Software). p values were 
calculated for non normal data using mann-whitney U test (graphPad Software).  
Significant difference between groups or samples were indicated with asterisks, 
denoting as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. 
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2.4 Methodologies Used for Identifying Erythroid Cells by Flow 
Cytometry. 	
2.4.1 Establishing infection 
Infection of laboratory animals with P. berghei ANKA was performed intra-
peritoneal (IP) using cryopreserved parasites. Cryopreserved parasites were 
thawed at room temperature for 30 mins and 0.2-0.5 ml of the cryovial contents 
taken up into a 1 ml syringe. Using a 26G, 0.45x12 mm needle (14-12117, 2019-
20, Henke sass wolf) the infected blood was injected IP into the right hand side 
(avoiding the spleen) of a securely scuffed uninfected animal.  Parasitaemia was 
monitored daily by visual inspection of Giemsa stained thin blood smears.  
 
2.4.2 Seven-day infection  
Infection was established by the mechanical passage of tail blood obtained from 
a previously infected animal (Section 2.4.1). Vasodilation of uninfected mice was 
induced at 37 °c for 15-20 mins. Mice were appropriately restrained and 
infected intravenously (IV) with 104 parasites diluted in 1 x PBS (Gibco). 
Parasitaemia was monitored daily either by visual inspection of Giemsa stained 
thin blood smears or by flow cytometry 
 
2.4.3 Giemsa staining of thin blood smears  
Tail blood was used to make thin blood smears on standard microscope slides.  
The blood was air-dried, fixed for 30 seconds in 100 % methanol and stained in 
12 % (v/v) Giemsa for 15 mins. The slides were washed in water, dried and 
examined under a standard light microscope using a 100 x objective and 
immersion oil. 10 fields were examined and parasitaemia was expressed as a 
percentage of infected erythroid cells in the total population of erythroid cells. 
 
 
 
 
 
Materials	and	Methods	 90		
2.4.4 Whole body perfusion 
Once mice had been anesthetised (Isoflurane), a 5 cm incision was made through 
the integument and abdominal wall just below the rip cage. Incisions were made 
through the diaphragm and long the rib cage to expose the pleural cavity. 1.5 ml 
of blood was exsanguinated via cardiac puncture of the left atrium. Mice were 
then culled by schedule 1 neck dislocation (The Humane Killing of Animals under 
Schedule 1 to the Animals Act 1986). 10 ml of 1 x PBS (Gibco) was perfused 
through the animal using a 10 ml syringe (BD Plastipak) and a 26G, 0.45x12 mm 
needle (14-12117, 2019-20, Henke sass wolf) inserted into the right atrium. 
Successful body perfusion was judged by the absence of blood when performing 
tail vein puncture.  
 
2.4.5 Tissue harvesting 
Mice were culled by schedule 1 neck dislocation. Death was confirmed by cardio-
respiratory failure and unresponsiveness to pain stimuli. 2-5 µl of peripheral 
blood was collected in 1 ml of 1 x PBS (Gibco). The spleen was removed, 
weighted and placed in 1 ml of 1 x PBS (Gibco) and transported on ice. The 
femur was dislocated from the pelvis and the skin and muscle removed fully 
from the femur and tibia before the bones were added to 1 ml 1 x PBS (Gibco) 
and transported on ice. The epiphysis of the femur and tibia were removed using 
a single edge razor blade (Swann Morton). The bone marrow was perfused from 
the diaphysis and epiphysis using a 5 ml syringe (BD Plastipak) and 26G, 0.45x12 
mm needle (14-12117, 2019-20, Henke sass wolf) containing 3 ml 4 °C 1 x PBS 
(Gibco). The bone marrow and the spleen were gently dissociated into a 50 ml 
falcon tube (Greiner) on ice using a 40 µm cell strainer (Greiner), the plunger of 
a 5 ml syringe (BD Plastipak) and 4 °C 1 x PBS (Gibco). The blood, bone marrow 
and spleen cells were centrifuged at 400 g for 10 mins at 4 °C and the 
supernatant discarded. The bone marrow cells were suspended in 1 ml 4 °C 1 x 
PBS (Gibco) and the spleen in 10 ml. 10 µl of the single cell suspension was 
suspended 1:1 in 0.04 % trypan blue (Sigma). Viable cells (non stained) were 
counted using a haemocytometer (Nano Entek) and the total number of cells 
calculated for each sample. Approx. 3 x107 cells (total viable cells) of each 
sample were added per well to a 96 well plate (Costar). The plate was 
centrifuged at 400 g for 5 mins and the supernatant discarded.  
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2.4.6 Erythrocyte lysis 
Cells were centrifuged at 450 g for 8 mins and then the pellet suspended in 14 
ml 1 x erythrocyte lysis buffer (Roche) and incubated at 4 °C for 20 mins. The 
sample was wash for twice for 5 mins at 400 g in 1 x PBS. This process removed 
enucleated erythroid cells (early reticulocytes, reticulocytes and erythrocytes).  
2.4.7 DyeCycle Ruby optimisation 
The appropriate working concentration and staining temperature for DyeCycle 
Ruby (thermofisher) staining was determined through serial dilution. Blood, 
spleen and bone marrow tissue was collected from mice infected with 507 
clone1 and uninfected controls. Samples of blood and tissue were stained at 
different DyeCycle Ruby (thermofisher) concentrations and temperatures (Table 
2.1). Samples were then stained with the erytrhoid cell flow panel.   
 
 
 
 
 
 
  
 
 
2.4.8 Antibody titration  
To determine the appropriate working concentration of each antibody 
uninfected tissue was prepared and stained with a serial dilution and the data 
analysed (Table 2.2). 
 
 
 
 
 
 
 
 
Concentration Temperature 
1:100 37°C 
1:1000 37°C 
1:2000 37°C 
1:2000 4°C 
Table 2.1 Concentration and Temperature used for DNA stain optimisation 
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Anti- mouse Clone Fluorophore  Company  Dilution  
CD44 IM7 PE BD Biosciences 1 :200 
CD71 R17 APC eBioscience 1 :200 
CD71 R17 e450 eBioscience 1 :200 
CD45 30-F11 PECY5.5 BD Biosciences 1 :200 
CD11b M1/70 Alexa Fluor 
700 
eBioscience 1 :200 
CD11b M1/70 eFluor 450 eBioscience 1 :200 
CD44 IM7 PECP CY5.5 eBioscience 1 :200 
CD45 30-F11 eFluor 450 eBioscience 1 :200 
Ter119 Ter119 PECY7 eBioscience 1 :200 
Ter119 Ter119 APC eBioscience 1 :2000 
(imageStream) 
Sca-1 D7 PE eBioscience 1 :200 
c-kit 2BB FITc eBioscience 1 :200 
c-Kit 2BB APC eBioscience 1 :200 
Isotype  Rat IgG2b K 
Iostype 
control  
PE eBioscience 1 :200 
Isotype Rat IgG2b K 
Iostype 
control 
PECP CY5.5 eBioscience 1 :200 
	
Table 2.2 Antibody working concentrations 
 
2.4.9 Flow cytometry  
Cell pellets (3 x 107 cells) were suspended in 50 µl mouse Fc block targeting 
CD16/CD32 (grown in house from 2.4G2 cell line) and incubated at 4 °C for 30 
mins. The cells were then stained with fluorescently labeled antibodies diluted 
appropriately in 50 µl mouse Fc block and Vybrant DyeCycle Ruby stain 
(thermofisher) at a 1 in 2000 concentration before incubating in the dark at 4 °C 
for 30 mins. The cells were washed twice at 400 g for 3 mins with 4 °C 1 x PBS 
(Gibco), then stained with fixable viability dye eFluor 506 (ebioscience) at a 1 in 
1000 concentration in 4 °C 1 x PBS (Gibco). The cells were incubated at 4 °C for 
30 mins in the dark. The cells were washed once at 400 g for 3 mins with 1 x PBS 
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(Gibco) and suspended in FACS buffer (0.5 M EDTA in 1 x PBS). The cell 
suspensions were filtered over Nitex mesh (0.2 µm mesh) into FACS tubes 
(Falcon). Cells were analysed on MACSquant (Miltenyi Biotec) on the low flow 
rate setting. Quantitative cell numbers were derived from running 10 µl of each 
fully stained sample on the low flow rate setting. Data were analysed with 
FlowJo software (Treestar inc.). 
 
2.4.10 Statistical considerations for Flow Cytometry  
Identifying infected erythroblasts meant observing populations < 1 % of the 
sample population. In order accurately report the parasitaemia of the 
erythroblast stages and to satisfy the issue of poisson statisitcs (the counting of 
randomly distributed objects in a volume) the whole bone marrow sample was 
acquired. For the spleen the aim was to satisfy a calculation of the coefficient of 
variation at 10 – 15 %. A previously published calculation was carried out: r= 
(100/CV)2; where r is the number of events of a target population to be acquired 
(Hedley and Keeney, 2013).    
 
2.4.11 Intravascular staining of erythroid cells 
Intravascular staining for the discrimination of bone marrow vascular and extra 
vascular erythroid cells was adapted from a previously described protocol 
(Anderson et al., 2014). Briefly, mouse reactive fluorescent conjugated antibody 
was prepared in sterile 1 x PBS (Gibco) and kept on ice. The antibody was 
injected IV into an uninfected mouse. The mouse was culled by neck dislocation 
after injection. The femur, tibia and spleen were immediately removed and the 
bone marrow perfused out with Fc block (grown in house from 24G2 cell line) 
and all tissue dissociated separately over a 40 µm cell strainer (Greiner). The 
tissues were immediately washed three times at 400 g for 1 mins with 1 x PBS. 
The cells where then processed and stained ex vivo for flow cytometery (2.4.9). 
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2.4.12 Image stream  
Single cell suspensions of spleen samples from 507 clone1 infected mice were 
erythrocyte lysed (2.4.6). GFP+ cells were sorted on a S3 sorter (BioRad) into 
FACS tubes (Falcon) containing 100 µl 4 °C 1 x PBS (Gibco). The cells were 
centrifuged at 400 g for 10 mins and the supernatant removed. The cells were 
blocked in 50 µl mouse Fc block (grown in house from 24G2 cell line) and 
incubated at 4 °C for 30 mins. Cells were then stained for APC conjugated anti-
Ter119 (ebioscience) at 4 °C for 30 mins, then stained for DNA (0.25 µM 
DyeCycle Violet) at 37 for 30 mins. The sample was run on a ImageStream 
(amnis) flow cytometer. Images were analysed on the Ideas software (amnis) 
selecting for Ter119+ cells. 
 
2.4.13 Cell sorting 
Erythroid cells were sorted on a FACSARIA III (BD Biosciences), and using a 70 µm 
nozzle, into FACS tubes (Falcon) containing 1 ml 4 °C 1x PBS (Gibco).  
 
2.4.14 Imaging sorted cells 
The sorted cells were centrifuged at 400 g for 10 mins and the cell pellet 
smeared onto a standard microscope slide. The slides were stained in 12% (v/v) 
Giemsa or May-Grünwald (0.25 % (w/v) in methanol) (Sigma Aldrich) for 5 mins, 
washed in 1 % PBS (Gibco) or water. The slides were examined under a standard 
light microscope using a 100 x objective and immersion oil. 
 
2.4.15 Infection of mice with sorted cells 
Uninfected BALB/c mice were infected IV with 100 cell sorted GFP+ erythroid 
cells. Parasitaemia was monitored daily. 
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Line	
 
2.5.1 PCR reaction 
Protocol for PCR amplification of P. berghei genome fragments and rfp (Table 
2.3 and 2.4) using a master mix as follows: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Step Temperature (°C) Time  
Denaturation  95 10 mins 
95 30 s 
Annealing Tm ° C 30 s  
Extension  68 1 min/ kb  
 To go step 2 X 30 
Extension 68 10 mins 
Hold  10 ∞ 
Table 2.3 PCR parameters  
Reagents  Volume (µl)  Final concentration  
10 x PCR buffer  2.5 1x 
25mM dNTPs 0.5 0.5 nM 
10pmol sense primer 1 1 µM 
10pmol anti-sense primer 1 1 µM 
50mM MgCl2 1 2 mM 
Plat Taq polymerase  0.2 1 Unit 
DNA template 1 (50-100 ng) 
ddh20 To 50 µl  
Table 2.4 Master mix reagents 
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2.5.2 PCR amplification of rfp 
DNA constructs for used in the genetic modification of P. berghei were prepared 
using standard molecular biology techniques. The rfp gene was amplified using a 
standard PCR reaction (section 2.5.1) from plasmid pG0161 (unpublished). The 
pair of sense and anti-sense oligonucleotides had the restriction sites for Xhol 
and Xmal incorporated at the 5’ end respectfully. Primers designed using CLC 
workbench 5.0 and ordered from Eurofins MWG operons (Ebersberg, Germany) 
(Table 2.5). 
 
 
 
 
 
 
Table 2.5 Primes for rfp amplification. Lower case sequence indicated restriction 
enzyme site.   
 
2.5.3 Construct assembly   
The PCR products were purified using the Qiaquick PCR purification kit (Qiagen) 
following manufacturer’s instructions and the nucleic acid concentration 
measured using a nanodrop spectrotometer. During the molecular cloning 
workflow, the purified PCR product and the target plasmid were digested with 
the same appropriate enzyme(s). XmaI (New England Biolabs) and Xhol (New 
England Biolabs) were used to facilitate ligation into plasmid pG306 to create 
pG403 (Figure 2.1). The restriction digestions were carried out in accordance 
with the manufacturer’s instructions. The digested PCR product was purified 
using the Qiaquick PCR (Qiagen) kit. The digested plasmid was run on a 0.8 % 
(w/v) agarose gel using 5 x loading dye (Thermo) and 1 kb+ DNA ladder 
(Thermo).  The vector backbone was excised and purified using the Qiaquick gel 
purification (Qiagen) kit, following the manufactures instructions. The nucleic 
acid concentrations of the purified PCR product and vector were measured using 
a nanodrop spectrotometer. A vector and insert ligation reaction was set up in a 
molar ratio of 1:3 using the Rapid DNA ligation kit (Roche Diagnostics), following 
Gene  Sense 5’-3’ Antisense 5’-3’ 
rfp attctcgagATGAGTAGATCT
TCTAAGAACGTC 
attcccgggTTACAAGAACAAGTGG
TGTCTAC 
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the manufactures instructions. The ligated plasmid was transformed into 
competent E. coli cells by gently mixing 5 µl of the ligation reaction with 60 µl 
of cells and incubating on ice for 30 mins. The mixture was then heat-shocked at 
42 °C for 30 seconds and incubated on ice for 5 mins. The bacteria was then 
added to 250 µl LB broth (10 g/l tryptone, 5 g/l yeast extract, 5 g/l NaCl) and 
incubated at 37 °C for 45 mins, before being streaked out on a LB agar (1.5 % 
(w/v) agar in LB medium) (Amp+ 100 mg/ ml) plate and incubated for 37 °C 
overnight.  
 	
 		 									 	 								
 
 
Figure 2.1 Schematic of plasmid pG403. Restriction enzyme sites labeled.  
 
2.5.4 Construct confirmation  
Individual bacterial colonies were isolated and incubated in 3 ml LB broth 
(Amp+) at 37 °C overnight. 1 ml of each culture was added to a cryovial along 
with 200 µl of 100 % glycerol to make glycerol stocks which where then stored at 
-80 °C. The plasmid was extracted from the overnight culture using the Qiaquick 
Amp resistance 
Homology arm 
Homology arm 
rfp 
101870  
promoter 
3’ UTR 
45/ 48 
 
yFCU hDHFR 
eef1alpha 
promoter 
3’ UTR homology 
3’ UTR homology 
SacII 
SacII 
Xhol 
Xmal 
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miniprep kit (Qiagen), following the manufactures instructions. The extracted 
plasmids were digested with the appropriate restriction enzymes to excise the 
open reading frame and 10 µl of the reaction was analysis on a 0.8 %  (w/v) 
agarose gel using 5 x loading dye (Thermo) and 1 kb+ DNA ladder (Thermo). This 
was done as a diagnostic step to confirm the open reading frame and plasmid 
had ligated. The sequence of the open reading frame in each plasmid was 
validated by DNA sequencing (MWG eurofins) using appropriate primers.  
 
2.5.5 Preparation of construct for transfection  
The glycerol stock of the bacterial colony containing the confirmed plasmid was 
used to inoculate 25 ml LB broth (Amp+) and the plasmid extracted using the 
Qiagen midiprep kit (Qiagen). Plasmids were linearised with SacII (New England 
Biolabs) digestion in preparation for transfection and double homologous 
recombination integration within the parasite genome (Figure 2.1). 
 
2.5.6 Phenylhydrazine induced stress erythropoiesis 
To increase the percentage of circulating reticulocytes stress erythropoiesis was 
induced through hemolysis. 0.1 ml phenylhydrazine-Hcl (Sigma) (PHZ) (12.5 mg/ 
ml) was administered IP using a 26G, 0.45x12 mm needle (14-12117, 2019-20 and 
1 ml syringe (BD Plastipak) to an uninfected animal. PHZ was administered two 
days prior to any subsequent infection.  
 
2.5.7 Short-term culture of asexual stages  
Three days post infection 1-1.5 ml of blood was exsanguinated via cardiac 
puncture under anesthetic (Isoflurane), with 50 µl heparin (200 units/ ml). Death 
was confirmed by the permanent cessation of the circulation by the severing of 
the major blood vessels close to the heart. The infected blood was added to 150 
ml complete culture medium (RPMI1640, Sodium Bicarb, Hepes, HT suppl. FBS) 
split across two 75 cm2 non-vented flasks (falcon). The cultures were gassed (5 % 
CO2, 5 % O2, 90 % N2) for 30 seconds and incubated at 37 °C, 40 rpm over night. 
Thin blood smears were made the following day, Giemsa stained, parasitaemia 
calculated and maturation state of parasites examined (2.4.3). 
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2.5.8 Purification of schizonts 
The 75 cm2 asexual cultures were combined and centrifuged at 450 g for 10 mins 
to pellet the erythrocytes. All but 15 ml of the supernatant was removed. The 
pellet was suspended in the remaining 15 ml supernatant and 55 % (v/v) 
Nycodenz (Lucron bioproduct) solution was introduced slowly under the culture 
suspension to create two distinct layers. The Nycodenz culture was centrifuged 
for 20 mins at 450 g with no break. The thin brown interface between the 
medium and the nycodenz was gently removed. This layer contained schizonts 
that were then pelleted by centrifugation for 8 mins at 450 g.  
 
2.5.9 Transfection 
Transfection of PbGFPcon parasites with linearised constructs, positive and 
negative selection and cloning of the PbGFPCON/RFPGAM were performed as 
previously described (Chris J Janse, 2006; Janse et al., 2006; Orr, Philip and 
Waters, 2012). Briefly, 100 µl nucleofector solution and 5-10 µg linearasised DNA 
were added to Nycodenz purified schizonts and electroporated using an Amaxa 
Nucleofector device set to program U-33. The parasites where injected IV into 
an uninfected animal.  
 
2.5.10 Positive selection of transfected parasites 
Pyrimethamine (70 µg/ ml) (Sigma) was administered in the drinking water of 
the animals one day post infection and continued for 5 days. The correctly 
integrated construct conveys pyrimethamine resistance from the gene hdhfr. 
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2.5.11 Cryopreserving  
When an infected mouse exhibiting 1-2 % parasitaemia 1-1.5 ml of blood was 
exsanguinated via cardiac puncture under anesthetic (isoflorane) with 50 µl 
heparin (200 units/ ml). Death was confirmed by the permanent cessation of the 
circulation by the severing of the major blood vessels close to the heart. 0.4 ml 
of infected blood was added to an appropriately labeled cryovial and mixed with 
0.4 ml 30 % (v/v) glycerol solution (Hparin, glycerol, 1 x PBS). Tubes were 
incubated at 4 °C for 5 mins then incubated at -80 °C for 1 week before being 
transferred to liquid nitrogen. 
 
2.5.12 Extraction of parasite genomic DNA 
Peripheral blood was erythrocyte lysed (section 2.4.6). The lysis solution was 
centrifuged at 1700 rpm for 8 mins. The parasite pellet was suspended in 350 µl 
TNE buffer (10mM Tris (pH 8.0) and 5 mM EDTA (pH 8.0), 100 mM NaCl were 
subsequently added. The solution was incubate at 37 °C for 10 mins, 200 µg 
Proteinase K (Sigma) added and then incubated again at 37 °C for 1 hr. 1.5 ml 
Buffered Phenol (Sigma) was added to the solution, the ependorf tube inverted 
several times and centrifuged at 4 °C for 5 mins at 14000 rpm. The aqueous 
upper phase was gently removed and transferred to a new ependorf tube and 1.5 
ml buffered phenol: chloroform: isoamylalcohol (25:24:1) (Sigma) was added. 
The tube was inverted several times and centrifuged at 4 °C for 5 mins at 14000 
rpm. Again, the aqueous upper phase was transferred to a new ependorf tube 
and 1.5 ml chloroform: isoamylalcohol (24:1) (Sigma) was added. The tube was 
inverted several times and centrifuged at 4 °C for 5 mins at 14000 rpm. The 
aqueous upper phase was transferred to a new ependorf tube and 0.1 volume of 
3 M Sodium acetate, pH 5.2, and 2 volumes of 100 % ethanol were added. The 
tube was inverted several times and incubated at -20 °C overnight in order to 
precipitated the DNA. The tube was then centrifuged for 20 mins at 14000 rpm 
at 4 °C and the DNA pellet washed with 500 µl 70 % (v/v) ethanol. The tube was 
then centrifuged for 10 mins at 14000 rpm at 4 °C. The supernatant was 
removed and the DNA pellet was air-aired and suspended in 50 µl double 
distilled water.  
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2.5.13 PCR confirmation of construct integration 
A PCR reaction was carried out on the extracted parasite gDNA to confirm the 
correct and full integration of the introduced construct (Table 2.6). The PCR 
product was visualised on a 0.8 % (w/v) agarose gel using 5 x loading dye 
(Thermo) and 1 kb+ DNA ladder (Thermo) 
 
 
Table 2.6 Sequence of primers used for integration 
 
 
2.5.14 Cloning By limiting dilution 
In order to obtain a clonal parasite line from a single parent a limiting dilution of 
the desired genotype was carried out.  Briefly, a previously PHZ treated donor 
mouse (2.5.6) was infected IP using a stabolite of the desired genotype. 5 µl of 
tail blood was harvested from the donor mouse when peripheral blood 
parasitaemia reached 0.5 %. The tail blood was added to 1 ml 1 x PBS and the 
erythrocyte concentration determined using a haemocytometer. The parasite 
suspension was then diluted to 0.8 parasites/ 150 µl 1 x PBS. 10 mice were then 
inoculated IV with 150 µl of the parasite suspension. Parasitaemias were 
monitored from day 10 post infection and the infected blood exsanguinated 
exsanguinated via cardiac puncture under anesthetic (Isoflurane), with 50 µl 
heparin (200 units/ ml) when peripheral blood parasitaemia reached 1-5 %. 
Death was confirmed by the permanent cessation of the circulation by the 
severing of the major blood vessels close to the heart. Clonal populations were 
checked by PCR and cryopreserved.   
 
 
 
Pair name 
Primer 
ID Sequence 
3' 
integration  
GU1682 CATAAACGGTTTATTTAAAGTCATTTTTGG 
GU706 CGACTAGTCCCGGGCTTAACATTCACATATATTAATAATTTTAAT 
5' 
integration 
GU1681 TAGTTAGCTTAAATTGTCCAACTGG 
GU1132 GGTATTCTGGCAGAAG 
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2.5.15 Negative selection 
5- Fluorocytosine (5-FC)(1.5 mg/ ml) (Sigma) was administered in the drinking 
water of the animals one day post infection with a clonal parasite line and 
continued for 5 days. The selection pressure of this drug promotes the 
spontaneous excision (homologous recombination between 3’ UTR homology 
regions) of the drug selection cassette from the parasites genome due to yfcu 
encoding 5-FC sensitivity. When an infected mouse exhibited 1-2 % parasitaemia, 
1-1.5 ml of blood was exsanguinated via cardiac puncture (Isoflurane) with 50 µl 
heparin (200 units/ ml). The gDNA extracted (2.5.12) and PCR used to check for 
the loss of the drug selection cassette from the genome (2.5.1). Samples were 
cryopreserved (Table 2.7). 
 
Primer ID Sequence 
GU1682 CATAAACGGTTTATTTAAAGTCATTTTTGG 
GU1681 TAGTTAGCTTAAATTGTCCAACTGG 
 
Table 2.7 Sequence of primers used for identifying the excision of the drug 
selection cassette. 					
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2.6 Methodologies Used for Characterising a P. berghei Parasite 
Line 	
2.6.1 In vitro reinvasion assay  
A erythrocyte invasion assay was performed as described previously (Philip and 
Waters, 2015). Briefly, Nycodenz purified schizonts (2.5.8) were stained with 
anti Ter119 at a 6:100 concentration at room temperature for 3 mins before 
being washed with 1 x PBS (Gibco). Merozoites were released by rupturing 
schizonts by serially passing through a 5 µm (Acrodisc) and a 1.6 µm (Puradisc, 
Whatman) and adding to uninfected unstained blood (10 % haematocrit). Cells 
were incubated at 37 °C and 800 rpm for 10 mins before being added to schizont 
media. Samples were taken at various time points and analyzed by flow 
cytometry.   
2.6.2 Magnetic column removal of mature gametocytes  
Nycodenz enriched schizonts (2.5.8) where injected IV into uninfected mice. 15 
mins post injection blood was exsanguinated via cardiac puncture under 
anesthetic (Isoflurane), with 50 µl heparin (200 units/ ml). Blood was passed 
over a magnetic column (Macs) at 37 °C to remove mature gametocytes and 
residual schizonts. The flow through blood containing uninfected erythrocytes 
and ring stage parasite was collected and cultured (2.5.7). 
 
2.6.3 Gametocyte enrichment with Sulphadimizine  
Animals were phenylhydrazine treated (2.5.6) prior to infected IP with 
PbGFPCON/RFPGAM. Sulphadiazine (30 mg/ ml) was administered to the drinking 
water of the animals when blood parasitaemia reached >5 %. 48 hrs post drug 
administration peripheral blood was exsanguinated via cardiac puncture under 
anesthetic (Isoflurane). 
 
2.6.4 Gametocyte cell sorting 
Gametocytes from the sulphadimizine treated peripheral blood (2.6.3) were 
sorted on a S3 sorter (BioRad), into FACS tubes (Falcon) containing 1 ml 4 °C 1 x 
PBS (Gibco). Gametocytes were activated by incubating the cells at room 
temperature (approx. 25 °C).  Cells were imaged as descripted in section 2.4.14. 
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2.7 Methodologies used for the Drug Protection Study.  
 
2.7.1 Drug dosing  
Peters’ 4 day suppression test was carried out as previously described (Vega-
Rodríguez et al., 2015). A 10 mg/ ml stock solution was prepared for CQ 
diphosphate salt (Sigma-Aldrich) in 1 x PBS (Gibco) and subsequently diluted in 1 
x PBS (Gibco). A 10 mg/ ml stock solution was prepared for Pyrimethamine (PRY) 
(Sigma-Aldrich) in 100 % dimethyl sulfoxide (DMSO) and subsequently diluted in 1 
x PBS (Gibco). A 10 mg/ ml and 100 mg/ ml stock solutions of Artemisinin (ART) 
were prepared in 100 % dimethyl sulfoxide (DMSO). The 100 % DMSO ART stock 
solution was diluted in sterile water and 45 % cyclodextrin (Sigma) (final 
concentration of 10 %)(Sigma-Aldrich) so that the final concentration of DMSO 
was 3 %. BALB/c mice were infected IV with 106 PbGFPCON/RFPGAM parasites 
(Section 2.4.1 and 2.4.2) before being treated with either CQ (IP), PRY (IP) or 
ART (subcutaneous) 1 hr post infection and every 24 hrs for three additional 
doses. Mice in control groups received vehicle control (1 x PBS or 3 % DMSO and 
10 % cycle dextrin in sterile water). Parasitaemia was monitored daily by flow 
cytometry. On day 4-post infection parasitaemia was measured for all mice in 
the group. Bone marrow and spleen were harvested from 3-4 mice per group and 
flow cytometry analysis performed (Section 2.4.5 and 2.4.9) The parasitaemia of 
the remaining mice was monitored daily by flow cytometry.  
 
 	
Results	
	
104	
3. Establishing a Quantitative Approach to Investigating 
P. berghei Infection of Tissue Resident Erythroid Cells 		
 
3.1. Introduction 
The mammalian bone marrow and the murine spleen are characterised sites of 
erythropoiesis, a dynamic process that gives rise to erythrocytes via sequential 
maturation and differentiation of nucleated erythroblasts and enucleated 
reticulocytes. Histological analyses of intact autopsy samples have observed 
Plasmodium within the extravascular spaces of the bone marrow (Farfour et al., 
2012; Joice et al., 2014). A direct link can be drawn between this observation 
and evidence that Plasmodium can invade erythroblasts (Ru et al., 2009; Tamez 
et al., 2009; Imai et al., 2013; Peatey et al., 2013; Joice et al., 2014). While a 
number of Plasmodium species such as P. berghei and P. vivax isolates have a 
characterised tropism for circulating reticulocytes (stage III-IV), their tropism for 
stage I-II reticulocytes found in erythropoietic tissues (Malleret et al., 2015) is 
unclear. Therefore, the in vivo preference of Plasmodium within the different 
stages of maturing tissue resident erythroid cells is worthy of investigation. 
 
The pathology of in vivo infection adds an additional level of complexity to 
studying the infection of tissue resident erythroid cells. Malaria triggers anaemia 
and splenic remodelling, both are a consequence of the dynamic interplay 
between the parasite and the host immune system (Haldar and Mohandas, 2009; 
Buffet et al., 2011). Superimposed on this, the two erythropoietic tissues in the 
mouse (the bone marrow and the spleen) are accessible via different routes. The 
bone marrow parenchyma is reached via the active transmigration of cells out of 
the sinusoidal lumen, whereas arterial blood empties into the red pulp of the 
murine spleen as part of the open circulation (Travlos, 2006; Maxie, 2015). 
Furthermore, the maturation of erythroid cells within the murine bone marrow 
and the spleen are regulated under distinct conditions of homeostasis and stress 
respectively (Reichardt et al., 1998; Bauer et al., 1999). As such, alongside 
parasite preference, this chapter will identify the tissue specific erythroid stage 
that presents the highest tissue resident parasite burden within an infection.  
Results	
	
105	
Here a flow cytometric approach for identifying erythroid cells will be optimised 
for use with a P. berghei line constitutively expressing GFP (Janse et al., 2006; 
Liu et al., 2013). As such, the aims of this chapter are to: 
 
• Identify P. berghei susceptible erythroid cells. 
• Identify the tissue-specific erythroid stage with the highest parasitaemia.  
• Establish that tissue resident erythroid cells are also permissive to P. 
berghei development.   
• Identify erythroid cell stages that present the highest parasite burden in 
vivo in tissue resident infections. 
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3.2. Results  
 
3.2.1. CD71 is an Unreliable Marker for Detecting Different Stages of 
Erythroid Cells  
 
Immunofluorescence identification of the surface proteins CD71 and Ter119 is 
currently the only protocol used to distinguish between different stages of 
circulating erythroid cells during Plasmodium infection (Martín-jaular et al., 
2013; Lelliott et al., 2014; Lelliott, Mcmorran and Foote, 2015). As such, the 
detection of tissue resident erythroid cells was initially optimised based on this 
combination of surface markers.  Spleen, bone marrow and peripheral blood 
were harvested from uninfected, non-perfused mice to allow direct comparison 
with the established haematology literature (Figure 3.1A). Using flow cytometry 
analysis of relative CD71 expression (Figure 3.1B) (Liu et al., 2006), viable 
erythroid cells (CD45-/low, Ter119+) cells identified in both organs were separated 
into erythrocytes (EryA; CD71- small cells), reticulocytes (EryB; CD71+ small 
cells) and erythroblasts (EryC; CD71+ large cells) (Figure 3.1C). Cells were 
detectable within the EryB gate of peripheral blood, thus making it impossible to 
distinguish between circulating and tissue resident reticulocytes (Figure 3.1B).  
This observation is corroborated by previous flow and immunoblot analysis (Chen 
et al., 2009; Martín-jaular et al., 2013). As such, the combination of these 
markers could not discretely resolve tissue resident and peripheral blood 
erythroid cells. Moreover, when this gating strategy was applied to samples 
harvested from P. berghei infected mice there was an obvious disparity (Figure 
3.1A & D). A significant decrease in CD71 abundance was observed, as 
determined by mean fluorescence intensity (MFI), in the EryB and EryC 
populations derived from infected spleen samples compared with uninfected 
samples (Figure 3.1E). To examine whether decreased CD71 expression was 
restricted to infected cells a P. berghei line that constitutively expresses GFP 
throughout its life-cycle (PbGFPko230p-SMCON: 507 clone1) was used (Janse et 
al., 2006). A difference in CD71 MFI between parasitised (GFP+) and non-
parasitised (GFP-) EryB or EryC populations in the P. berghei infected spleen was 
not observed (Figure 3.1F). This suggests that P. berghei infection results in the 
loss of CD71 from the maturing erythroid cell surface at a population level. More 
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importantly, this observation makes CD71 an unreliable marker for defining 
erythroid populations during Plasmodium infection. 
 
 
A.	
Harvest: femur, tibia, whole spleen and blood. 
Physical dissociation of tissue into single cell suspension  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, Ter119, CD71. 
Viability dye.  
Total cell numbers (all cell type. Viable cells) in sample 
extrapolated from cell count. 
Sample analysed by flow cytometery and gated with the 
strategy shown in Fig 3.1B 
Optimisation: Uninfected animals (Figure 3.1A) 
CD71 MFI of infected samples: Infected with 104  
GFP+ parasites on day 0. Cull on day 7 post 
infection alongside uninfected controls. 
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Peripheral	blood	 Bone	marrow	 Spleen	 		
	
	gate	A	 	gate	B	 gate	B	 gate	C	 gate	B	 gate	C	
uninfected	 75	±	4	 3500	±	1618	 1648	±	79	 3694	±	494	 2194	±	255	 4508	±	614	
infected		 82	±	3	 1423	±	212	 1549	±	30	 4160	±	541	 1767	±	43	 2495	±	187	
	
p	=	0.06	 p	=	0.09	 p	=	0.2	 p	=	0.3	 *	p	=	0.04	 **	p	=	0.005	
	
Spleen	
	
ER	 EB	
GFP-	 1561	±	444	 2079	±	603	
GFP+	 1902	±	131	 2626	±	214	
	
p	=	0.1	 p	=	0.6	
E.	
F.	
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Figure 3.1 CD71 is an unreliable marker for resolving different erythroid populations 
during P. berghei infection. A. Flow diagram of methodology used to generate data with 
the CD71 vs Ter119 gating strategy B, Representative FACS plots of uninfected bone 
marrow. Representative plots for spleen and peripheral blood can be found in the 
Appendix 8.1.1 The orange arrows indicate the sequential hierarchy of the gating strategy.   
Cells were gated successively as singlets and then as viable cells based on their 
impermeability to a viability dye. Leukocytes were removed from the viable population by 
excluding cells expressing the pan leukocyte marker CD45.  The gate was set as CD45-/low 
due to the most immature stages of erythroblasts expressing a low level of CD45 (Gordon 
et al., 2008). Next erythroid cells were selected from the CD45-/low population based on 
their expressed of the ubiquitous erythroid marker Ter119. Erythroid cells were separated 
into three populations based on their size (FS-A) and their expression of the transferrin 
receptor CD71 (a erythroid specific marker down regulated during maturation). Previous 
studies had determined that erythrocytes and mature reticulocytes fall into the EryA gate, 
maturing reticulocytes and late erythroblasts fall into the EryB gate and early erythroblasts 
into the EryC gate (Liu et al., 2006). The plots show that the reticulocytes within the 
peripheral blood and the tissue expressed similar levels of CD71. C. Schematic indicating 
which developmental stages of erythroid cells that fall into the gates EryC, EryB and EryA. 
CFU-E transform into A. pro-erythroblast, which then successively differentiate into B. 
basophilic erythroblast, C. polychromatic erythroblast and D. orthochromatic erythroblast. 
The orthochromatic stage enucleates to become an enucleated reticulocyte. The 
differentiation times in mice are marked above the cells (Chen et al., 2009; Filmanowicz 
and Gurney, 1961). E. Stage I-II reticulocytes mature within the tissue. F. Stage III-IV 
reticulocytes are within the circulation. The final differentiation stage is erythrocytes 
(RBC). The vertical dotted line indicates the separation between circulating and tissue 
resident stages. D. Representative Flow cytometry plots of viable, CD45-, Ter119+ cells 
gated against CD71 and FS-A. Left hand column contains plots from uninfected animals; 
right hand column contains plots from infected animals. The tissue from which the cells 
derive is labeled down the right hand side. BM: bone marrow E, Mean expression levels of 
CD71 as demonstrated by MFI (± SD) within the CD45-/low, Ter119+ circulating cell 
population (EryA) from the peripheral blood. The table also shows the mean MFI of CD71 
(± SD) of EryB and EryC extracted from organs of uninfected and P. berghei infected 
mice. The p values, calculated from a t test, describe the difference between the CD71 
MFI of the corresponding populations in the uninfected and infected mice (n=3). F, Mean 
expression levels of CD71, shown by MFI (± SD) of parasitised cells (GFP+) compared 
with non parasitised cells (GFP-) in the EryB and EryC gates taken from the spleens of P. 
berghei infected animals (n = 3).  NS= not significant. 
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3.2.2. Identifying Erythroid Cell Maturation Stages: Optimising the 
Methodology with CD44 		
3.2.2.1 CD44 vs Ter119 
Flow based approaches in the haematology literature have recently defined that 
a combination of CD44 detection and cell size (FS-A) can separate Ter119+ cells 
into discrete stages of erythroid maturation (Chen et al., 2009; Liu et al., 2013). 
Using this combination of immunofluorescence markers, optimisation was again 
initiated with uninfected non-perfused samples (Figure 3.2A). Viable, CD45-/low, 
CD11b-, Ter119+ were identified in the peripheral blood samples using flow 
cytometry (Figure 3.2B). The isotype control for CD44 staining indicated that 
this cell marker is not completely lost from erythroid cells in peripheral blood 
(Figure 3.2C). This is in agreement with both immunoblotting and flow analysis 
from previous studies (Bony et al., 1999; Chen et al., 2009). 	
 
 	
	
A. 
Harvest: femur, tibia, whole spleen and blood. 
Physical dissociation of tissue into single cell suspension  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, CD11b, Ter119, CD44. 
Viability dye.  
Total cell numbers (all cell type. Viable cells) in sample 
extrapolated from cell count. 
Sample analysed by flow cytometery and 
gated with the strategy shown below 
(Figure 3.2B). 
Gating with the strategy shown 
below and cell sorting of 
population of interest (Figure 3.3).  
Optimisation; uninfected animals (Figure 3.2 & 3.3)  
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Figure 3.1 Two exclusively tissue resident erythroid populations can be 
identified by CD44 expression. A. Flow diagram of methodology used to generate 
data with the CD44 vd Ter119 gating strategy B. Representative FACS plots of the 
uninfected tissue sample (bone marrow. Representative plots for uninfected spleen 
can be found in the Appendix 8.1.2. The purple arrows indicate the sequential 
hierarchy of the gating strategy.   Cells were gated successively as singlets and then 
as viable cells based on their impermeability to a viability dye. Leukocytes were 
removed from the viable population by excluding cells expressing the pan leukocyte 
marker CD45. The gate was set as CD45-/low due to the most immature stages of 
erythroblasts expressing a low level of CD45 (Gordon et al., 2008). Granulocytes can 
be gated as CD45low, to ensure all of these cells were removed from the population of 
interest cells negative for CD11b, a marker on granulocytes, were selected. Next 
erythroid cells were selected from the CD11b- population based on their expressed of 
the ubiquitous erythroid marker Ter119. Ter119+ cells within the peripheral blood had 
a CD44low profile. The CD44low peripheral blood gate was transposed onto Ter119+ 
cells from the tissue. Two additional Ter119+ populations could be gated in the tissue 
samples based on CD44 expression and cell size (FS-A). These where called 
CD44high small and CD44high large. C. The left hand graph is a representative FACS 
plot of the CD44 isotype control. The right hand graph is a representative FACS plot 
of CD44 staining of CD45-/low, CD11b-, Ter119+ cells in the peripheral blood. 	
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3.2.2.2 Reliably Separating Nucleated and Enucleated Tissue Resident 
Erythroid Cells 
 
In addition to the Ter119+CD44low population, the bone marrow and the spleen 
both contained a Ter119+CD44high population with low forward scatter (FS-A; 
small size) and a Ter119+CD44high population of larger cells (Figure 3.2B). Based 
on previous studies (Chen et al., 2009; Liu et al., 2013) these gates were termed 
early reticulocyte and erythroblast, respectively (Figure 3.3). The CD44high large 
cells from uninfected bone marrow were cell sorted to determine whether the 
population exclusively contained nucleated erythroblasts. However, light 
microscopy of the sorted population revealed contamination with enucleated 
cells (Figure 3.3).  
 
 
 
 
ER	
EB	
CD44low  	
 	
FS-A	
C
D
44
	
1	 2	 3	
4	 5	 6	
Figure 3.3 Erythroblasts and early reticulocytes could not be easily resolved. FACS 
plot shows uninfected bone marrow Viable, CD45-/low, CD11b-, Ter119+ cells gated 
against CD44 and FS-A. The CD44low population was defined on the peripheral blood 
samples then transposed onto the tissue sample. The CD44high, FS-A low (small) cells and 
the CD44high large cells were termed early reticulocyte (ER) and erythroblasts (EB), 
respectively. Six representative images of cells sorted from the proposed erythroblasts 
(CD44 high, FS-A high) gate. Cells were stained with Giemsa and examined by light 
microscopy. This revealed that the gate was contaminated with enucleated cells (images 
4 and 5). Scale bar 6 µm. 
Results	
	
116	
To circumvent this problem, a fluorescent DNA dye was included in the flow 
cytometry staining panel, allowing for the separation of DNA+ and DNA- cells in 
uninfected samples. However, as this methodology would be applied to infected 
tissues, the staining protocol was also tested on P. berghei infected blood and 
tissue samples. When the gating strategy, defined by the uninfected samples, 
was superimposed onto the infected samples DNA+ staining of parasites in the 
peripheral blood was observed. This also affected the integrity of the gating 
strategy in the infected tissue samples, making it difficult to define enucleated 
and nucleated erythroid cells.. However, the DNA staining protocol was 
optimised, through titrating the concentration and incubating at different 
temperatures, to ensure that the erythroid cell nucleus was stained but the 
intracellular parasite nucleus was not; the chosen staining condition was a  
1:2000 concentration at 4°C (Figure 3.4 E).  
 
 
 
 
 	
 
 
 
 
 
 
 
	
A.  
Harvest: femur, tibia, whole spleen and blood. 
Physical dissociation of tissue into single cell suspension.  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, CD11b, Ter119, CD44. 
Dycle Ruby DNA stain. 
Viability dye.  
Total cell numbers (all cell type. Viable cells) in sample 
extrapolated from count.  
Sample analysed by flow cytometery and gated 
with the strategy shown below (Figures 3.4, 3.5 
& 3.8). 
CD44 MFI of infected samples (Figure 
3.9). 
Comparing DNA stain in infected 
samples (Figure 3.4 D & E). 
Infection with 104 GFP+ parasites on 
day 0. Cull on day 7 post infection 
alongside uninfected controls. 
Optimisation (Figures 3.4, 3.6 & 
3.7). 
Evidence for Robust gating 
strategy (Figure 3.8). 
uninfected animals.  
Gating with the strategy shown 
below and cell sorting of population 
of interest (Figures 3.6 & 3.7). 
Analysing separation of 
nucleated and 
enucleated cells (Figure 
3.5). 
RBC lysis  
All gates are defined on the uninfected control 
then transposed onto the corresponding 
infected tissue sample (Figures 3.9 & 3.4 D-E). 
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Figure 3.4 Using a DNA stain to discriminate nucleated and enucleated erythroid 
cells allows resolution of a more distinct erythroblast population.  This figure 
represents the gating strategy used throughout the rest of the study in order to identify 
erythroid cells. This will be further highlighted by the use of red arrows when extending 
the strategy. A. Flow diagram of methodology used to generate data using the CD44 vs 
Ter119 gating strategy. B. Representative FACS plots of uninfected peripheral blood and 
C.  tissue sample (Bone marrow tissue). Samples were stained with 2.5 µM DyeCycle 
Ruby DNA stain at 4°C for 30 mins. Viable, CD45-/low, CD11b-, Ter119+ cells were gated 
against DNA staining (DNA) and cell size (FS-A). In the peripheral blood sample all 
erythroid cells were DNA-. The tissue samples contained DNA- and DNA+ erythroid cells. 
The DNA- population in the peripheral blood sample was gate against CD44 and cell size 
(FS-A) to reveal one CD44low population called ‘peripheral blood’. Note the outliers 
included in the plot to highlight the homogeneity of the CD44 expression of peripheral 
blood erythroid cells. The CD44low ‘peripheral blood’ gate was imposed on the DNA- cells 
in the tissues, to define the population called Ter119+CD44low these two populations are 
tinted red in the diagram as both where considered to contain cells that were not tissue 
resident. The DNA- cells in the tissues contained a second population that was CD44high 
small cells. Based on previous studies (Chen et al., 2009; Liu et al., 2013) these gates 
were termed early reticulocytes.  The DNA+ cells in the tissue were also gated against 
CD44 and cell size (FS-A). This revealed a population of CD44high large erythroid cells that 
I termed erythroblasts based on previous studies (Chen et al., 2009; Liu et al., 2013). Only 
the early reticulocytes and erythroblast gate contained cells considered tissue resident D. 
Schematic indicating which developmental stages of erythroid cells that fall into the gates 
erythroblasts, early reticulocytes and Ter119CD44low. CFU-E transform into A. pro-
erythroblast, which then successively differentiate into B. basophilic erythroblast, C. 
polychromatic erythroblast and D. orthochromatic erythroblast. The orthochromatic stage 
enucleates to become an enucleated reticulocyte. The differentiation times in mice are 
marked above the cells (Chen et al., 2009; Filmanowicz and Gurney, 1961). E. Stage I-II 
reticulocytes mature within the tissue. F. Stage III-IV reticulocytes are within the 
circulation. The final differentiation stage is erythrocytes (RBC). The vertical dotted line 
indicates the separation between circulating and tissue resident stages. E. Representative 
FACS plots of DNA stain titration. Represented here are concentrations of 1:100, 1:1000, 
1:2000 stained at 37°C and 1:2000 stained at 4°C. For each condition there is a 
representative plot for uninfected and infected peripheral blood and tissue (spleen), cells 
on these plots are CD45-/low, CD11b-, Ter119+. Gates were set on the uninfected samples 
then imposed onto the corresponding infected sample. The only condition where 
intercellular parasites where not stained, as judged best by the peripheral blood plots, was 
the 1:2000 concentration stained at 4°C.	
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3.2.2.3 Evidence for Classification of Erythroid Stages 
 
The most mature erythroblasts are small and have highly condensed nuclei. 
Therefore, it was important to ensure that these cells could be identified within 
the DNA+ gate observed in tissue samples (Figure 3.4). To evaluate this, two 
samples were taken from an uninfected spleen. Erythrocyte lysis was performed 
on one of the samples to remove all enucleated cells (Figure 3.5). Through 
analysis of both samples by flow cytometry a total loss of the Ter119+DNA- 
population was observed in the lysed sample, indicating that the Ter119+DNA- 
population is a totally enucleated population. This was direct evidence that 
mature erythroblasts could be separated from enucleated erythrocyte 
populations on the basis of DNA staining. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. Nucleated and enucleated erythroid cells can be separated using a DNA 
stain. Both FACS plots showing viable, CD45-/low, cd11b-, Ter119+ cells. Two samples 
were taken from an uninfected spleen, one was erythrocyte lysed to enrich for nucleated 
erythroid cells (left hand graph) and the other was not. The right hand graph shows DNA 
presence (identified with DyeCycle Ruby DNA stain) in the erythrocyte-lysed sample 
(red) can be clearly distinguished from the DNA- population in the non-lysed sample 
(blue). 
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Moreover, nucleated cells were not observed in the sorted early reticulocyte 
population (Figure 3.4) when stained with Giemsa (Figure 3.6). The cell sorted 
viable, CD45-/low, CD11b-, Ter119+, DNA- peripheral blood cells and corresponding 
(Ter119+CD44low) population (Figure 3.4) in the bone marrow both contain cells 
notably paler than the early reticulocyte population (Figure 3.6), demonstrating 
the presence of mature erythrocytes and maturing reticulocytes in both 
locations (Lee et al., 2013).  	 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6 Ter119+CD44low cells in tissue samples are mature reticulocytes and 
erythrocytes. Viable, CD45-/low, CD11b-, Ter119+ DNA- CD44low cells were cell sorted 
from bone marrow and peripheral blood uninfected samples. All contain pale Giemsa 
stained cells. The sorted early reticulocyte population contained dark blue cells.  
FS-A
C
D
44
Peripheral blood
Ter119+CD44low
Early reticulocytes
FS-A
C
D
44
Peripheral blood	
Ter119+CD44low	
Early reticulocytes	
C
D
44
FS-A
Early reticulocytes 
Ter119+CD44low 
Ter119+CD44low 
Early reticulocytes 
Peripheral blood 
Bone marrow 
Spleen 
Results	
	
124	
The Ter119+CD44low cells identified in tissue samples have the same cellular 
profile as the erythroid cells within peripheral blood, which is a heterogeneous 
population made up of stage III-IV reticulocytes and erythrocytes (Lim et al., 
2016). Reflecting this, it was inappropriate to label the tissue Ter119+CD44low 
population mature erythrocytes/ erythroid cells. Likewise, this population could 
not be referred to it as ‘peripheral blood’ as it was identified within tissue 
samples.  There was not conclusive evidence that the tissue Ter119+CD44low gate 
contained an intra vascular (this will be examined further in 3.2.4) population, 
as such it could not be referred to as intravascular erythroid cells. Consequently, 
throughout this work the Ter119+CD44low population identified in tissue samples 
will be referred to as Ter119+CD44low.  
 
3.2.2.4 Distinguishing Erythroblast Maturation Stages 
 
An overlay of the DNA+ erythroblast population and the two DNA- populations 
revealed that there is an overlap in cell size between enucleated early 
reticulocytes and erythroblasts (Figure 3.7A). This is supported by reported cell 
measurements of early reticulocytes and erythroblasts (Khurana, 2005) however, 
this has not been incorporated into flow based approaches previously. Moreover, 
the gradation in cell size in the erythroblast population was exploited to gate 
three sub-populations (large, intermediate and small) based on the 1:2:4 ratio 
previously and extensively defined by Liu et al (2013). The three erythroblast 
populations from uninfected bone marrow were cell sorted. Visualising the cells 
under light microscopy showed the populations contained exclusively nucleated 
cells and were not contaminated with enucleated cells (Figure 3.7B). 
Additionally, the images corroborate that the erythroblasts decrease in size 
during maturation. Nonetheless, as the gates are defined by an internal ratio to 
one another that may vary between replicates, and due to evidence in the 
literature that these gates do not define pure populations of any given 
erythroblast stage, the populations within the gates were referred to as 
immature, intermediate and mature (to reflect their decrease in size through 
maturation), rather than by stage names (e.g. orthoblast)  
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Figure 3.7 The stages of erythroblast maturity can be differentiated by cell size. A. 
Representative FACS plot overlay for uninfected bone marrow (plots for spleen tissue can 
be found in Figure 3.9). Viable, CD45-/low, CD11b-, Ter119+ DNA-  were gated against 
CD44 and FS-A to identify the Ter119+CD44low (blue) and early reticulocyte (green) 
populations. Viable, CD45-/low, CD11b-, Ter119+ DNA+  were gated against CD44 and FS-A 
to identify the erythroblast population (red). The three erythroid populations were overlaid 
onto one another in Flowjo software.  B. Representative FACS plots from uninfected bone 
marrow. Viable, CD45-/low, CD11b-, Ter119+ DNA+ erythroblasts were gated as immature, 
intermediate and mature, (labelled 1,2,3 respectively,) in a 1:2:4 ratio. To confirm their 
identity, cells were sorted, stained with May-Grunwald and examined by light microscopy. 
Three representative cells from each group are shown. Scale bar is 6 µm.  			
3.2.2.5 Comparison of Cell Identification by Flow Cytometry to Published 
Methods 
 
It was important to ensure that the erythroid populations the modified, 
Plasmodium-compatible gating strategy identified were comparable with 
published observations. Previously Liu et al (2006) had calculated the proportion 
that each erythroid population contributed to the overall Ter119+ population 
from the bone marrow and the spleen of uninfected BALB/c mice. In our work I 
observed that Ter119+CD44low cells, early reticulocytes and erythroblasts (using 
the gating strategy outlined in Figure 3.4) contributed 46% ±10%, 15% ±6%, 37% 
±16%, receptively to the total Ter119+ population in the bone marrow and 86% ± 
0.5%, 7% ± 5%, 6 ± 5%, receptively to the total Ter119+ population in the spleen 
of naïve BALB/c mice (±SD) (Figure 3.8). These values were reflective of the 
graphical data presented by Liu et al (2006) in their study into homeostatic 
erythropoietic regulation in Blab/c mice, I therefore concluded that our gating 
strategy was a useful tool for identifying tissue resident erythroid populations. 
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3.2.2.6 CD44 to Distinguish Erythroid Populations 
  
The MFI of CD44 in uninfected and P. berghei infected peripheral blood, bone 
marrow and spleen samples was investigated. Samples were analysed by flow 
cytometry and gated according to the developed strategy (Figure 3.4). The MFI 
of CD44 was calculated for cells in the peripheral blood, early reticulocytes and 
erythroblast populations. There was no significant change in CD44 MFI between 
any of the erythroid populations during P. berghei infection compared with 
uninfected mice (Figure 3.9). This therefore makes CD44 a useful marker for 
defining erythroid populations during Plasmodium infection. 
 
	 	
Bone	marrow	 Spleen	
	
peripheral	
blood	 ER	 EB	 ER	 EB	
uninfected	 19	±	14	 99	±	60	 180	±	98	 45.7	±	19	 128	±177	
infected		 20	±	14	 100	±	60	 203	±	126	 45.9	±	19	 64	±	37	
	
p	=	0.8	 p	=	0.9	 p	=	0.3	 p	=	0.9	 p	=	0.14	
Bone marrow Spleen 
EB
ER
Ter119+CD44low
6%
7%
86%
37%
15%
46%
EB
ER
Ter119+CD44low
Figure 3.8 The average percentage contributions of erythroid cells to the total 
Ter119+ population. Erythroblasts (EB), Early Reticulocytes (ER) and Ter119+CD44low 
cells to total Ter119+ cell in the bone marrow and Spleen of BALB/c mice (n=9). 
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3.2.3. Tissue Perfusion  
 
The gating strategy defined tissue resident cells based on their CD44 expression 
and their absence from peripheral blood (Figure 3.4). It is a standard procedure 
to perform whole body perfusion to define extravascular cell populations, 
although this is subject to variable performance (Anderson et al. 2014). 
Therefore, the compatibility of tissue perfusion with my flow approach was 
tested. Whole body, post mortem perfusion was performed on uninfected mice. 
To confirm complete perfusion, samples from the vasculature were taken post-
perfusion by venepuncture of a tail vein. Bone marrow was harvested from mice 
with visibly clear tail vein samples. Analysing the perfused bone marrow samples 
using our flow methodology (Figure 3.4) revealed the presence of residual 
Ter119+ CD44low cells within the bone marrow compartment, which on average 
made up 5% ± 0.16% (n=3. ± SD) of total Ter119+ population (Figure 3.10). As it is 
unprecedented to observe recirculation of erythroid cells into the bone marrow 
parenchyma (Itkin et al., 2016), it was therefore concluded that these cells were 
present in the bone marrow vasculature and consequently that perfusion of this 
tissue was inefficient. I therefore decided not to perform tissue perfusion during 
my work. This was done in order to prevent the potential erroneous mis-
interpretation of parasitised circulating erythroid cells infiltrating the bone 
marrow tissue during infection.  
 
 
Figure 3.9 CD44 MFI. A. The table shows the average MFI of CD44 (± SD) of CD45-/low, 
CD11b-, Ter119+ in circulating cells from the peripheral circulating blood, early reticulocytes 
(ER) and erythroblasts (EB) in both uninfected and P. berghei infected mice. The p values 
describe the difference between the CD44 MFI of the corresponding populations in the 
naïve and infected mice (n=3). B. Representative FACS plots from infected and uninfected 
tissue. Cells displayed on the plots are CD45-/low, CD11b-, Ter119+. These cells were then 
gates as DNA+ or DNA- (top plot). Both DNA+ and DNA- were then gated CD44 vs FS-A. 
The plots displayed are 5% contort plots. There is a notable decrease in the number of early 
reticulocytes within the infected splenic early reticulocyte gate, this will be addressed later in 
Figure 3.23, however the decrease in cell numbers did not effect the MFI of the population 
as calculated in Figure 3.9 A.    
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Harvest: femur, tibia. 
Physical dissociation of tissue into single cell suspension.  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, CD11b, Ter119, CD44. 
Dycle Ruby DNA stain. 
Viability dye.  
Sample analysed by flow cytometery and gated with the 
strategy in figure 3.4 
Uninfected animal. Whole body perfusion. 
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3.2.4. Intravascular Staining of Erythroid Cells  
 
To further explore techniques to directly distinguish between extra- and intra- 
vascular cell populations, the use of an in vivo staining protocol was investigated 
(Pereira et al., 2009; Anderson et al., 2014). Injecting an erythroid targeting 
immunofluorescence label intravenously would stain erythroid cells within the 
vasculature but not within the extravascular spaces of tissue. Combining this 
with my flow-based approach (Figure 3.4) would allow for the determination 
between erythroid cell population that are within the vasculature and those that 
are not. Fluorescently conjugated anti-Ter119 IgG was intravenously (IV) 
introduced into uninfected mice 3 mins prior to organ and blood harvesting. The 
samples were stained ex vivo to comply with the flow-based approach and 
samples were examined through the gating strategy (Figure 3.4). The erythroid 
populations (peripheral blood, Ter119+Cd44low, early reticulocytes and 
erythroblasts) were then individually gated on a histogram with cell count on the 
y-axis and in vivo administered Ter119 on the x-axis. The histograms from each 
tissue sample were over-laid along with the in vivo stained peripheral blood 
(positive control) and a sample of peripheral blood from a animal that did not 
receive in vivo anti-Ter119 (negative control: FMO). Unsurprisingly due to the 
Figure 3.10 Perfusion leaves a residue of Ter119+CD44low cells in the bone 
marrow. A. Flow diagram depicting the experimental procedure. B. Representative 
FACS plots of (viable, CD45-/low, CD11b-, Ter119+ DNA-) peripheral blood before 
perfusion (left hand side) and (Viable, CD45-/low, CD11b-, Ter119+ DNA-) early 
reticulocytes and Ter119+CD44low from the bone marrow after perfusion (right hand side). 
C.  Pie chart shows the average percentage proportion of all Ter119+ cells in the bone 
marrow (n=3). 
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murine splenic open circulation, staining of spleen extracted tissue resident 
erythroid cells was observed (Figure 3.11 A). However, it was also observed that 
bone marrow derived erythroid cells exhibited fluorescence intensity higher than 
the fluorescence minus one (FMO) negative control for the in vivo staining 
antibody (Figure 3.11 B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Harvest: femur, tibia, whole spleen and peripheral blood 
Physical dissociation of tissue into single cell suspension.  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, CD11b, Ter119, CD44. 
Dycle Ruby DNA stain. 
Viability dye.  
Sample analysed by flow cytometery and gated with the 
strategy in figure 3.4 B & C 
Uninfected animal. IV anti-Ter119 conjugated fluorophore.   
A. 
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Figure 3.11 Early reticulocytes and erythroblasts in spleen and bone marrow are 
labelled by in vivo administration of Ter119 antibody. A. Flow diagram of experiment. 
B. In all plots the black peaks are in vivo Ter119 FMO, the pink are positive in vivo 
staining of peripheral blood, indigo are Ter119+CD44low cells from the organ, the green 
are early reticulocytes and the red are erythroblasts.  a. and b. spleen and bone marrow, 
respectively, from an animal injected with 3 µg Ter119- PE-Cy7. c. Bone marrow from an 
animal injected with 2 µg Ter119- pecy7. d. Bone marrow from an animal injected with 1 
µg Ter119- pecy7. 
in vivo  
TER119 
C
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This suggested that in vivo staining of the early reticulocytes and erythroblasts 
was due to leakage of the antibody into the bone marrow tissue. Therefore the 
approach was repeated using a second antibody specific to the stem cell growth 
factor receptor (c-Kit) which should only be expressed by Haemopoietic Stem 
Cells (HSC) found in the bone marrow parenchyma (Matsuoka et al., 2011). The 
harvested blood and bone marrow were stained ex vivo and analysed by flow 
cytometry (Figure 3.12). A population of lineage-, DNA+, ex vivo c-Kit+, sca1+ 
cells where identified in the bone marrow, this cellular profile matches HSCs. An 
average of 45% ± 3% (n= 3) of these cells were positive for the in vivo injected c-
kit antibody. HSC can mobilise and circulate throughout the body, thus a small 
fraction may be expected to stain with in vivo c-kit. However, as the peripheral 
blood was negative for in vivo c-kit staining, it can be concluded that injected 
antibody leaks into the bone marrow parenchyma.  
 
 	
 													
Figure 3.12 Bone marrow HSCs stain positive for in vivo administered c-Kit 
antibody. Top row: representative FACS plots showing the gating strategy to define in 
vivo positive c-Kit. Below: a representative FACS plot of peripheral blood staining 
negative for ex vivo and in vivo c-Kit.   
 
As it has not directly proven that the cells within the early reticulocyte and 
erythroblast gates are within the extra-vascular tissue of the bone marrow, they 
will be referred to only as tissue resident cells.  
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3.2.5. Establishing the Model: Identifying Infected Cells  
 
The optimised flow methodology was used to investigate the dynamics of the 
tissue resident infection during acute murine malaria. ECM resistant BALB/c 
mice were infected with parasites of a well-characterised P. berghei line 
(PbGFPko230p-SMCON: 507 clone1) that constitutively expresses GFP throughout 
its life-cycle (Janse et al., 2006). For accuracy, the gates defining the GFP+ cells 
were set using a negative control sample from mice infected with 104 parasites 
of a wild-type P. berghei line (HPtbb) (Figure 3.13 A). In parallel, a separate 
group was injected with 150 µl 1 x PBS. Bone marrow, spleen and peripheral 
blood were harvested on day 7 post-infection from the animals in these two 
groups as well as from uninfected animals (Figure 3.13). The mean blood 
parasitaemia of the HPtbb infected animals was 4% (Appendix 8.1.3). The flow 
analysis revealed that the erythroid GFP- populations defined by the uninfected 
animal samples could be applied directly to the HPtbb and 1x PBS samples 
(groups n=3) (Figure 3.13). This showed that infection with P. berghei or 
injection of 1 x PBS does not mobilise granulated auto-fluorescent cells that may 
be misinterpreted as GFP+ parasites in the 507 clone1 samples. As such, in the 
interests of reducing animal usage, the uninfected samples were used 
throughout this work as the negative control. Throughout this study, all gates 
were defined using the uninfected control samples and imposed onto the 
infected samples. 
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Figure 3.13 Wild type P. berghei Infection and PBS treatment do not result in 
aberrant GFP+ gating. A. Flow diagram of methodology used to generate data using the 
CD44 vd Ter119 gating strategy. B. Viable, CD45-/low, CD11b-, Ter119+ DNA- early 
reticulocytes and viable CD45-/low, CD11b-, Ter119+ DNA+ erythroblasts where gated 
against Ter119 and GFP. C. Representative FACS plots from uninfected, PBS-treated and 
HPtbb (wild-type) P. berghei infected bone marrow. The gates show early reticulocytes do 
not spontaneously contain GFP due to infection or PBS treatment. Nor do viable CD45-/low, 
CD11b-, Ter119+ DNA+ erythroblasts. 
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3.2.6. Establishing the Model: Patterns of Characterised P. berghei    
Accumulation.  
 
Bone marrow, spleen and peripheral blood were harvested on day 7 post-
infection with 104 asynchronous P. berghei 507 clone1 parasites (Figure 3.14).  
 
Non-sequestering peripheral blood parasite stages were passaged from a donor 
animal to establish an asynchronous infections. Within asynchronous infections 
taken from or occurring within animals housed in standard day-night light 
conditions, 83 % ±4% of parasites undergo schizongy within the vasculature at 12-
7 am and at the point of tissue harvest (9am) 91 % ±2% of asexual parasites were 
rings and early trophozoites within the peripheral blood (Figure 3.15A). This is 
directly reflective of the partly synchronized dynamics of P. berghei 
asynchronous infections characterised elsewhere (Franke-Fayard et al., 2005; 
Mideo et al., 2013). However, as the dynamics of P. berghei development within 
the tissue resident erythoid cells have yet to be directly established, this study 
restrained from making conclusion as to the parasite life stage beyond what is 
defined by the florescence markers: parasites are GFP+ and GFP MFI increases 
during asexual development and gametocyte maturation (Franke-Fayard et al., 
2004; Janse et al., 2006). 	 
 
The parasitaemia of the Ter119+CD44low cells extracted from the bone marrow 
tended to be higher in comparison to peripheral blood (Figure 3.15 C). The 
fluorescence intensity of GFP in the 507 clone1 parasite line peaks during female 
gametocytogenesis and in parallel, increases during asexual maturation (Franke-
Fayard et al., 2004; Janse et al., 2006). The GFP MFI of the Ter119+CD44low cells 
extracted from the bone marrow and the spleen were not significantly higher 
than the peripheral blood, thus there is not an indication for a greater presence 
(combined or exclusively) of mature asexual parasites or gametocytes (Figure 
3.15B) in any of the three populations.  
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Figure 3.14. Finalised flow diagram of methodology used to investigate erythroid 
cell infection.  
 
 
 
 
 
 
 
 
 
Harvest: femur, tibia, whole spleen and blood. 
Physical dissociation of tissue into single cell suspension.  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, CD11b, Ter119, CD44. 
Dycle Ruby DNA stain. 
Viability dye.  
Cell counts taken and total cell numbers extrapolated.  
Infected with 104  parasites. 
Uninfected controls 
Cull day 7 post infection 
Sample analysed by flow cytometery. 
All gates defined on the uninfected control then 
transposed onto the corresponding infected tissue 
sample.  
Using cell counts the total number of each population in 
each samples is calculated.  
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Figure 3.15 Selective accumulation of infected erythroid cells in the bone marrow 
and the spleen. A. Peripheral blood samples from the asynchronous infection of the 507 
clone1 parasite line where cultured in vitro for 24 hrs and the proportion of each life stage 
calculated from Giemsa stained smears. HPI; hours post infection B. Representative 
FACS plots showing viable, CD45-/low, CD11b-, Ter119+ DNA- Ter119+CD44low cells from 
bone marrow tissue (top) from uninfected and infected animals.  Representative FACS 
plots showing viable, CD45-/low, CD11b-, Ter119+ DNA- peripheral blood cells from tissue 
(top) from uninfected and infected animals. C. The percentage parasitaemia (right) of the 
peripheral blood gate compared with the Ter119+CD44low cells extracted from the bone 
marrow (BM) and spleen (S). The average MFI of GFP (left) in peripheral blood gate 
compared to Ter119+ CD44low cells extracted from the bone marrow (BM) and spleen (S). 
Representative graphs (n=3) of three experimental repeats. Differences between the 
means tested using a one way ANOVA with multiple comparisons. Significant differences 
between groups or samples are indicated with asterisks, denoting as follows: * p < 0.05, ** 
p < 0.01. Error bars ± SD.  
 
3.2.7. Erythroblasts are Susceptible to P. berghei Invasion in vivo 
	
Both the bone marrow and the spleen harvested on day 7 post-infection with 104 
asynchronous P. berghei 507 clone1 parasites (Figure 3.14) contained GFP+ 
erythroblasts (Figure 3.16). However, when the erythroblast population was sub-
divided (as described in figure Figure 3.7), a significantly higher parasitaemia was 
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not detectable within the mature stage compared with the other stages. This 
suggested that P. berghei does not have a stage-specific preference for 
nucleated erythroid cells in vivo (Figure 3.17).  
 
It should also be noted that the GFP+ signal was detected in the CD45-/low, 
CD11b- and Ter119+ cell population, identified using a protocol for extracellular 
protein staining. Therefore, it can be concluded that the GFP+ parasites are 
within erythroblasts that have not been phagocytosed.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 	
Figure 3.16 GFP+ parasites were detected in erythroblasts in both tissues. 
Representative FACS plots from uninfected and infected animals showing viable CD45-
/low, CD11b-, Ter119+ DNA+ (top row bone marrow; bottom row spleen) erythroblasts gated 
against Ter119 and GFP.    
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Figure 3.17 P. berghei does not show a preference for a particular erythroblast 
stage. A.  Representative FACS plots from uninfected and infected animals showing 
viable CD45-/low, CD11b-, Ter119+ DNA+ erythroblasts gate 3 (mature. Plot from bone 
marrow) gated against Ter119 and GFP.   B.  Mice were injected with 104 P. berghei 507 
clone1 and culled on day 7-post infection. The bone marrow and spleen were harvest 
and analysed by flow cytometry. Through this analysis the erythroblast populations in 
both tissues were sub gated into the previously defined maturation stages. The cells in 
each of these gates were then gated against Ter119 and GFP to calculate the 
parasitaemia of each maturation stage. Bone marrow (BM) and spleen of BALB/c mice 
Error bars ± SD. n = 9. 
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3.2.8. The Highest Observed Parasitaemia was in Splenic Early 
Reticulocytes  
	
Both spleen and bone marrow (Figure 3.14) contained P. berghei infected (GFP+) 
early reticulocytes (Figure 3.18). There was a significantly higher parasitaemia 
in early reticulocytes compared with erythroblasts (as a whole population). 
Moreover, the parasitaemia of splenic early reticulocytes was significantly higher 
compared with all other tissue resident erythrocyte populations (Figure 3.19A). 
The relative selectivity index of P. berghei for bone marrow (BM) and spleen-
derived early reticulocytes (ER) and erythroblasts (EB) was calculated. The fold 
increase in parasitaemia was calculated relative to the tissue resident erythroid 
population containing the lowest parasitaemia. This revealed a BM EB: BM ER: 
spleen EB: spleen ER selectivity ratio of 1:12:3:26 (Figure 3.19B). 
 
 
 
 
 
 
 
 
 
 											
Figure 3.18 GFP+ parasites were detected in early reticulocytes in both tissues. 
Representative FACS plots (bone marrow top row; spleen bottom row) from uninfected 
and infected animals showing viable CD45-/low, CD11b-, Ter119+ DNA- early reticulocytes 
gated against Ter119 and GFP.  
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Figure 3.19 Splenic early reticulocytes have the highest P. berghei parasitaemia in 
BALB/c mice. Mice were injected with 104 P. berghei 507 clone1 and culled on day 7-post 
infection. The bone marrow and spleen were harvested and analysed by flow cytometry. A. 
The percentage parasitaemia in both erythroblasts (EB) and early reticulocytes (ER) in 
spleen and bone marrow. Error bars ± SD. n = 9. Differences between the means were 
tested using a one way ANOVA with multiple comparisons. B. Graph shows relative 
selectivity index (SI) for tissue resident erythroid cells. This was calculated for each animal 
by normalising the percentage parasitaemia as a fraction of the smallest parasitaemia. 
Error bars ± SD. n = 9. Difference between the means was tested with a paired t test. 
Significant differences between groups or samples are indicated with asterisks, denoting 
as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. C. MFI of GFP in the 
tissue resident populations and the peripheral blood (n=3). Groups were not significantly 
different as judged by a one way ANOVA. 
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The intensity of GFP signal, expressed as MFI, was not significantly higher in 
cells extracted from either organ or the peripheral blood suggesting that the 
organs did not contained a higher proportion of mature parasites than the blood.  
 
The parasitaemias of the early reticulocytes and the erythroblasts were not 
compared directly to the peripheral blood parasitaemia. P. berghei has a 
characterised tropism for circulating stage III-IV reticulocytes (Cromer et al., 
2006). These cells are reported to make up ~10% of the circulating erythroid 
population (Cromer et al., 2006). However, our flow approach cannot distinguish 
between erythrocytes and circulating stage III-IV reticulocytes. Therefore, 
comparing a population of susceptible tissue resident erythroid cells with the 
circulating population that contains an assortment of susceptible and non-
susceptible cells would bias our observations and possibly skew the results. 
 
3.2.9. Conservative gating of GFP+ cells  	
The uninfected samples were used as a FMO controls to define the gating for 
GFP+ cells in each corresponding erythroid population. The GFP+ gates were 
consistently defined on the uninfected control samples as containing 0% (no 
signal) of any given erythroid population. This was done to ensure the 
parasiteamia and whole cell numbers of parasites were defined by a GFP+ gate 
containing parasites and not background fluorescence. Nonetheless, the 
conservative approach to defining the GFP+ gate may have led to a proportion of 
GFP low young parasites being excluded from the analysis, as can be observed in 
Figure 3.18. The conservative gating practice was applied across all erythroid 
populations and the GFP signal of the parasites in each population was 
comparable (Figure 3.19 C). However, to ensure that the observation that 
splenic early reticulocytes contained the relative highest parasiteamia on day 7 
pi (Figure 3.19) was not an artifact of conservative gating the plots were re-
gated to include all potential parasites. This re-analysis of the data yielded a 
comparable result to the conservative gating strategy: splenic early 
reticulocytes contain the relatively higher parasiteamia compared to all other 
tissue resident populations (Figure 3.20).  
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Figure 3.20 Re-analysis of GFP gating in tissue samples. A. representative FACS 
plots showing viable CD45-/low, CD11b-, Ter119+ bone marrow early reticulocytes (BM 
ER) and erythroblasts (BM EB) gated against Ter119 and GFP. The red line represents 
the conservative gating strategy and the black line represents the re analysed gates. 
The percentages on the plots refer to the re analysed gates.  B. Graph showing the 
parasiteamias generated from the re analysed plots. Bone marrow erythroblasts (BM 
EB) and early reticulocyts (BM ER) and the corresponding populations in the spleen (S 
EB and ER). The splenic early reticulocytes have the highest parasiteamia as judged 
by a one way ANOVA.  
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3.2.10. P. berghei May Undergo Schizogony in Erythroblasts 
To confirm the presence of parasites within erythroblasts, nucleated GFP+ 
splenocytes were cell sorted, then stained with anti-Ter119 and a DNA dye and 
visualised on a ImageStream flow cytometer. Although it was difficult to 
distinguish the lifecycle stages of the parasites, multinucleated GFP parasites, 
most probably schizonts were observed (Figure 3.21 D&F) indicating that 
parasites could multiply within erythroblasts.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 							
B 
Day 7 post infection. Harvest: whole spleen. 
Physical dissociation of tissue into single cell suspension.  
Samples blocked and stained with fluorescent conjugated 
antibodies: 
Ter119 
Dycycle Violet DNA stain. 
Cells analysed on ImageStream flow cytometer 
Animal infected with 104 GFP+ parasites. 
Erythrocyte lyse sample. 
Cell sort GFP+ cells 
A. 
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3.2.11. Infected Erythroblasts and Early Reticulocytes can initiate P. 
berghei Infection 
 
Using the flow based approached depicted in Figure 3.4 and the experimental 
procedure outlined in Figure 3.14, infected early reticulocytes and erythroblasts 
were cell sorted. 100 cells were then injected into separate uninfected mice to 
determine the viability and functionality of parasites they contained. A positive 
control of 100 GFP+ parasites sorted from peripheral blood was set up in tandem. 
All mice had detectable parasitaemia by day 6 post-infection (n=1). This suggests 
that: 1. Both the early reticulocytes and erythroblasts contained asexual 
parasites, although the proportion of asexual and gametocytes were not 
quantified; 2. Both of these tissue resident erythroid cell populations are 
F. 
Figure 3.21 P. berghei parasitises erythroblasts. A. Flow diagram of the experiment. 
All panel images: Channel 1 (Ch01) DNA stain (dye cycle violet), Channel 2 (Ch02) 
GFP, Channel 3 (Ch03) bright field, Channel 5 (Ch05) anti- Ter119 APC. B, D-F: bottom 
single images: merge of Ch01, Ch02 and Ch05. C. Left hand single image: merge of 
Ch01 and Ch02. Right hand single image: merge of Ch01, Ch02 and Ch05. Number in 
the left hand corner indicates the position of image in the sequence of all images taken 
from the sample. Images taken from spleen samples (n=1).  
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permissive to P. berghei infection as both populations must have contained fully 
functioning asexual parasites that had undergone schizogony.  
 
P. berghei has a characterised multiplication rate of 10x per 24 hrs. The 
parasitaemia detected on day 6 in both mouse groups was 0.1%. Therefore, the 
viable parasitaemia immediately after infection on day 0 was 0.000001%. As a 
BALB/c mouse contains 1ml of blood with 6 x 106 erythroid cells per µl, it would 
mean that 60 viable asexual parasites were injected into the mice on day 0.  
	
3.2.12. Splenic Early Reticulocytes have the Highest Parasitaemia in a 
Mixed Genetic Background.  
 
The in vivo spatial dynamics of Plasmodium cannot be fully appreciated in 
isolation. It is well established that the pathology of malaria is dependent on the 
interplay between parasite and host factors (Swanson et al., 2016). Therefore, 
our model of tissue resident erythroid cell infection should be considered to be a 
closed but undefined system, with contributing elements deriving from the host 
response to infection. The BALB/c background is reportedly biased towards a 
particular adaptive immune response (Th2 response) (Fukushima et al., 2006). 
To investigate whether the significant high parasitaemia observed in splenic 
early reticulocytes is dependent on the host genetics, the workflow depicted in 
Figure 3.14 was repeated in an outbred mouse strain (NIH). Again parasites 
where observed within erythroblasts and early reticulocytes of both organs, with 
splenic early reticulocytes containing the significantly highest parasitaemia 
compared to all other tissue resident erythroid populations (Figure 3.22 and 
Appendix 8.1.4). It should be noted that the parasiteamia in NIH tissue resident 
erythroid populations were not directly reflective of those observed in the 
BALB/c mice (Figure 3.19), nonetheless, like the BLAB/c mice, the highest 
parasiteamia was observed in the NIH splenic early reticulocytes. 
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Figure 3.21 Host genetic background does not influence parasite preference for 
erythroblast and early reticulocytes. Mice were injected with 104 P. berghei 507 clone1 
and culled on day 7-post infection. The bone marrow and spleen were harvested and 
analysed by flow cytometry. A. The percentage parasitaemia of erythroblast stages in the 
bone marrow (BM) and spleen in NIH outbred mice. Error bars ± SD. n = 6. B. Percentage 
parasitaemia of erythroblasts (EB) and early reticulocytes (ER) in the bone marrow (BM) 
and spleen in NIH mice. Error bars ± SD. n = 6. Differences between the means were 
tested using a one way ANOVA with multiple comparisons.  C. Graph shows relative 
selectivity index for tissue resident erythroid cells. This was calculated for each animal by 
normalising the percentage parasitaemia as a fraction relative to the smallest parasitaemia. 
SI ratio of BM EB: BM ER: Spleen EB: Spleen ER is 1:22:29:114. Difference between the 
means was tested with a paired t test. Error bars ± SD. n = 6. Significant difference 
between groups or samples is indicated with asterisks, denoted as follows: * p < 0.05, ** p < 
0.01, *** p < 0.001.  
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3.2.13. Splenic Early Reticulocytes Contain the Highest Parasite 
Burden 	
It is established that Plasmodium infection causes impaired murine splenic and 
bone marrow erythropoiesis leading to a decrease in erythroid progenitor 
populations (Maggio-Price, Brookoff and Weiss, 1985; Villeval, Lew and Metcalf, 
1990; Chang, Tam and Stevenson, 2004).  Similarly, the results generated using 
the workflow depicted in Figure 3.14 demonstrate	 a significant decrease in 
erythroblast numbers within the bone marrow of both BALB/c and NIH mice on 
day 7 post infection compared with the corresponding uninfected mice (Figure 3. 
23 A&C).  Furthermore, this effect was consistent with a trend observed in the 
spleen and independent of genetic background (Figure 3.23 B&D). An altered 
erythroblast stage ratio was also observed in the infected BALB/c spleen 
compared with the uninfected BALB/c spleen (Figure 3.23 G-H). This was not 
observed between the uninfected and infected NIH mice, which may be 
reflective of the NIH mice having a relatively increased erythropoietic response 
to EPO compared to BALB/c mice (Ohr, 1967). 
  
The total parasite numbers (working under the assumption that each infected 
cell contains one parasite) in each tissue erythroid population were quantified. 
The greatest parasite population overall was observed in splenic early 
reticulocytes (Figure 3.23 I&J). This observed was consistent between the two 
genetic host backgrounds despite NIH mice having splenic and bone marrow 
pools of early reticulocytes quantifiably the same size in (p = 0.7), whereas they 
were different in Balb/c mice (* p =0.01). Therefore, despite the host genetic 
background the greatest parasite burden was consistently observable within the 
splenic early reticulocytes.  
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Figure 3.23. Parasite burden and erythroid population size could be quantified. Mice 
were injected with 104 P. berghei 507 clone1 and culled on day 7-post infection. The bone 
marrow and spleen were harvested and analysed by flow cytometry. Numbers of total 
erythroblasts (EB), though not early reticulocytes (ER) are reduced in bone marrow (A & 
C) and spleen (B & D) of infected mice. Error bars ± SD. Whole cell numbers of total 
erythroblast stages in infected bone marrow (BM) and spleen in BALB/c (E) and NIH mice 
(F). Error bars ± SD.  Note the altered erythroblast stage ratio in the BALB/c spleen. Pie 
charts show the average proportion of each erythroblast stage in uninfected spleen (G) 
and infected spleen (H) of BALB/c mice. These charts demonstrate that on average, the 
proportion of the immature and intermediate erythroblasts doubles, whereas the mature 
proportion decreases by half. Total cell numbers of parasites in each erythroid population 
and of (I)  BALB/c and (J) NIH mice. All BALB/c samples n = 9;. NIH all samples n=9. 
Differences between the means was tested using a one way ANOVA with multiple 
comparisons. Error bars ± SD	
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3.2.14. Results Summary  	
Work in this chapter successfully: 
• Optimised a robust flow based methodology to identify different 
populations of erythroid cells.  
• Observed P. berghei parasitising erythroblasts and early reticulocytes.  
• Identified splenic early reticulocytes as containing the highest 
parasitaemia of tissue resident cells. 
• Identified that splenic early reticulocytes contain the highest parasite 
burden of the tissue resident infection. 
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3.3. Discussion  	
The key discussion points are: 
• Optimising the methodology: 
o The decreased abundance of CD71 during P. berghei infection is 
likely a by-product of a host response to inflammation.  
o Tissue perfusion was not performed during this investigation; 
therefore our results cannot be used to discuss the extra-
vascularisation of mature erythrocytes.  
• Identified P. berghei susceptible erythroid cells: 
o In contrast to P. falciparum, all erythroblasts were susceptible to 
P. berghei infection. This may indicate a difference in how the 
merozoites of the two species interact with the host cytoskeleton.  
o P. berghei may preferentially invade splenic early reticulocytes.  
o The quantified significant parasite burden in splenic early 
reticulocytes will have implications for antimalarial 
pharmacokinetics.     	
3.3.1. Plasmodium Induced Erythroid Cell Changes make CD71 an 
Unreliable Marker 	
Currently Plasmodium studies routinely use a combination of CD71 and Ter119 to 
resolve different erythroid populations (Martín-jaular et al., 2013; Lelliott et al., 
2014; Lelliott, Mcmorran and Foote, 2015). Here a significant decrease in CD71 
abundance was observed on the splenic early reticulocyte and erythroblasts 
extracted from P. berghei infected mice. A similar decrease has previously been 
observed in P. vivax cultures with matured human cord blood (Malleret et al., 
2015). To our knowledge the only incidence in uninfected mice when CD71 
abundance fluctuates is during stress erythropoiesis, such as the response to 
anaemia or moving to high altitude. Stress erythropoiesis increases CD71 
abundance before returning it to basal levels (Porpiglia et al., 2012). It can 
therefore be suggested that the decrease in CD71 abundance I observed in 
infected mice is due to the presence of Plasmodium, rather than natural 
homoeostatic regulations. Under homeostatic conditions, CD71 is lost from the 
erythroid cell surface during terminal maturation (Chen et al., 2009). It could 
therefore be suggested that Plasmodium infection increases the maturation rate 
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of its host cell. However, the abundance of CD44 also decreases during 
homeostatic erythroid maturation and there was not an observable difference in 
CD44 abundance on tissue resident erythroid cells between infected and 
uninfected samples in this study.  
 
A recent transcriptional analysis of P. falciparum-infected erythroblasts revealed 
that infected cells down-regulate a number of genes (Tamez et al., 2011).  The 
down-regulated genes included some involved in clathrin-mediated endocytosis 
signalling (Tamez et al., 2011). Interestingly CD71 facilitates the internalisation 
of iron through this pathway, although Tamez et al (2011) did not comment on 
effects Plasmodium infection has on erythroid heme biosynthesis.  Significantly, 
by single cell, rather than population analysis, I showed that decreased CD71 
abundance occurs on a population level, on both parasitised and non- parasitised  
cells in vivo. There is evidence in the literature that CD71 abundance is a proxy 
mediator of hepcidin suppression, with high CD71 leading to decreased hepcidin 
levels (Keel et al., 2015). Hepcidin is protein released from cells in the liver and 
regulates the entry of iron into the circulation through interactions with gut 
enterocytes. Hepcidin production is increased by inflammatory cytokines, 
leading to a decrease in serum iron (Rossi, 2005). It is well documented that 
Plasmodium infection induces production of inflammatory cytokines (Mbengue et 
al., 2016). As such, my observation of decreased CD71 abundance during 
infection could be linked to a global down-regulation of iron absorption due to 
inflammation induced expression of hepcidin (Cavill, 2002). Thus it may be a 
host response aimed at starving a parasite that requires iron for a number of 
biological processes including DNA synthesis. There is some clinical evidence 
associating iron deficiency with protection against malaria (Scholl, Tripathi and 
Sullivan, 2005; Clark, Goheen and Cerami, 2014). Our work would therefore 
recommend that future Plasmodium studies do not use CD71 as a marker for 
erythroid maturation.  	
3.3.2. Identifying Tissue Resident Erythroid Cells 	
In this study I optimised a CD44 based gating strategy to identify P. berghei 
infected erythroid cells in the bone marrow and the spleen. The advantage of 
using a flow-based approach, as opposed to histology, is that it is sensitive 
enough to distinguish discrete erythroid populations based on the quantitative 
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abundance of cellular markers. In this work I defined the early reticulocyte and 
erythroblast populations based on their absence from peripheral blood. However 
flow cytometry cannot distinguish between intra- and extra-vascular cell 
populations. Attempts in this work to adapt an in vivo intra-vascular staining 
technique were unsuccessful due to vascular leakage of the fluorescently 
conjugated antibody. Although, Pereira et al (2009) selectively labelled, as 
shown by histology sections, intra sinusoidal B cells in the murine bone marrow, 
my results directly reflect substantial evidence that bone marrow sinusoids are 
highly permeable (Sarin, 2010; Itkin et al., 2016). Despite the incompatibility of 
the intra-vascular staining protocol with my methodology, tissue perfusion to 
remove vascular erythroid cells was not carried out in this work. Upon combining 
tissue perfusion with my flow approach I found an observable residual population 
of Ter119+ CD44low cells within the bone marrow that previous studies have 
shown cannot be resident in extravascular spaces (Chen et al., 2009; 
Muzykantov, 2011; Liu et al., 2013). This is reflective of the strong evidence in 
the CD8+ T cell literature that the post mortem perfusion of tissue is an 
unreliable process (Galkina et al., 2005; Anderson et al., 2012, 2014). As I did 
not want inefficient tissue perfusion to be misinterpreted as mature erythroid 
cells occupying extravascular spaces, I did not perform this procedure in my 
workflow. Nonetheless, my methodology allows us to study the infection of 
tissue resident early reticulocytes and erythroblasts ex vivo for the first time, 
moreover my approach will facilitate future studies investigating the pathology 
of malaria anaemia.  	
3.3.3. The Infection of Tissue Resident Erythroid Cells 	
In this work populations of P. berghei infected tissue resident cells were 
identified as CD45-/low, CD11b-, establishing that these infected cells were not 
within phagocytes. Moreover, infected early reticulocytes and erythroblasts 
were able to establish infection in uninfected animals, therefore these 
populations of host cells are permissive to functional asexual development.  
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3.3.4. Plasmodium Invasion of Nucleated Cells.  	
The observation of P. berghei within erythroblasts extracted from erythropoietic 
tissues is directly reflective of the observations that P. falciparum, P. vivax and 
P. yoelii can parasitise erythroblast populations in their hosts (Ru et al., 2009; 
Tamez et al., 2009; Imai et al., 2013). Moreover, I observed parasites within all 
stages of erythroblast maturation. Immature erythroblasts undergo cell division, 
which is coupled with differentiation, in order to reach maturity (Chen et al., 
2009). I did not detect a significant difference in parasitaemia between the 
three erythroblast sub-gates, this therefore indicates that all stages of 
erythroblasts are susceptible to merozoite invasion and P. berghei does not have 
a preference for a particular stage. This is in contrast to in vitro work that 
observed that erythroid cells are only susceptible to P. falciparum from the 
orthochromatic stage (Tamez et al., 2009). Orthochromatic cells are the 
smallest, most mature erythroblast and thus would not appear in our immature 
or intermediate erythroblast gates, in which I observed P. berghei infection.  
 
The Plasmodium merozoite utilises a number of host receptors in order to gain 
entry into the host cell. The ligand-receptor interactions, which are well 
characterised in P. falciparum and P. vivax, remain undefined between the host 
cell and P. berghei. Both P. vivax and P. falciparum have the ability to interact 
with multiple host receptors in order to gain entry into the cell. These 
interactions, for P. falciparum at least, are redundant apart from the ones with 
the host receptors Basigin (CD147) and CD55 (Egan et al., 2015). Both CD147 and 
CD55 are expressed at high levels on early erythroblasts (Bony et al., 1999; Noji 
et al., 2001). Therefore it would seem that erythroblast susceptibility to P. 
falciparum is not correlated with essential merozoite receptor expression.  
 
Merozoite invasion, which has been characterised predominantly in P. 
falciparum, is believed to also involve interactions with the dynamic 
cytoskeleton of the erythrocyte, mediated by the defined parasite ligand-
receptor’s CR1 and GPA (Glodek et al., 2010; Chais et al., 2011; Koch and Baum, 
2015; Zuccala et al., 2016).  This may be the precluding factor defining 
erythroblast susceptibility to P. falciparum. In contrast the only defined ligand-
receptor interaction P. vivax makes with the host cell is PvDBP binding to the 
Duffy antigen. The downstream effects of this binding on the host cytoskeleton 
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has not been defined and it is believed to be unable to initiate intracellular 
signals when bound to CXC chemokines (Apostolakis et al., 2011). The Duffy 
antigen is detectable on the erythroid cell surface by immunoblotting from the 
basophilic stage (Chen et al., 2009). Directly correlated with Duffy detection, an 
ex vivo transmission electron microscopy study observed P. vivax in all 
erythroblast stages from the basophilic stage onwards (Ru et al., 2009).  
 
Taken together, this evidence indicates that P. berghei, like P. vivax, may not 
require the full assembly of the terminally differentiated erythroid cytoskeleton 
to gain entry into its host cell. Nonetheless, it must be noted that patients with 
genetic conditions resulting in both disordered spectrin arrangement and 
abnormal erythrocyte rigidity are still susceptible to P. falciparum infection 
within endemic malaria areas (Boctor and Dorion, 2008; Muley, Lakhani and 
Parekh, 2011; Makani et al., 2017). As such, in light of the evidence that 
Plasmodium can invade nucleated and less deformable cells, the investigation 
into merozoite invasion should be extended to ensure any developed 
therapeutics also target the tissue resident infection.    
 
3.3.5. P. berghei Preferentially Parasitises Early Reticulocytes   
 
Erythropoiesis leads to the enucleation of erythroblasts resulting in the 
formation of reticulocytes. The maturation of reticulocytes is divided into four 
stages, with stages I-II residing within the erythropoietic tissue. To our 
knowledge, this work is the first time tissue resident reticulocytes have been 
studied ex vivo in the context of a Plasmodium infection. Malleret et al. (2015) 
previously observed that P. vivax has a preference for early reticulocytes 
differentiated in culture from human cord blood. Nonetheless, their study lacked 
anatomical context and a comprehensive definition of circulating and tissue 
resident reticulocytes. 
 
Here I observed the highest parasitaemia of the tissue resident P. berghei 
infection within the early reticulocytes of both the bone marrow and the spleen. 
Erythropoiesis is a dynamic process with the cell successively maturing through 
the various erythroid stages. However, as I only sampled at one time point, the 
results presented in this chapter are a static snapshot of infection. As such, my 
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observations cannot directly rule out that P. berghei preferentially invades 
erythroblasts prior to day 7-post infection and that the host cell matures into 
reticulocytes in parallel to parasite development. In fact, in vitro work has 
directly shown that infected erythroblasts can enucleate and therefore mature 
into reticulocytes (Tamez et al., 2009; Joice et al., 2014). Nonetheless, the 
literature is conspicuously silent on whether infection in preceding erythroblast 
stages disrupted cell division and therefore maturation. In this study I observed 
that the erythroblasts of both tissues have the same expression of GFP compared 
with the early reticulocyte population. This observation can be discussed in the 
context of infected erythroblast being observed, using the image stream, to 
contain multinucleated parasites that suggested the presence of schizonts; thus 
would suggest that early reticulocytes contain schizonts as well. As stated 
previously, the fluorescence intensity of GFP in the 507 clone1 parasite line 
peaks during female gametocytogenesis and in parallel, increases during asexual 
maturation (Franke-Fayard et al., 2004; Janse et al., 2006). Therefore the 
higher the expression of GFP, the more mature the parasites are within an 
erythroid population. This suggests that the parasites within the erythroblast 
population are at the same or at more progressed maturation stage then the 
parasites in the early reticulocytes. This therefore implies there is not a linear 
model of merozoite invasion and ring development within erythroblasts that 
differentiate into early reticulocytes in parallel to parasite development. 
Moreover, this will be re-addressed in chapter 4.  
 
 
3.3.6. Anaemia and Tissue Resident Parasite Burden  
 
Malaria causes decreased erythroid cell numbers and altered stage distribution, 
resulting in anaemia (Yap and Stevenson, 1992; Lamikanra et al., 2015). On day 
7-post infection I observed a decrease in the numbers of erythroblasts in the 
bone marrow and the spleen compared with uninfected animals. As a result, the 
erythroid population containing the highest parasitaemia is not indicative of the 
erythroid population that contains the highest parasite burden in terms of whole 
numbers. To our knowledge this is the first study that has quantified the 
parasite burden (number of infected cells) in tissue resident erythroid cells. I 
identified that the erythroid population contributing the highest burden in tissue 
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resident infection mirrors the parasites cellular preference. The splenic early 
reticulocytes contain the greatest number of parasites in comparison to all other 
tissue resident erythroid cells. This has important implications for the 
pharmacokinetics of antimalarial drugs. In order to successfully resolve a malaria 
infection all parasites must be targeted. If the organs containing tissue resident 
infection present barriers that result in differential partitioning of drugs into 
tissue from the blood, this may lead to recrudescence and sub-optimal dosing.    
 
3.4. Summary  	
In this chapter I optimised a method to resolve tissue resident erythroid cells 
using a flow-based approach. I then combined this with a P. berghei infection 
and observed that the greatest parasitaemia of tissue resident infection was 
consistently within the splenic early reticulocytes.  													
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4 The Largest Tissue Resident Gametocyte Population 
Lies in the Splenic Early Reticulocytes. 
	
4.1 Introduction  
 
The postnatal erythropoietic tissue of the bone marrow and the spleen contain 
developing erythroid cells, which includes erythroblasts and stage I-II 
reticulocytes. A wide scale histological screen of autopsy tissue from malaria 
patients observed a significant enrichment of P. falciparum immature 
gametocytes within the parenchyma of the bone marrow (Joice et al., 2014). In 
the aforementioned study, the authors concluded that immature gametocytes 
were parasitising mature erythroid cells (reticulocyte stage III-IV or 
erythrocytes), based on the absence of CD71 expression on the host cell.  
Evidence was presented in the previous results chapter showing that CD71 was 
down regulated during P. berghei infection, in agreement with previous studies 
in P. vivax  (Malleret et al., 2015), highlighting that CD71 is not a reliable 
marker of erythroid development during Plasmodium infection. Nonetheless, a 
hypothesis was constructed around the findings of Joice et al (2014) theorising 
that immature gametocyte infected circulating erythroid cells could home to, 
and migrate across the bone marrow sinusoidal endothelium (Nilsson et al., 
2015). Recent intravital imaging has observed the translocation of parasitised 
mature reticulocytes out of the vasculature into the bone marrow tissue after 
intravenous injection with synchronous and purified P. berghei ring stages (De 
Niz, submitted; Marti Lab, Glasgow, 2016). Although the authors could not 
definitively define the ring stages as early gametocytes, they did observe the 
transmigration of mature P. berghei gametocytes out of the bone marrow into 
the vasculature at subsequent points during infection. Nonetheless, the authors 
did not make observations concerning host cell maturation; a young ring stage 
parasite within a reticulocyte translocating into the bone marrow should emerge 
back into circulation as a mature parasite within a mature and aged erythrocyte. 
This therefore sustains the possibility that the authors observed mature 
gametocytes emerging into the blood stream in stage III reticulocytes after 
having undergone gametocytogenesis within a tissue resident erythroid cell. 
Moreover, they observed the ready translocation of merozoites into the bone 
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marrow parenchyma and the extra vascular presence of schizonts (De Niz, 
submitted). Consequently, the formation of gametocytes de novo within tissue 
resident erythroid cells remains a feasible and complementary model of 
gametocyte extravascularisation.  
  
P. falciparum gametocytes undergo a protracted development, resulting in 
discrete morphologies that allow various maturation points to be easily classified 
into stages. Therefore, the absence of the immature stages of P. falciparum 
gametocytes from the peripheral blood is highly conspicuous. The developing 
gametocytes of parasite species within the sub-genus of Plasmodium, such as P. 
berghei and P. vivax, are morphologically indistinguishable from asexual 
trophozoites. As such, the dynamics of P. berghei gametocytes within the host 
are under-investigated and it is unclear whether they serve as a useful model for 
human gametocyte extravascularisation.  
	
Here a parasite line will be developed in order to specifically identify P. berghei 
gametocytes using flow cytometry. As such, the aims of this chapter are: 
 
• Construct a PbGFPCON/RFPGAM parasite line. 
• Characterise the PbGFPCON/RFPGAM parasite line. 
• Investigate spatial dynamics of gametocytes within tissue resident 
infection. 
• Numerically investigating the preferential invasion of early reticulocytes 
by P. berghei.  
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4.2 Results 	
4.2.1 Construction of the PbGFPCON/RFPGAM parasite line 
In order to visualise P. berghei maturing gametocytes a fluorescent protein was 
placed under the control of a recently identified promoter (PBANKA_101870) 
that has early gametocyte activity (Sinha et al., 2014).  The commercially 
available gene encoding red fluorescent protein (RFP) was PCR amplified from a 
previously constructed plasmid, pG0161 (Dr. Katie Hughes; unpublished). The 
open reading frame in the pG306 plasmid was then exchanged with the rfp 
sequence (Sinha et al., 2014).  This brought rfp under the transcriptional control 
of the early gametocyte promoter (PBANKA-101870) creating plasmid pG403.  
The plasmid also contained a positive (pyrimethamine resistance) and negative 
(5-fluorocytosine (5-FC) sensitivity) drug selection cassette flanked by 
homologous sequence designed to facilitate sequence excision. The vector was 
linearised and then incorporated into the genome of the P. berghei 507 clone 1 
parasite line at a silent locus (P230p) through double homologous recombination 
(Janse et al., 2006). This created the parasite line G1137. Naïve mice were 
infected intravenously with G1137 immediately after the parasite transfection 
(day 0). 
 
Incorporation of the vector into the parasite genome was positively selected by 
the administration of 70 µg/ ml pyrimethamine to the animal’s drinking water on 
day 1. The peripheral blood was harvested when the parasitaemia was at an 
appropriate level (<1%). Correct integration of the vector into the parasite 
genome was confirmed by PCR (Figure 4.1). The parasite line was then cloned 
through limiting dilution to create G1137cl2. The clonal line was negatively 
selected in vivo through the administration of 1.5 mg/ ml 5-FC to the animal’s 
drinking water on day 1 post infection (pi). This selects parasites in which 
excision of the vector-derived drug selection cassette from the parasite genome 
has occurred via the recombination of the flanking homologous sequences. 
Excision of the drug selection cassette was confirmed by PCR (Figure 4.1 and 
Appendix 8.2.1) and G1137cl2 was cloned through limiting dilution to create 
PbGFPCON/RFPGAM. This parasite line undergoes schizogony at 21-22 hrs-post 
invasion (hpi) and has a gametocytaemia directly reflective of the parental 
parasite line (Appendix 8.2.2).  
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Figure 4.1 Construction of the PbGFPCON/RFPGAM  line. A. Schematic showing the 
homologous recombination event that introduces the linearised vector into the parasite genome. 
Primers used to check integration by PCR are depicted and colour-coded as 3’ integration (red) 
and 5’ integration (blue). Green line indicated the size of the wild type P230p locus. Purple boxes 
are regions of homologous sequence in the vector, under 5-FC selection pressure these regions 
drive the excision of the drug selection cassette B. PCR gel showing integration of vector into 
the parasite genome. Lane 1 contains PCR reaction using G1137  genomic DNA. Primers are 
colour-coded to the schematic in A. correct 3’ integration and 5’ integration gives bands 1.4 Kb 
and 2 kb respectively. The ladder is located in the left hand lane and labeled.  C. PCR gel 
showing removal of drug selection cassette after 5-FC treatment. Genomic DNA from G1137cl2 
parasites after treated with 5-FC, G1137cl2 before treatment and wild type parasites with no 
vector integration at the P230p locus was used as templates in a reaction with primers spanning 
the P230p locus. Excision of the drug selection cassette should generate a band 5.2 Kb in 
length. No excision of the drug selection cassette will generate a band 8 Kb in length. 
Amplification of endogenous wild type locus will produce a band 2.5 Kb in length. The ladder is 
located in the left hand lane and labeled. D. Schematic showing the excision of the drug 
selection cassette under 5-FC pressure. The primers and band fragment length are colour-coded 
to the gel in C.  
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4.2.2 Characterising PbGFPCON/RFPGAM 	
Samples of peripheral blood from animals infected with asynchronous 
PbGFPCON/RFPGAM were analysed by flow cytometry. Comparison of RFP/GFP 
expression produced four cell populations: GFP/RFP double negative uninfected 
erythrocytes, GFP+ cells, GFP+ RFP+ cells and GFP++ RFP+ cells (Figure 4.2).  
 
 
 
 
 
 
 
 
 
 
 
 
The fluorescence dynamics of GFP under the control of the eef1-alpha promoter 
have been previously characterised throughout the life cycle of P. berghei. 
Female gametocytes have a GFP MFI three times higher than the male 
gametocytes (Franke-Fayard et al., 2004). The GFP MFI of our GFP+ RFP+ cells 
and GFP++ RFP+ cells was quantified as 428 relative fluorescence units (RFU) and 
1086 RFU, respectively. This led to the speculation that these populations were 
exclusively male and female gametocytes. This was confirmed by cell sorting the 
two populations from a gametocyte-enriched, synchronised peripheral blood 
infection, performed at 48 hpi. The two gametocyte populations were activated 
and visualised by light microscopy. The GFP+ RFP+ sample contained exclusively 
exflagellating male gametes and the GFP++ RFP+ contained exclusively 
extracellular, activated female gametes (Figure 4.3).  
 
GFP	R
FP	
Figure 4.2 PbGFPCON/RFPGAM contains two RFP+ populations. Representative FACS 
plots of peripheral blood.  Resolving cell populations based on GFP and RFP expression 
reveals two RFP+ populations with different intensities of GFP expression (left). These 
cells were gated separately as GFP+ RFP+ cells and GFP++ RFP+ cells. 
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Next, the dynamics of RFP under the control of the early gametocyte promoter 
were investigated. The parasite line was characterised in vitro in order to 
circumvent gametocyte accumulation outwith the peripheral blood. As P. 
berghei schizonts do not spontaneously undergo merozoite egress in vitro, a 
donor mouse was used initially to stimulate re-invasion in vivo. Highly enriched 
synchronized schizonts were injected IV into the donor animal and the 
peripheral blood was harvested 10 mins post injection.  Any residual mature 
gametocytes were removed by magnetic column sorting and samples were taken 
at specific time points from the newly invaded blood. RFP fluorescence was 
observed from 8 hpi and by 12 hpi the GFP+RFP+ GFP++RFP+ populations were 
distinguishable (Figure 4.4 and Appendix 8.2.3). The rfp promoter was active 
throughout the remaining developmental stages of maturing and mature 
gametocytes (Appendix 8.2.4).  
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Figure 4.3 Distinguishing male and female gametocyte populations.  The two 
GFP+RFP+ populations were cell sorted and then activated. Representative photos from 
the male and female gametocyte populations are shown. The two populations contained 
exclusively male or female gametes when Giesma stained and examined under light 
microscopy.  
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However, due to the hypothesis in the literature that immature gametocytes 
home to or develop in the bone marrow (Nilsson et al., 2015), I felt the initial 
results were perhaps ambiguous as a result of the in vivo re-invasion step. 
Therefore, mature, synchronised schizonts were mechanically lysed to introduce 
re-invasion in vitro. Prior to this, residual mature gametocytes had been 
labelled with anti Ter119 IgG therefore ensuring they could be excluded from 
the analysis. Samples taken at specific time points were analysed by flow 
cytometry. Again RFP fluorescence was detected from 8 hpi and further 
demonstrated that this was not detectable at 6 hpi (Figure 4.5).  
 
 
Figure 4.4 RFP was detectable from 8 hrs post invasion. Samples were taken at each 
time point from in vitro culture. The RFP expression in GFP postive cells was monitored by 
flow cytomotery. Graph showing the mean numbers of RFP positive gametocytes during 
the synchronized in vitro development of PbGFPCON/RFPGAM.  Error bars ± SD. n = 3. 	
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4.2.3 Asexual Parasites and Gametocytes can be Separated in an 
Asynchronous Infection 	
During an asynchronised infection with PbGFPCON/RFPGAM there is a GFP+ RFP- 
population that has a similar GFP MFI to the GFP+RFP+ population (Figure 4.2). 
To ensure this population is not composed of gametocytes at < 8 hpi, 100 
asynchronous GFP+RFP- cells were sorted and injected into an uninfected mouse. 
These parasitised cells were able to establish an infection in peripheral blood 
that was detectable on Giemsa smears 6 days pi (n=1). This confirmed that 
GFP+RFP- populations contain asexual parasites; therefore ensuring asexual and 
sexual cells could be distinguished robustly.  
 
 
4.2.4 Reproducible Infection Dynamics  	
The PbGFPCON/RFPGAM parasite line was subsequently combined with the flow 
based approach established in the previous chapter to observe the temporal and 
spatial dynamics of P. berghei gametocytes within tissue resident erythroid cells 
in vivo (Figure 4.6A). Both BALB/c and NIH outbred mice were infected with 104 
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Figure 4.5 RFP was detectable from 8 hrs post invasion. Samples were taken at 
each time point from in vitro culture. The RFP expression in GFP postive cells was 
monitored by flow cytomotery. Graph showing the mean number of RFP positive 
gametocytes during synchronized in vitro development of PbGFPCON/RFPGAM.  Error 
bars ± SD. n = 3. 
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asynchronous parasites (9 am). As shown in the previous results chapter, the 
majority of asynchronous parasites undergo schizogony within the peripheral 
blood at 12-7 am and at the point of tissue harvest, the majority of parasites 
were ring or early trophozoite stages (as judged by examination of Giesma stain 
blood smears) within the peripheral blood (Figure 3.15 A). However, as the 
dynamics of parasite development within tissue resident erythroid cells have yet 
to be directly established, I focused my analysis on parasite life stage defined by 
the fluorescence markers: RFP+ cells were gametocytes. RFP- cells were asexual 
and the GFP MFI increased during asexual maturation.  	 
 
Peripheral blood, bone marrow and spleen were harvested every 24 hrs (9 am) 
up to and including day 7 pi (Figure 4.6A). The parasitaemia (total GFP+ cells) of 
the Ter119+CD44low cells extracted from the spleen of BALB/c mice was 
significantly higher than the parasitaemia of the peripheral blood, beginning at 
day 5 pi (Figure 4.6; * p < 0.05), consistent with the results in the previous 
chapter (day 7 pi). Moreover, the splenic Ter119+CD44low population contained a 
higher proportion of gametocytes than the peripheral blood. This occurred as 
early as day 4 pi (Figure 4.7). The observations in NIH mice were also consistent 
with the results in the previous chapter, where a non-significant difference 
between the parasitaemia of the tissue extracted Ter119+CD44low cells and the 
peripheral blood in NIH mice was detected on day 7 pi (Figure 4.6 and Appendix 
8.2.5).  
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A.	
Harvest: femur, tibia, whole spleen and blood. 
Physical dissociation of tissue into single cell suspension.  
Bone marrow perfused from bones with needle and PBS 
(diaphysis, epiphysis and metaphysis). 
Samples blocked and stained with fluorescent conjugated 
antibodies: 
CD45, CD11b, Ter119, CD44. 
Dycle Ruby DNA stain. 
Viability dye.  
Cell counts taken and total cell numbers extrapolated.  
Infected with 104  parasites. 
Uninfected controls 
Cull day 7 post infection 
Sample analysed by flow cytometery. 
All gates defined on the uninfected control then 
transposed onto the corresponding infected tissue 
sample.  
Using cell counts the total number of each population in 
each samples is calculated.  
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Figure 4.6 Parasitaemia of Ter119+CD44low cells across a 7 day infection. A. Flow 
diagram depicting the experimental protocol. B. BALB/c mice. All time points n=9; day 7 
n=8. The parasitaemia in the splenic extracted Ter119+CD44low cells was significantly 
higher compared to the peripherial blood from day 5 pi C. NIH mice. All times points n =6. 
There was no difference in parasitaemia between the tissue and blood groups across 
infection. Significant differences between a tissue group and peripheral blood at a given 
time point was investigated with a one way ANOVA comparing the mean of each group. 
Significanct differences in parasitaemia compared with the peripheral blood are indicated 
with asterisks, denoting as follows: * p < 0.05, ** p < 0.01. Error bars ± SD 	
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1
Figure 4.7 Gametocytaemia of Ter119+CD44low cells across a 7 day infection.  A. 
BALB/ c mice. All time points n=9; day 7 n=8. The gametocytaemia in the splenic 
extracted Ter119+CD44low cells was significantly higher from day 4 pi compared to the 
peripheral blood. Significant differences between a tissue group and peripheral blood at a 
given time point was investigated with a one way ANOVA comparing the mean of each 
group. Significanct differences in parasitaemia compared with the peripheral blood are 
indicated with asterisks, denoting as follows: * p < 0.05, ** p < 0.01, *** p < 0.001. Error 
bars ± SD. B. Defining the RFP+GFP+ gate. CD45-/low, CD11b-, Ter119+ RFP+ cells were 
identified within infected samples (gated defined by uninfected control). RFP+ cells were 
then gated RFP vs GFP to define where they sit on the graph. C. GFP+ cells in infected 
samples where gated RFP vs GFP. The RFP+GFP+ were identified with the gate defined 
in figure 4.7 B in order to calculate the percentage of the RFP+GFP+ cells within the GFP+ 
population. The plots displayed are representative FACS plots from day 5 post infection 
(D5 pi).  
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GFP+ parasites were observable within early reticulocytes and erythroblasts of 
the bone marrow and spleen from as early as day 3 pi. Moreover, splenic early 
reticulocytes had the highest parasitaemia and highest parasite burden 
compared with any other tissue resident erythroid population from as early as 
day 5 pi (Figure 4.8 and Appendix 8.2.6). As discussed in the previous results 
chapter, the parasitaemia of the tissue resident erythroid cells (early 
reticulocytes and erythroblasts) was not compared with the peripheral blood.  
 
It should also be noted that all parasites were within viable erythroid cells that 
had not been internalised by phagocytes (CD45- and CD11b- cellular phenotype). 
Taken together, the dynamics of the GFP+ parasite populations showed that the 
model generates reproducible results, and moreover the PbGFPCON/RFPGAM 
parasite line displays infection dynamics reflective of the parental line.  
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Figure 4.8 Parasitaemia and parasite burden of tissue resident erythroid cells 
across a 7 day infection. Left graphs show parasitaemia; Right graphs show whole cell 
numbers of parasites for A. BALB/ c mice. All time points n=9; day 7 n=8. There is a 
significant difference between the erythroid groups in terms of both percentage 
parasitaemia and parasite whole cell numbers from day 5 pi. B. NIH mice. All time points 
n =6. There is a significant parasite burden between the erythoid groups from day 5 pi. 
Mean values at each time point were compared using a one way ANOVA without multiple 
comparisons and significant differences between groups or samples are indicated with 
asterisks, denoting as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. S ER; 
splenic early reticulocytes.  S EB; splenic erythroblasts. BM ER; bone marrow early 
reticulocytes. BM EB; bone marrow erythroblasts. Error bars ± SD.  
 
 
4.2.5 Gametocyte Enrichment in Splenic Early Reticulocytes Transcends Host 
Genetics 	
	
The relative enrichment of gametocytes within the individual tissue resident 
erythroid populations was investigated during a simulated natural infection 
(Figure 4.6A). Gametocytaemia was calculated as the percentage of RFP+ cells in 
the total GFP+ cell population, therefore gametocyte enrichment was normalised 
for varying parasite burden. This analysis revealed a difference in 
gametocytaemia between the two early reticulocyte populations, where splenic 
early reticulocytes were significantly enriched for gametocytes on day 5 and day 
7 pi in both host backgrounds (BALB/c * p = 0.0113 and * p = 0.0370, 
respectively. NIH *** p = 0.0004 and * p = 0.018, respectively. Paired t test). 
Furthermore, as speculated in the previous results chapter, this population was 
significantly enriched for gametocytes compared with peripheral blood from as 
early as day 5 pi (Figure 4.9). The relative fold increase in the gametocytaemia 
of the splenic early reticulocyte population compared with peripheral blood was 
calculated for each individual mouse on days 5,6 and 7 pi (Figure 4.9). From 
this, the ratio of gametocytaemia for peripheral blood and splenic early 
reticulocytes was calculated as 1:11, 1:17 and 1:16 (BALB/c mice) on days 5, 6, 
and 7 pi, respectively and 1:4, 1:8 (NIH) on days 6 and 7 pi, respectively. BALB/c 
and NIH mice both displayed similar enrichment of gametocytes in early splenic 
reticulocytes compared with peripheral blood.  
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4.2.6 Erythroblasts are not a Niche for Consistent Gametocytogenesis  
	
There was no significant difference in gametocytaemia between splenic and 
bone marrow erythroblasts on any day pi. Moreover, there was no significant 
difference between the gametocyte enrichment of erythroblasts of either organ 
and the peripheral blood at any time point. This reflects the high variability in 
erythroblast gametocytaemia between individuals and in relation to the 
infection of other erythroid populations. For example, within one independent 
experimental repeat (n=3) gametocytaemia was measured as 18% ± 22% (SD) 
(range 44% - 0%) within BALB/c splenic erythroblasts on day 7 pi (Appendix 
8.2.8).
Figure 4.9 Gametocytaemia of early reticulocytes and peripheral blood across a 7 
day infection. A. BALB/ c mice. Gametocytaemia was significantly higher within splenic 
early reticulocytes compared to the peripheral blood from day 5 pi. All time points n=9; 
day 7 n=8. B. NIH mice. Gametocytaemia was significantly higher within splenic early 
reticulocytes compared to the peripheral blood from day 6 pi. All time points n =6. 
Significant differences between splenic early reticulocytes and peripheral blood samples 
are indicated with asterisks, denoting as follows: * p < 0.05, ** p < 0.01. Significance 
values were generated from a one way ANOVA comparing the means of the tissue 
groups to the mean of the peripheral blood. BM ER; bone marrow early reticulocytes. S 
ER; splenic early reticulocytes. Error bars ± SD. C. Representative FACS plots showing 
CD45-/low, CD11b-, Ter119+ cells from the populations with the highest gametocyteamia 
(splenic early reticulocytes; S ER) and the lowest gametocyteamia (bone marrow 
erythroblasts; BM EB). Cells where gated as either erythroblasts or early reticulocytes 
(see Figure 3.4), then gated as GFP+, the GFP+ cells where then gated RFP vs GFP. 
Plots are from day 5 post infection (D5 pi) to day 7 post infection (D7 pi).   
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4.2.7 The Spleen Contains the Highest Gametocyte and Asexual Burden  
	
Next, the tissue resident erythroid populations that contained the majority of 
the gametocyte burden was examined (Figure 4.10) (workflow depicted in Figure 
4.6A).  
 
	
	
	
	
	
	
	
	
	
	
	
	
 
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 4.10 Gametocyte numbers in erythroblasts and early reticulocytes across a 7 
day infection. A. BALB/ c mice. All time points n=9; day 7 n=8. B. NIH mice. All time points 
n =6. Both mouse backgrounds had a significantly higher number of gametocytes within the 
splenic early reticulocytes compared with all over groups from day 5 pi. Significant 
differences between groups are indicated with asterisks, denoting as follows: * p < 0.05, ** 
p < 0.01. Significance values were generated from a one way ANOVA comparing all 
groups. S ER; splenic early reticulocytes. S EB; splenic erythroblasts. BM ER; bone marrow 
early reticulocytes. BM EB; bone marrow erythroblasts. Error bars ± SD. 
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The PbGFPCON/RFPGAM parasite line also allowed for the accurate quantification 
of the burden of asexual parasites (GFP+ RFP-) within the tissue resident 
populations (Figure 4.11). 
	
Figure 4.11 Asexual parasite numbers in of erythroblasts and early reticulocytes 
across a 7 day infection. A. BALB/c mice. All time points n=9; day 7 n=8. B. NIH mice. 
All time points n =6. Both mouse backgrounds had a significantly higher number of 
asexual parasites within the splenic early reticulocytes compared to all over groups from 
day 5 pi. Significant differences between groups are indicated with an asterisk (* p < 
0.05). Significance values were generated from a one way ANOVA comparing all groups. 
S ER; splenic early reticulocytes.  S EB; splenic erythroblasts. BM ER; bone marrow 
early reticulocytes. BM EB; bone marrow erythroblasts. Error bars ± SD. 
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There is a significant difference from day 5 pi in the number of asexual and 
sexual parasites observed within the four tissue resident populations, with the 
splenic tissue resident populations (SER and SEB) containing the greatest number 
of both types of parasites (Figure 4.10 & Figure 4.11). Interestingly, within the 
splenic populations the early reticulocytes contained sexual parasites compared 
to the splenic erythroblasts from day 5 pi within the NIH mice (Paired t test. d5 
pi p = 0.001, d pi p = 0.04, d7 pi p = 0.04) and the BALB/c mice (Paired t test. d5 
pi p = 0.03, d pi p = 0.04, d7 pi p = 0.03). 
 
4.2.8 Variation in the Size of Bone Marrow and Splenic Early Reticulocytes 
 
Whilst the splenic and bone marrow pools of early reticulocytes in NIH mice 
were quantifiably the same size, in BALB/c mice they were significantly 
different (Figure 4.12). Therefore, despite the host genetic background, the 
greatest sexual and asexual parasite burden was consistently observable within 
the splenic early reticulocytes compared with all other tissue resident cells.  
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Figure 4.12 Whole cell numbers of bone marrow and splenic early reticulocytes 
across a 7 day infection. A. BALB/ c mice. All time points n=9; day 7 n=8. Significant 
differences in numbers bone marrow and splenic early reticulocytes were observed, except 
at days 3 and 5 (p = 0.06 and p = 0.07, respectively) B. NIH mice. All time points n =6. At 
all time points erythroblast and early reticulocyte populations are not significantly different. 
Statistical analysis at each time point was performed using an unpaired t test and 
significant differences are indicated with asterisks, denoting as follows: * p < 0.05. BM ER; 
bone marrow early reticulocytes. S ER; splenic early reticulocytes. Error bars ± SD. 
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4.2.9 Splenic Early Reticulocytes and Peripheral Blood Contain Similar 
Numbers of Gametocytes 	
A higher proportion of splenic early reticulocytes contain gametocytes than any 
other erythroid population within the body from day 5 pi (Figure 4.9). This 
population also contains the greatest number of gametocytes within the tissue 
resident infection from day 5 pi (Figure 4.10). However, the relevance of splenic 
early reticulocyte gametocytes to parasite transmission remains unclear.  
Therefore, the total number of gametocytes in the peripheral blood was 
compared with the total number of gametocytes in splenic early reticulocytes 
(Figure 4.13). Proportionally, there was a trend for preferential gametocyte 
location towards the peripheral blood as the infection progressed. This trend 
was exhibited in both mice strains (Figure 4.14). This could possibly suggest that 
gametocytes are initially formed within the tissue resident erythroid population 
before migrating into and accumulating within the peripheral blood. However, 
due to the dynamics of the promoter controlling rfp expression it is not possible 
to conclude whether the gametocytes within the tissue resident population are 
early gametocytes which would then go on to populate the peripheral blood as 
mature gametocytes.  
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Figure 4.13 Gametocyte numbers in the peripheral blood and splenic early 
reticulocytes across a seven day infection.  A. BALB/ c mice. All time points n=9; day 
7 n=8. B. NIH mice. All time points n =6. Statistical analysis was performed using a one 
way ANOVA comparison. Error bars ± SD. 
A. BALB/c 
A. BALB/c 
B 
da
y 4
da
y 5
da
y 6
da
y 7
0
50
100
150
Days Post Infection
%
 o
f t
ot
al
 g
am
et
oc
yt
es
 Blood 
SER
Tissue 
Resident
da
y 1
da
y 2
da
y 3
da
y 4
da
y 5
da
y 6
da
y 7
100
101
102
103
104
105
106
Days Post Infection
G
am
et
oc
yt
e 
nu
m
be
rs
 (l
og
) Blood 
S ER
Results	 182	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Figure 4.14 Proportion of total gametocytes in the peripheral blood and splenic 
early reticulocytes A. BALB/ c mice. All time points n=9; day 7 n=8. B. NIH mice. All time 
points n =6. Error bars ± SD. SER; splenic early reticulocytes. Tissue resident population 
is the combined number of parasites in the bone marrow early reticulocytes, erythroblasts 
and splenic erythroblasts.  
	
	
	
4.2.10  Invasion of Splenic Early Reticulocytes  
	
The suggestion that splenic early reticulocytes are the tissue resident erythroid 
stage for preferential P. berghei invasion and gametocyte formation was tested 
experimentally (workflow depicted in Figure 4.6A). 
 
The P. berghei asexual life cycle is 22 – 24 hrs. In an asynchronous infection 
schizogony occurs for the majority of asexual parasites in the peripheral blood 
population at 12-7 am. In this study, samples were taken from the bone marrow, 
spleen and peripheral blood at 24 hr intervals at 9 am when the majority of 
asexual parasite forms were rings and early trophozoites in the peripheral blood. 
It takes 36 hrs for the most immature erythroblasts to mature into early 
reticulocytes (Chen et al., 2009). Therefore, if the temporal dynamics of asexual 
B. NIH 
da
y 4
da
y 5
da
y 6
da
y 7
0
50
100
150
Days Post Infection
%
 o
f t
ot
al
 g
am
et
oc
yt
es
Blood 
SER
Tissue Resident
Results	 183	
maturation in tissue resident erythroid cells is reflective of the 22-24 hrs life 
cycle in the peripheral blood, all asexual parasites will have undergone egress 
from immature erythroblasts before reaching the early reticulocyte 
compartment. It takes 20 hrs for the intermediate erythroblasts to mature into 
early reticulocytes (Chen et al., 2009). Under normal maturation dynamics, a 
ring stage parasite in an intermediate or mature erythroblast would have 
developed and undergone egress within 24 hrs. As such, parasites observed in 
the erythroblast population at any given time point of this experiment would 
have not contributed to the early reticulocyte population at the ensuing time 
point.  
 
Nonetheless, there is no evidence that P. berghei parasites develop at the same 
rate or undergo the same synchronicity as observed in the peripheral blood. 
Therefore, the combined total number of GFP+RFP- parasites in the intermediate 
and mature splenic erythroblasts at each 24 hr time point was calculated. The 
percentage contribution this total made to the quantified parasite burden in the 
splenic early reticulocytes at each ensuing time point was determined. Here 
<13% of the parasites observed within splenic early reticulocytes could be the 
result of an invasion event occurring within a splenic erythroblast population 
(Figure 4.15).  
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Days	pi	
Contribution	of	EB	
to	ER	parasites	%	
(±	SD)	
Day2	 0	
Day3	 0	
Day4	 0.34	±	0.6	
Day5	 2.56	±	3.89	
Day6	 2.28	±	1.24	
Day7	 12.83	±	9.88	
Figure 4.15	 	 Percentage contribution of splenic EB parasites to the splenic ER  
parasite population 24 hours later. Plotted on the graph are the mean ± SD whole cell 
numbers of GFP+RFP- splenic early reticulocytes (ER) and the mean ± SD whole cells 
numbers of GFP+RFP- splenic intermediate and mature erythroblasts (EB). Tables show 
the percentage contribution the parasitised splenic intermediate and mature erythroblasts 
make to the parasitised splenic early reticulocytes population at the ensuing time point ± 
SD. A. BALB/c mice. All time points n=9; day 7 n=8. B. NIH mice. All time points n=6.  
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Gametocyte maturation of P. berghei takes 26-27 hrs and the gametocytes are 
stable for a further 10-11 hrs. Therefore gametocytes within the intermediate or 
mature splenic erythroblast population at any given time point, could contribute 
to the gametocyte population in the splenic early reticulocytes at the ensuing 24 
hr time point. I calculated the percentage contribution the total number of RFP+ 
gametocytes in the intermediate and mature erythroblasts made to the 
gametocyte burden in the early reticulocytes at each ensuing time point (Figure 
4.16). Here <25 % of the gametocytes observed within splenic early reticulocytes 
could be the result of an invasion and gametocyte conversion event occurring 
within a splenic erythroblast population. Therefore the majority of gametocytes 
observed within early reticulocytes were formed within this erythroid population 
and not the preceding erythroblast population.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Days	pi	
Contribution	of	EB	to	
ER	parasites	%	(±	SD)	
Day2	 0	
Day3	 0	
Day4	 0	
Day5	 9.92	±14	
Day6	 0.8	±	0.8	
Day7	 5.81	±	5	
Days	pi	
Contribution	of	EB	to	
ER	gametocytes	%	(±	
SD)	
Day2	 0	
Day3	 0	
Day4	 0	
Day5	 0.8	±	2.3	
Day6	 1.6	±	2.6	
Day7	 25	±	24	
A. BALB/c 
Results	 186	
	
	
	
	
	
	
	
	
	
 
4.2.11 Invasion of Bone Marrow Early Reticulocytes  	
The bone marrow early reticulocyte and erythroblast data generated from the 
time course did not mirror the splenic data discussed above. The parasitised 
(GFP+) erythroblast population in the bone marrow was equal or greater than the 
parasitised early reticulocyte population at the ensuing time point (Appendix 
8.2.9) and on each corresponding day (Figure 4.11: BALB/c all time points NS. 
NIH all time points NS). Nonetheless, as the gametocytaemia (GFP+RFP+) in the 
erythroblast population was less than the gametocytaemia of early reticulocyte 
population at the ensuing time point, it likely that the early reticulocytes are 
the site of preferential gametocyte formation in the bone marrow (Appendix 
8.2.10). Therefore, although it is difficult to conclude as to the dynamic of bone 
marrow erythroid invasion and development, it would seem that the early 
reticulocytes universally provide a niche for gametocyte formation within tissue 
resident erythroid cells.  
 
 
 
 
Days	pi	
Contribution	of	EB	to	
ER	gametocytes	%	(±	
SD)	
Day2	 0	
Day3	 0	
Day4	 0	
Day5	 0	
Day6	 0.6	±	0.1	
Day7	 10	±	19	
Figure 4.16. Percentage contribution of splenic EB gametocytes to the splenic ER 
gametocyte population 24 hours later. Tables show the percentage contribution the 
RFP+ splenic intermediate and mature erythroblasts make to the RFP+ splenic early 
reticulocytes population at the ensuing time point ± SD. A. BALB/c mice. All time points 
n=9; day 7 n=8. B. NIH mice. All time points n=6. 
B. NIH 
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Together the data in this chapter suggests that splenic early reticulocytes are 
the tissue resident erythroid population preferentially invaded by P. berghei and 
that subsequently these cells selectively promote gametocyte formation.   
 
In this chapter I successfully: 
• Developed a parasite line that can distinguish male and female 
gametocytes from asexual parasites at >8-12 hrs post invasion. 
• Identified that splenic early reticulocytes have the highest 
gametocytaemia in the host. 
• Identified that P. berghei preferentially invades splenic early 
reticulocytes and not the preceding erythroblast population. 
• Identified that P. berghei gametocytes preferentially form within early 
reticulocytes and not the preceding erythroblast population. 
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4.3 Discussion 	
The key discussion points are: 
• The development of the PbGFPCON/RFPGAM reporter line for young 
gametocytes. 
• The preferential invasion by P. berghei of early reticulocytes within the 
spleen may be due to the stress regulation of the splenic erythroblasts.  
• The preferential invasion of splenic early reticulocytes compared to all 
other tissue resident erythroid population may be due to accessibility.  
• Early reticulocytes may be the “Goldilocks” niche for gametocyte 
conversion.  
 
4.3.1 Generating the Gametocyte Reporter Line 	
In the previous chapter, I established that P. berghei parasitises erythroblasts 
and early reticulocytes to different degrees both within an organ and between 
organs on day 7 pi. As these parasitised cells could establish an infection in naïve 
mice, a percentage of erythroblasts and early reticulocytes must contain asexual 
cells. In this chapter, I wanted to quantify the gametocyte burden of these 
tissue resident cells. In order to achieve this aim I constructed a parasite line 
that allowed me to identify gametocytes from an early developmental stage. 
Moreover, in successfully generating PbGFPCON/RFPGAM I have created a tool that 
easily revolves sexual parasites from asexual parasites, whilst at the same time 
defining gender specific populations. To our knowledge, this parasite line offers 
gender discrimination at the earliest developmental time point available in the 
P. berghei.  
 
4.3.2 P. berghei Preferentially Invades Early Reticulocytes Compared with 
Erythroblasts in the Spleen, a Dynamic Not Mirrored in the Bone 
Marrow  	
In the previous chapter, GFP MFI was used to infer the life stage of parasites 
within early reticulocytes and erythroblasts at a single time point. Through 
inferring that both tissue resident populations contained parasites at the same 
maturation stage, it was suggested that the parasites observed in early 
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reticulocytes on day 7 pi were not a result of invasion events within 
erythroblasts on day 6 pi. As such, it was postulated that P. berghei 
preferentially invades early reticulocytes in both tissues. Here, this assertion 
was numerically justified for the splenic erythroid populations, but not the bone 
marrow, with data derived from 24 hr time intervals across a 7 day infection. 
The random sampling of mice in two (NIH) or three (BALB/c) independent 
experiments generated reproducible data with regard to the proportions of 
parasitaemia and gametocytaemia between the splenic early reticulocytes and 
other erythroid compartments.  
 
4.3.3 Parasite Preference due to Host Cell Metabolism  
P. berghei has a characterised tropism for stage III- IV reticulocytes within 
peripheral blood. There is evidence that such tropism benefits the parasite 
through access to the greater metabolic capabilities of the circulating 
reticulocyte compared with the erythrocyte (Srivastava et al., 2015).  A recent 
preliminary screen comparing the metabolomics of reticulocytes (stage I-IV) 
extracted from human cord blood revealed a continual decrease in metabolite 
concentrations during reticulocyte maturation to erythrocytes (Malleret et al., 
2013). These data indicate that tissue resident reticulocytes are more nutrient 
rich than the erythroid cells in circulation. Nonetheless, the results of a 
transcriptional comparison between polychromatic and orthochromatic 
erythroblasts suggest that earlier erythroid stages are even more metabolically 
active than reticulocytes and mature RBC (Tamez et al., 2011). As such, 
parasitising erythroblasts might be comparatively more beneficial for parasite 
growth. While this might explain the invasion dynamics implied by the bone 
marrow data, it does not explain the observed preference of P. berghei for 
splenic reticulocytes over splenic erythroblasts. 
 
4.3.4 Physical Accessibility of Early Reticulocytes and Erythroblasts  
It should be acknowledged that the architecture of the erythropoetic tissue in 
the spleen and the bone marrow are different. As such, physical accessibility to 
the different maturation stages of erythroid cells may be an influencing factor 
for the difference in parasite selectivity for early reticulocytes between the two 
tissues. However, there is evidence that erythroid maturation correlates with 
peri-sinusoidal localisation in the bone marrow; with the most mature cells 
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being closer to the sinus endothelium (Yokoyama et al., 2003). Therefore, 
parasites (free merozoites or schizont infected erythrocytes) migrating into the 
bone marrow would have disproportionate access to early reticulocytes 
compared with erythroblasts. In contrast, studies observing erythroblast islands 
within the human and mouse spleen have not commented on the spatial 
arrangement of maturing tissue resident erythroid cells (Palitzsch et al., 1987; 
Deiwick, 1992). However, when taking into consideration that the endothelium-
free, open circulation within the splenic red pulp would not differentially 
restrain parasite access to erythroblasts versus reticulocytes, it seems unlikely 
that physical accessibility is a driving factor for the different erythroid cell 
selectivity observed between the two tissues.  
 
4.3.5 Erythroblast Apoptosis and the Parasite’s Preference in the Spleen for 
Early Reticulocytes  
It has been demonstrated that Plasmodium-infected erythroblasts can present 
parasite derived peptides via MHC class I, stimulating a CD8+ cytotoxic T cell 
response (Imai et al., 2013). Moreover, this interaction stimulates apoptosis of 
the erythroblast via the Fas pathway (Imai et al., 2015a). Apoptosis pathways 
result in the fragmentation of DNA and the permeabilisation of the 
mitochondria. During reticulocyte maturation the cell undergoes mitochondrial 
disruption, nonetheless, this event is not accompanied by cell death as the 
apoptotic machinery is also undergoing degradation (Koury et al., 2005). 
Moreover, reticulocytes do not display Fas (Liu et al., 2006). Although 
reticulocytes do display MHC class I, it is down regulated during maturation 
(Carayon et al., 2011; Imai et al., 2013; Martín-Jaular et al., 2016). As such, the 
preference of P. berghei for splenic early reticulocytes over splenic 
erythroblasts may stem from the continued expression by the latter of proteins 
involved in apoptosis and immune surveillance pathways. Nonetheless, as the 
data implies that P. berghei does not preferentially invade an erythroid age class 
within the bone marrow, it might be the case that a significant proportion of P. 
berghei parasites invade splenic erythroblasts but were not observed in this 
work due to immune regulatory driven apoptotic events occurring to a greater 
extent in the spleen than in the bone marrow prior to sampling. Although, it 
should be noted that there is no evidence of difference in erythroblast driven 
immune responses between the two tissues (Imai et al., 2013).  
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On the other hand, the homeostatic regulation of splenic and bone marrow 
derived erythroblasts is well documented to be different. During basal conditions 
the splenic erythroblasts and erythroid progenitors undergo a higher rate of 
apoptosis compared with the corresponding populations in the bone marrow (Liu 
et al., 2006; Varricchio et al., 2012). Moreover, during erythropoetic stress 
responses the cell surface apoptotic markers Fas and FasL are down-regulated to 
a greater extent by the splenic erythroblasts than the bone marrow 
erythroblasts (Liu et al., 2006). Consequently, splenic erythroblasts inhabit a 
distinctively different niche to bone marrow erythroblasts in vivo. This might be 
a factor fuelling the parasite’s preferential tropism for early reticulocytes in one 
tissue and not the other, although how factors involved in regulating the host’s 
stress erythropoetic influence parasite selectivity remains to be investigated.   
 
4.3.6 Parasites Preferentially Invade Splenic Early Reticulocytes Compared 
to those in the Bone Marrow 
 
Within this work I observed that P. berghei preferentially invades splenic early 
reticulocytes compared with all other tissue resident erythroid populations. 
Although variation in erythroblast regulation may influence the difference in the 
parasites selectivity for erythroid age classes within the two tissues, there is no 
evidence that splenic early reticulocytes and bone marrow early reticulocytes 
are different. As such, in order to explain the parasite’s preference for early 
reticulocytes in spleen versus bone marrow, the accessibility of the two 
erythropoietic tissues, due to the different anatomical structure of the organs, 
should be taken in account again (Steiniger, Bette and Schwarzbach, 2011; Itkin 
et al., 2016). As mentioned above, the blood in the murine spleen empties into 
the red pulp where it drains through the splenic cords before re-entering the 
closed circulation. In contrast, the tissue of the bone marrow and the cells 
within the vasculature are separated by endothelium (Steiniger, Bette and 
Schwarzbach, 2011; Itkin et al., 2016). Therefore, it is possible that the parasite 
preferentially invades splenic reticulocytes in vivo due to the relative ease of 
access. Nonetheless, it should be taken into account that the perisinusoidal 
niche of erythropoiesis in the bone marrow is a high reactive oxygen species 
(ROS) environment, whereas the splenic cords are an acidotic and hypoxic 
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environment (Steiniger, Bette and Schwarzbach, 2011; Itkin et al., 2016). 
Although early reticulocytes are enucleated they retain a residual mitochondrial 
metabolism and an active TCA cycle (Malleret et al., 2013; Srivastava et al., 
2015, 2016), however, the environmental differences between the two niches 
implies that the metabolism of the splenic early reticulocytes may be more 
dependent on glycolysis then the bone marrow early reticulocytes. Nonetheless, 
the features of the cell’s metabolism driving parasite selectivity remain to be 
investigated.  
 
4.3.7 Preferential Gametocyte Formation in Early Reticulocytes Compared to 
Erythroblasts  	
In this chapter, I combined the newly generated parasite line with our previously 
described flow based approach and observed that the highest gametocytaemia 
within each tissue was detectable within the early reticulocyte population. 
Sampling every 24 hrs allowed me to determine that the majority of these 
gametocytes had undergone invasion and subsequent commitment within the 
early reticulocyte and not the preceding erythroblast population in both tissues. 
Moreover, the highest gametocyteamia within the host was observable within 
splenic early reticulocytes. Considering that the spleen is an interface for the 
circulatory and immune systems, and that mature asexual stages of P. berghei 
display defined parasite-derived proteins, it is likely that the clearance of 
asexually parasitised early reticulocytes is greater in relation to gametocytes 
(Engwerda, Beattie and Amante, 2005; Imai et al., 2013, 2015b). Although it 
should be noted that antibodies in the plasma of malaria patients have indicated 
the existence and immune recognition of gametocyte specific antigens (Dinko et 
al., 2012; Saeed et al., 2008). Based solely on proportional data, it could be 
argued that the splenic early reticulocytes may seem to have the highest 
gametocyte enrichment due to the relatively higher clearance of asexual 
parasites. However, in this work I also quantified the tissue resident erythroid 
population containing the highest asexual and total parasite burdens as the 
splenic early reticulocytes. Taken together these data suggested that a 
relatively elevated clearance of asexual parasitised early reticulocytes does not 
occur, and therefore cannot explain the selective enrichment of gametocytes 
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within this population. Splenic early reticulocytes therefore represent the tissue 
resident population where preferential gametocyte formation occurs.  
 
The transcription factor AP2G has been identified as the master regulator for 
initiating Plasmodium gametocytogenesis (Sinha et al., 2014). Downstream 
events during gametocytogenesis are accompanied by a shift in parasite 
metabolism away from rapid fermentation glycolysis towards the more efficient 
TCA cycle and oxidative phosphorylation. This metabolic transition is associated 
with development within a relatively nutrient deprived environment (MacRae et 
al., 2013; Salcedo-Sora et al., 2014; Srivastava et al., 2016). It has recently 
been demonstrated that ap2g is regulated in a similar manner to var genes, with 
gametocyte commitment being plastic up to the trophozoite stage (Dr Robyn 
Kent. unpublished;(Brancucci et al., 2014; Coleman et al., 2014). It would 
therefore be tempting to theorise that the host cell’s metabolic profile 
influences signaling pathways upstream of ap2g transcription within newly 
invaded merozoites, promoting a parasite shift towards oxidative 
phosphorylation. However, studies have shown that cord blood derived early 
reticulocytes and circulating stage III-IV reticulocytes retain residual 
mitochondrial metabolism and an active TCA cycle and therefore have a more 
enriched metabolic profile than erythrocytes (Malleret et al., 2013; Srivastava et 
al., 2015, 2016). Therefore early reticulocytes provide a more metabolically 
enriched environment for the parasite then erythrocytes (Malleret et al., 2013; 
Srivastava et al., 2015, 2016). Nonetheless, it should be taken into account, as 
mentioned above, that the splenic early reticulocytes may have a more 
glycolytic based metabolism due to their local niche which is believed to be 
hypoxic, but this remains to be investigated. As such, the gametocyte 
stimulating factors provided by the host cell metabolism and immature status 
are yet to be directly studied. 
 
4.3.8 Gametocytes in the Splenic Early Reticulocytes and the Peripheral 
Blood 
 
The dynamics of the gametocyte-specific fluorescence proxy in the 
PbGFPCON/RFPGAM parasite line was defined in this chapter with the RFP signal 
distinguishing gametocytes from 8 hpi. This parasite line was used in an 
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asynchronous infection to determine the gametocyte dynamics of tissue resident 
erythroid cells. The methodology used meant that the whole cell numbers of 
gametocytes in the peripheral blood could be quantified in tandem with the 
quantification of erythroid populations. Calculating the proportional distribution 
of total gametocytes within the host indicated that there was a trend for sexual 
cells to be formed in the tissue resident erythroid population prior to being 
observed within the peripheral blood. Nonetheless, the maturation stages of the 
gametocytes within either population could not be determined, therefore the 
biological relevance to transmission of gametocyte formation outwith the 
peripheral blood cannot be determined. This can be addressed by further work 
using a synchronised infection across 24 hrs.  The workflow for this experiment 
would be as follows: a known amount of highly synchronised and purified 
schizonts in erythrocytes stained with anti-Ter119 IgG would be intravenously 
injected into mice in order to undergo merozoite egress and re-invasion. The 
fluorescent conjugated antibody will identify residual schizonts and mature 
gametocytes from the previous cycle. Samples of peripheral blood will be taken 
at 0 hpi and then at 8 hpi when the tissue of three mice will be harvested at 
random. The RFP+ signal in the peripheral blood and the tissue resident erythroid 
cells will be quantified by flow cytometry of tissues sampled from mice at 12, 15 
and 18 hpi. If the splenic early reticulocytes are the location of gametocyte 
formation in the host then it would be expected that at 8 hpi a greater number 
of RFP+ cells will be observed within this population compared with the 
peripheral blood. As gametocyte maturation progresses it would be expected 
that the ratio of RFP+ cells in the splenic early reticulocytes compared to the 
peripheral blood would skew positively in favour of the latter population. This 
would indicate that gametocytes leave the tissue and enter the peripheral 
blood. This point is important, as although the previous results chapter 
demonstrated that sorted parasitised early reticulocytes and erythroblasts were 
permissible to functional parasite development, it has yet to be shown that 
parasitised tissue resident erythroid cells can leave the tissue join the peripheral 
blood.  
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4.4 Summary 	
In this chapter I developed a parasite line that discriminates sexual cells from 
asexual parasites early in their development. I coupled this with our previously 
optimised flow based methodology and observed that P. berghei preferentially 
invades and preferentially forms gametocytes within splenic early reticulocytes 
compared to all other tissue resident erythroid populations.  
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5 Artemisinin Treatment Failure and Tissue Resident 
Erythroid Infection.  	
5.1 Introduction  
The initial steps in evaluating the effectiveness of antimalarial drugs and novel 
antimalarial compounds are carried out in vitro with parasitised mature 
erythrocytes (Traore et al., 2015). This directly reflects the dogma that 
effective malaria treatment correlates with the concentration of active drug 
within the blood stream (White, 2013). The data in the previous chapters of this 
thesis demonstrate that P. berghei can parasitise both nucleated and enucleated 
tissue resident erythroid cells of the bone marrow and the spleen. The infection 
dynamics described by this work may confound effective chemotherapy and 
represent a route for malaria recrudescence and generation of drug resistance. A 
recent study carried out on circulating erythroid cells linked the metabolic 
enrichment of the host cell to an increase in IC50 of antimalarials targeting the 
metabolic pathways of Plasmodium (Srivastava et al., 2015). Studies have 
demonstrated that early reticulocytes and erythroblasts are more metabolically 
enriched than circulating erythroid cells (Tamez et al., 2011; Malleret et al., 
2013; Srivastava et al., 2015). It is therefore likely that the IC50 of a drug may be 
further increased in relation to parasitised tissue resident erythroid cells 
(Srivastava et al., 2015).  
	
Currently the WHO advocates ACTs as front line therapy against all species-
specific malarias (WHO, 2015). ARTs are pro-drugs that are activated by the end 
products of parasite metabolism (Klonis, Creek and Tilley, 2013). There are 
emerging reports from the field documenting the treatment failures of both 
ARTs mono and worryingly even ACTs combined therapies due to the 
recrudescence of infection (Chang et al., 2016).  
 
In this chapter the PbGFPCON/RFPGAM parasite line was combined with an 
established recrudescence assay in order to: 
• Identify parasitised tissue resident erythroid cells that may fuel infection 
recrudescence after ART treatment. 	
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• Investigate any effects ART has on the tissue resident erythroid cell 
populations.   
   
Results		 198	
5.2 Results  	
5.2.1 Parasitised Splenic Early Reticulocytes May be a Source of Infection 
Recrudescence 
The Peters “4 day suppressive test” was used, as previously described, to 
ascertain recrudescence after treatment with ART (Figure 5.1) (Vega-Rodríguez 
et al., 2015). ART doses ranged from 1 mg/kg through to previously reported 
curative doses (10-40 mg/kg) (Janse et al., 1994; Vega-Rodríguez et al., 2015) 
Mice infected with 106 PbGFPCON/RFPGAM  parasites on day 0 where treated with 
ART beginning 1 hpi, and daily until day 3 pi (Figure 5.2).  
 
 
 
 
 
 
 
 
 
 
1 hr PI Day 1 PI Day 2 PI Day 3 PI Day 4 PI 
Dose of ART Dose of ART Dose of ART Dose of ART 
Infected with 106 
 PbGFPCON/RFPGAM : 
Groups receiving ART concentrations; 
Infected vehicle control. 
Plus uninfected vehicle control   
Harvest bone marrow 
Spleen  
Peripheral blood 
n = Half of each drug group 
Daily monitoring of 
peripheral blood 
parasitaemia  
of remaining 
members of drug 
groups. 
Peripheral blood parasitaemia monitored by flow cytometry  
Parasitaemia, parasite 
burden and whole cell 
numbers of tissue 
resident erythroid cells 
analysed using 
optimised gating 
strategy.     
Figure 5.1. Work flow of the Peters 4 day suppressive test. PI; post infection. 
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On day 4 pi peripheral blood, bone marrow and spleen were harvested from 
animals from each group. As expected, the peripheral parasitaemia of all drug-
treated groups was significantly attenuated compared with the infected vehicle 
control (Figure 5.3A). As such, the ART IC50 for peripheral blood was calculated 
on day 4 pi as 0.04 mg/kg (Figure 5.3B). Due to the dynamics of the fluorescent 
proxies in the PbGFPCON/RFPGAM parasite line it was determined that the 10 
mg/kg – 1mg /kg ART treated groups contained asexual (GFP+RFP-) parasites, 
therefore assuring us the analysis was not based on degrading gametocytes 
(Figure 5.3C).  
Figure 5.2 Impact of ART treatment doses on daily parasitaemia. BALB/c mice were 
infected with the PbGFPCON/RFPGAM parasite line and treated daily with the indicated doses 
of ART. Blood parasitaemia of animals was monitored daily by flow cytometry and mice 
dosed with 20mg/kg and 40mg/kg ART had undetectable parasitaemia by day 4 post 
infection. n=7. Error bars ±SD.  
da
y1
da
y2
da
y3
da
y4
0.00
0.02
0.04
0.06
0.08
0.10
2
4
6
Days Post Infection
%
 P
ar
as
ita
em
ia
1mg/kg
3mg/kg
10mg/kg
20mg/kg 
40mg/kg 
infected vechicle control
Results		 200			 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Parasites were undetectable in the peripheral blood of BALB/c mice 
dosed with ART at 20 mg/ kg and 40 mg/kg A. Peripheral blood parasitaemia at day 4 
pi of  BALB/c mice dosed with different ART concentrations. n = 4; 1 mg/kg n = 3. ±SD B.  
The IC50 of ART was calculated as 0.04mg/kg for the blood infection parasitaemia of the 
groups dosed. C. Percentage of peripheral blood containing GFP+RFP- asexual parasites. 
n = 4; 1 mg/kg n = 3. ±SD. Drug dose concentrations displayed on the x-axis. The groups 
were compared using a one-way ANOVA with multiple comparisons. Significant 
difference between groups or samples is indicated with asterisks, denoting as follows: **** 
p < 0.0001.  
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Despite being unable to detect parasites within the peripheral blood by flow 
cytometry, mice from both the 20 mg/kg and 40 mg/kg groups contained 
parasitised splenic early reticulocytes (Figure 5.4A). Unsurprisingly, the 
administration of all concentrations of ART attenuated splenic early reticulocyte 
parasitaemia and parasite whole numbers compared with the infected vehicle 
control (Figure 5.4B). Nonetheless, the dose dependent attenuation was lost 
beyond 1 mg/kg. GFP+ parasites could not be detected within splenic 
erythroblasts or any tissue resident erythroid population in bone marrow. 
Incidentally, the IC50 for bone marrow tissue resident erythroid cells was 
calculated as 0.0019 mg/ kg (Appendix 8.3.1).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Uninfected	Splenic	ER	 20mg/kg	Splenic	ER	 40mg/kg	Splenic	ER	 
GFP T
er119 100% 0% 0.05% 99.9% 0.15% 99.8% 
A.  
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The splenic early reticulocytes were colonised by both sexual and asexual 
parasites (Figure 5.5A&C). Through quantifying the number of gametocytes 
within the splenic early reticulocyte population it was determined that ART 
treatment does not stimulate an increase in sexual cells (Figure 5.5B). The 
significantly increased gametocytaemia of early reticulocytes observed in mice 
treated with 20 mg/kg is likely due to the degradation of asexual parasites 
rather than an increased gametocyte conversion rate (Appendix 8.3.2). 
 
Figure 5.4 GFP+ parasites were detectable within splenic early reticulocytes of 
BALB/c mice after ART treatment. ER; early reticulocyte. A. Representative FACS plots 
showing splenic early reticulocytes from the uninfected vehicle control, 20 mg/kg ART 
dosed group and the 40 mg/kg ART dosed group harvested on day 4 pi. Note the GFP+ 
parasites in the drug-dosed animals. B. The percentage parasitaemia and whole cell 
numbers of parasites within the splenic early reticulocytes of infected mice treated with 
ART.  The splenic early reticulocyte parasitaemia and parasite whole numbers are not 
significantly different between the 3 mg/kg – 40 mg/kg groups.  n = 4; infected vehicle 
control and 1 mg/kg n = 3. ±SD. Drug dose concentrations displayed on the x-axis. The 
groups were compared using a one-way ANOVA with multiple comparisons. Significant 
difference between groups or samples is indicated with asterisks, denoting as follows: * p 
< 0.05, ** p < 0.01, *** p < 0.001. BALB/c mice. 
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Figure 5.5 ART treatment does not increase gametocytogenesis within early 
reticulocytes of BALB/c mice. A. Whole cell numbers of gametocytes within the splenic 
early reticulocyte population of infected BALB/c mice treated with ART. B. 
Gametocytaemia of splenic early reticulocytes. C. Whole cell numbers of asexual 
parasites within the splenic early reticulocytes. Mean values ± SD are shown for n = 4, 
except infected vehicle control and 1 mg/kg n = 3. Drug dose concentration displayed on 
the x-axis. The groups were compared using a one-way ANOVA with multiple 
comparisons. Significant differences between groups or samples is indicated with 
asterisks, denoting as follows: * p < 0.05, ** p < 0.01, *** p < 0.001. 
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The remaining mice in the 20 mg/kg and 40 mg/kg (n=3) dosed groups 
experienced recrudescence of infection from day 6 pi (72 hrs after final drug 
dose). On day 6 pi the average parasitaemia of mice in the 40 mg/kg dosing 
group was 0.0006% (Figure 5.6). When taking into account that the average 
BALB/c mouse contains 1ml of blood with 6 x106 erythroid cells/µl, it can be 
extrapolated that the mice on average contained 36,000 parasites on day 6. P. 
berghei has a x 10 replication rate/ 24 hrs (Janse, 2014), as such, it can be 
extrapolated that on day 4 the mice would need to contain 360 asexual 
parasites. On average the mice contained 683 ± 341 asexual parasites in the 
splenic early reticulocytes on day 4 (Figure 5.5C and Appendix 8.3.3). As such, 
the hypothesis that the recrudescence in the 40mg/kg group is due solely to the 
survival of parasites in the tissue resident erythroid cells is mathematically 
sound. 															
		
5.2.2 ART Treatment Promotes Splenic Erythropoiesis in P. berghei Infected 
Mice  
Using the flow-based approach I was also able to investigate the effects ART 
treatment has on erythropoiesis. The samples investigated here were harvested 
from mice on day 4 post-infection after treatment under the modified Peters “4 
day suppressive test” (Figure 5.1).  
 
Figure 5.6 Recrudescence of infection after ART treatment. Parasitaemia of BALB/c 
mice dosed with 40 mg/kg and 20 mg/kg ART. n=3. Error bars ± SD. 
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A significantly higher proportion of tissue resident erythroid cells were 
nucleated erythroblasts in the spleens of mice treated with doses of ART 
between 1- 10 mg/kg compared with the uninfected vehicle control. This was 
reflective of the erythropoietic dynamics stimulated by the untreated P. berghei 
infection (infected vehicle control) (Figure 5.7A).  When the populations of 
splenic tissue resident erythroid cells were quantified it became apparent that 
treatment with non-curative doses of ART between 3 – 10 mg/kg significantly 
increased the number of early reticulocytes and erythroblasts compared with 
untreated P. berghei infection (infected vehicle control) (Figure 5.7B). In 
contrast, when mice were treated with 40 mg/kg the stimulatory effects of ART 
on erythropoiesis were significantly reduced compared with 10 mg/kg (whole 
cell numbers of reticulocytes ** p = 0.011; whole cell numbers of erythroblasts 
**** p = <0.0001) (Figure 5.7B). Nonetheless, treatment of infected mice with 40 
mg/kg maintained greater levels of erythropoiesis than uninfected mice that 
were similar to that observed in untreated infection control mice. (Figure 5.7 
A&B). However, treatment with this concentration of ART resulted in altered 
stage distribution of splenic erythroblasts, with a significant lower number of 
mature erythroblasts compared to the intermediate group (Figure 5.7C&D). This 
is in stark contrast to the 1:2:4 ratio of immature: intermediate: mature 
erythroblasts observed under steady state conditions and thus implies 
dysregulation of erythropoiesis.  
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5.2.3 ART Administration Promotes Splenic Erythropoiesis in Uninfected 
Mice  
Next it was investigated whether the stimulating effects observed after ART 
treatment were independent of P. berghei infection. To do this, four daily doses 
of ART were administered to uninfected mice. Bone marrow and spleen tissue 
was harvested 24 hrs after the final drug dose. Quantifying the populations of 
tissue resident erythroid cells demonstrated a significant increase in both splenic 
early reticulocytes and erythroblasts in animals dosed with 40 mg/kg compared 
Figure 5.7 ART treatment stimulates splenic erythropoiesis in a dose dependent 
manner in infected mice.  ER; early reticulocyte. EB; Erythroblast. A. The proportion of 
splenic tissue resident erythroid cells that are erythroblasts (EB) is significantly increased 
in BALB/c mice infected with P. berghei compared with the uninfected vehicle control. B. 
Whole cell numbers of splenic early reticulocytes (ER; left) and whole cell numbers of 
splenic erythroblasts (right). C. Whole cell numbers of splenic erythroblast stages. D. 
Proportion of total splenic erythroblasts falling within the immature, intermediate and 
mature gates. Drug dose concentration displayed on the x-axis. The groups were 
compared using a one-way ANOVA with multiple comparisons.  Values shown are means 
of n = 4 except infected vehicle control and 1 mg/kg n= 3. ±SD. Significant differences 
between groups or samples is indicated with asterisks, denoting as follows: * p < 0.05, ** p 
< 0.01, *** p < 0.001, **** p < 0.0001. 
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with the vehicle control (Figure 5.8). Moreover, treatment with this 
concentration of ART did not result in altered stage distribution of splenic 
erythroblasts (Figure 5.8). This suggested that ART treatment stimulates 
erythropoiesis in a dose dependent manner independently of P. berghei 
infection. 	
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Figure 5.8 ART administration results in the increased numbers of splenic early 
reticulocytes and erythroblasts in uninfected BALB/c. ER; early reticulocyte. EB; 
Erythroblast.A. Whole cell numbers of early reticulocytes. B. Whole cell numbers of 
erythroblasts. C. Whole cell numbers of splenic erythroblast stages. n= 4. ±SEM. Drug 
dose concentration displayed on the x-axis. The groups were compared using a one-way 
ANOVA with multiple comparisons. Significant difference between groups or samples is 
indicated with asterisks, denoting as follows: * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 
0.0001. BALC/c mice.  
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5.2.4 ART Administration does not Promote Erythropoiesis in the Bone 
Marrow.  
To investigate whether the impact of ART on erythropoiesis was tissue specific, 
we also analysed bone marrow samples after treatment. No significant increase 
in erythroid cells was observed in P. berghei infected mice given four 
consecutive daily doses of ART compared with untreated or uninfected controls 
(Figure 5.9).  
	
	
	
	
	
	
Figure 5.9 ART treatment does not stimulate erythropoiesis in the bone marrow of 
BALB/c mice. ER; early reticulocyte. EB; Erythroblast. Whole cell numbers of bone 
marrow early reticulocytes (left; top) and whole cell numbers of bone marrow erythroblasts 
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(right; top) from infected mice. n = 4; infected vehicle control and 1 mg/kg n = 3. Whole 
cell numbers of bone marrow early reticulocytes (left; top) and whole cell numbers of bone 
marrow erythroblasts (right; top) from uninfected mice. n=4 of all groups. Drug dose 
concentration displayed on the x-axis. The groups were compared using a one-way 
ANOVA with multiple comparisons. Error bars ±SD. 
	
5.2.5 Chloroquine or Pyrimethamine Administration does not Promote 
Splenic Erythropoiesis  
To investigate whether the stimulating effects of ART on splenic erythropoiesis 
are exclusive to this class of antimalarial, mice were infected with 106 
PbGFPCON/RFPGAM parasites and treated with either CQ or PYR under the 
previously mentioned Peters “4 day suppressive test” regime (Figure 5.1). Under 
CQ treatment, the numbers of early reticulocytes in the spleen of animals 
administered with the curative dose, 10 mg/kg, were the same as the uninfected 
vehicle control (Figure 5.10A). Compared with untreated P. berghei infection, 
CQ doses of either 3mg/ kg or 1mg/ kg had no impact on splenic early 
reticulocyte numbers (Figure 5.10B).  In contrast, the whole numbers of splenic 
erythroblasts in the drug treated groups did not differ from either the 
uninfected or infected vehicle control (Figure 5.10B).  Under PYR treatment 
(Figure 5.10C) the whole cell numbers of either splenic early reticulocyte or 
splenic erythroblasts were not significantly different to the infected vehicle 
control (Figure 5.10D). 
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Figure 5.10 CQ or PYR treatment does not stimulate splenic erythropoiesis. ER; early 
reticulocyte. EB; Erythroblast. A. Parasitaemia of animals dosed with CQ. B. Whole cell 
numbers of splenic early reticulocytes (left) and whole cell numbers of splenic erythroblasts 
(right; top) from infected mice dosed with CQ. n = 3. C. Parasitaemia of animals dosed with 
PYR. D. Whole cell numbers of splenic early reticulocytes (left) and whole cell numbers of 
splenic erythroblasts (right; top) from infected mice dosed with PYR. n = 3. Drug dose 
concentration displayed on the x-axis. The groups were compared using a one-way 
ANOVA with multiple comparisons. Error bars ±SD.  
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5.3 Discussion  
 
5.3.1 Recrudescence of Infection Despite Undetectable Parasites in 
Peripheral Blood 
The phenomenon of antimalarial drug resistance initially emerged in Thailand in 
1957 in the form of CQ resistant P. falciparum (White, 2013). The prominent use 
of CQ was replaced by alternative synthetic antimalarials, which in turn fuelled 
treatment specific failure. The global use of ARTs began in the 1990s. 
Artemisinin treatment reduces parasite burden very rapidly (Miller et al., 2013) 
and ART monotherapies have been tested with duration as short as 2 consecutive 
days (Nguyen Duy Sy et al., 1993). Although 50 % of patients under this regime 
suffered recrudescence of infection, regimes of the same ART concentration but 
administered for 7 days also suffered recrudescence (Nguyen Duy Sy et al., 
1993). To tackle the high ART monotherapy treatment failure and to prevent a 
surge in ART residence, the WHO recommends a ACT treatment duration of 
three consecutive days (World Health Organisation, 2015). Nonetheless, 
treatment failure of ACT combined therapies, due to infection recrudescence 
following initial blood clearance, were reported as early as 2000 (Packard, 
2000). In this chapter I have shown that after four daily administrations of ART 
at 20 mg/kg or 40 mg/kg, previously reported IC90 values in BALB/c mice (Janse 
et al., 1994; Vega-Rodríguez et al., 2015), GFP+ parasites are undetectable by 
flow cytometry in the peripheral blood but readily apparent in splenic early 
reticulocytes.  It is interesting to note that the disparity between parasite 
persistence within bone marrow and spleen after drug treatment is unlikely to 
be due to the pharmacokinetics of ART. Multiple studies have observed 
radiolabeled (14C) ART reaches relatively higher concentrations (14% of total 
radioactivity) in the spleen across 192 hrs after a single dose of 3mg/kg 
compared to all other sampled tissues (Li et al., 2006; Xie et al., 2009).  
 
It is important to acknowledge that although flow cytometry is highly sensitive 
at detecting rare events (Domingo et al., 2010), the peripheral blood 
parasitaemia of the mice treated with 20 mg/kg or 40mg/kg may have been 
below the level of detection by this method.  The ability of a single parasitised 
erythrocyte to establish an infection is the basis for the use of limiting dilution 
during the acquisition of clonal parasite lines. However, the asexual numbers 
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shown here to be present in the splenic early reticulocytes on day 4 could 
generate the blood stage parasite numbers on day 6, it is reasonable to argue 
that the recrudescence of infection witnessed on days 6 and 7 may be the result 
of a residual peripheral blood parasitaemia.  In future work this concern may be 
circumvented through the use of RT-PCR against parasite specific markers in 
peripheral blood samples. Work assessing technical approaches for the detection 
of minimal residual disease (MRD) have shown that PCR-based studies are >1-log 
more sensitive than flow cytometry (Domingo et al., 2010). I chose to use flow 
cytometry in this study as it allowed us to define the erythroid populations that 
contained parasites after drug treatment, a characterisation that could not be 
made with RT-PCR. However, the sensitivity of flow cytomety prevents us from 
identifying the persistent splenic early reticulocyte infection as the sole source 
of the recrudescing infection following ART treatment.	 	
Interestingly, multiple reports have stated that post ART treatment, 
recrudescing parasites are not resistant to ART in vitro and re-administration of 
ART to patients is effective in clearing the recrudesced infection (Looareesuwan 
et al., 1997; Ittarat et al., 2003; Cheng, Kyle and Gatton, 2012). In this study I 
did not test the viability and drug sensitivity of the parasites within the splenic 
early reticulocytes. But this is the next logical step in the experimental 
workflow. This could be achieved by cell sorting the asexual (GFP+RFP-) infected 
splenic early reticulocytes from the 20 mg/kg and 40 mg/kg ART dosed mice. 
These cells could then be injected into uninfected mice to establish new 
infections, which could then be treated with the same drug concentration as the 
primary infection.  
 
A prominent hypothesis in the field to how drug sensitive parasites can survive 
treatment is ART-induced dormancy, whereby some parasites within a 
population can suspend their growth during drug administration only to resume it 
after drug clearance (Bwijo et al., 1997; Cheng, Kyle and Gatton, 2012). This 
theory has supporting evidence in vitro (Bwijo et al., 1997) and in vivo (LaCrue 
et al., 2011) where dormant parasites, morphologically identified as ring stages 
with unusually condensed cytoplasm and nucleus, have been observed after ART 
treatment (Teuscher et al., 2010).  In this work I did not visualise the splenic 
infected early reticulocytes and therefore cannot comment on whether they 
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displayed a dormant morphology. Nonetheless, there is evidence that the 
maturation stage of the host cell may affect treatment outcome.  Srivastava et 
al (2015) showed that the effects of drugs that target the parasites intermediary 
metabolism are compensated by the relatively ready availability of host derived 
metabolites in mature reticulocytes compared to erythrocytes, this effect could 
be potentially amplified in the more nutrient rich immature tissue resident 
reticulocytes. Thus in future work I need to identify whether parasites within 
splenic early reticulocytes are arrested or growing in a protective environment. 
This could be achieved by analysing the population with the same gating strategy 
on an Imagestream opposed to standard flow cytometry. The images generated 
will attest to whether the parasites are ring stages with unusual morphology or 
parasites developing through their life cycle.  
 
	
5.3.2 ART Stimulating Erythropoiesis in a Dose Dependent Manner  
The enhanced survival of parasites within splenic early reticulocytes post ART 
treatment may perpetuate infection through recrudescence and arguably may 
also create a cradle for drug resistance. Exacerbating this phenomenon, I 
observed that ART doses between 3- 10 mg/kg stimulated erythropoiesis in the 
spleen of P. berghei infected mice, thus enlarging the resource for parasite 
survival. It is established within the literature that ARTs treatment leads to 
haemolysis in both humans and mice, a well defined trigger for the stimulation 
of stress erythropoiesis (Jaureguiberry et al., 2014; Arguin, 2017). Nonetheless, 
the delayed onset time of ART associated haemolysis, > 1 week post parasite 
clearance, would suggest that the stimulatory effects I observed under 3 – 
10mg/ kg treatment were due to a more immediate erythropoietic dynamics 
(Jaureguiberry et al., 2014; Arguin, 2017). Moreover, administrating ART to 
uninfected mice suggested that splenic erythropoiesis is amplified in a dose-
dependent manner independent of malarial infection. Furthermore, this effect is 
likely drug class dependent as treatment with CQ or PYR did not elicit the same 
significant increase in tissue resident splenic erythroid cells.  
 
The murine spleen is the predominant site of stress erythropoiesis, which is 
regulated differently to basal erythropoiesis. It has been shown that stress 
erythropoiesis, but not basal erythropoiesis, is regulated via the glucocorticoid 
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(GC) receptor and this protein is essential for the expansion of erythroid 
progenitors (BFU-E) (Bauer et al., 1999). There is evidence that ART up-
regulates this receptor on different cell lineages in vivo (Bauer et al., 1999; Wu 
et al., 2011). ARTs also have been shown to possess anti-cancer, anti-viral and 
anti-inflammatory activities (Krishna et al., 2008; Cheng et al., 2011). 
Artesunate inhibits and blocks the production of inflammatory cytokines from 
stimulated macrophages by the inhibition of the PI3K/Akt signaling pathway in a 
dose dependent manner (Xu et al., 2007; Li et al., 2008). Of particular interest 
is the noted suppression of TNF-alpha and IL-6, both of which are negative feed 
back regulators of erythropoiesis secreted by the central erythroblast island 
macrophage (Xu et al., 2007; Li et al., 2008). It is therefore tempting to 
speculate that the significantly increased splenic tissue resident erythroid cell 
populations I observed after treatment of infected and uninfected mice, was due 
to ART targeting pathways in the stress erythropoietic pathway in a dose 
dependent manner. I detected dysregulation of postnatal splenic erythropoiesis 
only after the administration of 40 mg/kg to P. berghei infected mice. This can 
be linked to the observations that ART effects human developmental 
erythropoieisis in vitro in a dose dependent manner (Finaurini et al., 2010). The 
same authors later showed this was the result of a dose dependent disruption of 
cell cycle progression (Finaurini et al., 2012).  Taken together, the dose 
dependent effects I observe during ART treatment of P. berghei are likely due to 
the balance between the de-repression of erythropoiesis and the disruption of 
erythroid maturation.  
	
5.4 Summary  
In this chapter observed persistent parasitism of the erythropoietic tissue and an 
unprecedented expansion of this niche under treatment with artemisinin 
concentrations that elicit clearance of the peripheral blood infection. 								
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6. General Discussion; Relevance to Human Disease. 
 
The overarching narrative of the work in this thesis is (Figure 7.1):  
• P. berghei can invade the tissue resident erythroid cells located in the 
murine bone marrow and spleen. 
• This cell population provides a niche for the highest gametocyte 
conversion rates in the body. 
• It also provides a protective niche during treatment with ART doses that 
clear the peripheral blood infection. 
These observations extend the asexual life that classically has been considered 
to be within circulating erythrocytes and maturing reticulocytes (Figure 7.1).  
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Figure 7.1 Summary of thesis observations. Blue arrows are events suggested by this 
work. Dotted arrows are events indirectly observed to occur. MΦ: central ‘nurse’ 
macrophage. The Plasmodium life cycle (untreated infection), carried out in erythrocytes 
and maturing reticulocytes, is depicted in an endothelium lined blood vessel (top left; bone 
marrow) and the non-endothelium lined splenic red cords (top left; open circulation 
spleen). The observations made in this work suggest that: A. Merozoites can invade 
erythroblasts and early reticulocytes; these infected cells are permissive to P. berghei 
therefore schizonts can form and merozoites can undergo egress. B. Merozoites can 
invade tissue resident erythroid cells and develop as gametocytes, with the most 
consistent gametocytaemia being observed in early reticulocytes. C. Under ART 
treatment that cures the peripheral blood infected, a population of parasites within splenic 
early reticulocytes are not cleared. 1. Dotted lines indicate the migration of parasites into 
the erythropoietic tissue. The establishment of a tissue resident infection is dependent on 
a merozoite invading tissue resident erythroid cells, as such, a migration event must 
occur, however work in this thesis has not established that mechanism or parasite stage.  
2. The establishment of a cryptic cycle within the tissue from merozoites released from 
tissue resident erythroid cells. 3. The migration of parasite infected stage III reticulocytes 
into circulation. 4. The infected tissue resident population may lead to disease 
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recrudescence, as judged by detectible parasites within the peripheral blood, due to the 
maturation and release of the infected early reticulocytes into circulation.   
 
6.1 Relevance to Human Infective Plasmodium  
There are five species of Plasmodium that cause human malaria, but the 
greatest morbidly and mortality is caused by just two of these species, P. vivax 
and P. falciparum, respectively. Plasmodium merozoites initiate entry to their 
host cell through a series of hierarchal ligand-receptor interactions (Weiss, 
Crabb and Gilson, 2016). The repertoire of ligands expressed by the parasite 
govern its tropism for a particular maturation stage of erythroid cell 
development (Han et al., 2016; Lim et al., 2016). Both P. vivax and P. 
falciparum, like P. berghei, can invade reticulocytes within the peripheral blood 
(Lim et al., 2016). Furthermore, P. falciparum and P. vivax have also been 
observed to invade nucleated erythroid progenitors (Ru et al., 2009; Tamez et 
al., 2009) and P. falciparum has directly been shown to accumulate within the 
parenchyma of the bone marrow (Farfour et al., 2012; Joice et al., 2014). Joice 
et al (2014) observed that the majority of extravascular parasites within the 
bone marrow reside within enucleated cells. CD71 is expressed on erythroid cells 
and down regulated during maturation. Due to the low expression levels of CD71 
on the observed infected cells Joice et al (2014) postulated that they could be 
erythrocytes that had been infected within the vasculature and then migrated, 
by undefined mechanisms, across the endothelium into the tissue (Joice et al., 
2014). The work presented in this thesis demonstrated that the murine infective 
parasite, P. berghei can invade tissue resident erythroid cells. My work is the 
first time that parasite burden, alongside parasite preference for the different 
maturation stages of erythroid cells has been measured in vivo. Reflecting the 
observation made by Joice et al (2014), my work showed that the highest 
parasite burden is observable within the enucleated tissue resident erythroid 
populations: the early reticulocytes. Moreover, I showed that during infection 
CD71 is down-regulated in the stress erythropoietic tissue, which in humans is 
believed to be located to an extent in the bone marrow, (Palitzsch et al., 1987; 
Nandakumar, Ulirsch and Sankaran, 2016). This evidence suggests that the highly 
parasitised erythroid population previously observed within the extra vascular 
spaces of the bone marrow (Joice et al (2014) were most likely early 
reticulocytes and perhaps not transmigratory erythrocytes.   
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Moreover, through calculating gametocytaemia within erythroid cell 
compartments in vivo, I observed that the highest gametocyte conversion rates 
occur within the early reticulocyte population. Again, this directly reflects the 
ex vivo observations of Joice et al (2014) that the immature gametocytes of P. 
falciparum are observable within an enucleated extra vascular population within 
the bone marrow.  Therefore, I have provided evidence that my murine model is 
directly comparable with the observations made in the human host.  
Furthermore, although my data does not exclude a role for immature 
gametocyte infected erythrocytes directly transmigrating into the bone marrow, 
it does give considerable weight to the hypothesis that extracellular merozoites 
or schizont parasitised erythrocytes infiltrate haematopoietic tissue, whereby 
the proceeding invasion event into early reticulocytes triggers gametocyte 
formation.  
	
		
6.2 Human Definitive Erythropoiesis 	
As mentioned above, I identified murine splenic early reticulocytes as the 
erythroid cell niche with highest parasite burden and the greatest gametocyte 
conversion.  
 
In contrast to the mammalian bone marrow, blood flow in the murine spleen and 
the open circulation of the human spleen is not bound by vascular endothelium. 
Inward blood flow in each situation empties into the red pulp where it drains 
through the splenic cords before re-entering the closed circulation (Steiniger, 
Bette and Schwarzbach, 2011). Therefore, the erythroid pool in the murine 
spleen is arguably more accessible than the bone marrow pool and this may 
explain parasite preference. Furthermore, the expansion and maturation of the 
erythroid pool within the murine spleen is governed by stress erythropoiesis 
signalling within a hypoxic environment, compared with the constitutive nature 
of murine bone marrow erythropoiesis (Reichardt et al., 1998; Bauer et al., 
1999).  
 
In contrast to the mouse, the erythropoiesis in humans has defined as 
predominantly residing in the bone marrow (Nandakumar, Ulirsch and Sankaran, 
Discussion		 221	
2016).  This would mean that both stress and basal erythropoiesis occur in 
parallel within the same low hypoxic environment, and consequently the 
parasite would need to transmigrate out of the vasculature in order to access 
either erythroid pool.  However, it should be noted that extramedullary 
haematopoiesis (EMH) has been observed within human spleens during disease, 
such as myeloproliferative disorders, lymphomas, leukaemias and notably beta 
thalassemia, a hemoglobinapathy under stablising selection in malaria endemic 
regions (Freedman and Saunders, 1981; Bird et al., 2016). It has even been 
observed within the spleens of the ‘healthy’ controls in a multi-organ histology 
screen of autopsy samples taken from patients with terminal cirrhotic livers 
(Palitzsch et al., 1987). Splenomegaly is a common feature of human malaria 
resulting from architectural remodelling and accumulation of parasitised 
erythrocytes (Engwerda, Beattie and Amante, 2005). Such gross distortions may 
have masked any the role splenic EMH plays in perpetuation of the Plasmodium 
life cycle and commitment to gametocytogenesis. Moreover, in the Plasmodium 
literature the cellular marker CD71 is used to demark immature erythroid cells 
(Martín-jaular et al., 2013; Lelliott et al., 2014; Lelliott, Mcmorran and Foote, 
2015). As discussed previously, I have shown that CD71 is down regulated in 
stress erythropoieitic tissue during Plasmodium infection, therefore making it an 
unreliable marker for separating tissue resident from mature erythroid cells in 
circulation. This, coupled with the open circulation of the splenic cords, may 
have led histological examinations of the spleen to misinterpret tissue resident 
infected early reticulocytes as mature circulating erythrocytes (Joice et al., 
2014).  
 
Human EMH is not restricted to the spleen, it has been reported within the 
paravertebral area, intracranial area, liver sinusoids and lymph nodes and is a 
well-recognised complication of conditions with ineffective hematopoiesis, such 
as in patients with beta thalassemia (Baden, 2013; Lanigan and Fordham, 2017; 
Ricchi, 2017; Varshney et al., 2017). These observations imply a wide range of 
non-bone marrow niches have the capability to support erythropoiesis within the 
human. Consequently, the observation in this thesis that niches of 
extramedullary erythropoiesis contribute to significant tissue resident parasite 
burden and are a source of recrudescence maybe directly relevant to human 
malaria.  
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6.3 ART and Malaria Transmission  
 
Work presented in this thesis demonstrated that ART both de-represses and 
disrupts the expansion of the stress erythropoietic niche in mice in a dose 
dependent manner. Thus, it would seem that a front-line anti-malarial has the 
ability to fuel the expansion of the parasite’s preferential tissue niche. 
Moreover, splenic early reticulocytes are the site of preferential gametocyte 
formation in the host, a feature reflected by the observation of both asexual and 
sexual parasites in this niche after ART treatment. Thus, the off-target effects 
of ART may incidentally provide parasites with a niche for evasion of 
chemotherapy, the evolution of drug resistance, whilst in parallel also promoting 
the transmission of both sensitive and any subsequent ART resistant parasites. As 
such, it would be interesting to tease out the dose dependent effects ART on 
erythroid expansion. The transcriptional changes ART induces directly or 
indirectly within erythroid cells could be investigated by performing RNAseq on 
cell-sorted erythroblasts from mice administered different concentrations of the 
drug. Comparing the transcriptomes from these groups will give an indication of 
the pathways ART effects and suggest approaches that may avoid these off 
target, counterprotective effects.  
 
It is important to note that the regulation of human EMH has not been 
investigated (Paulson, Shi and Wu, 2011). Therefore it is impossible to conclude 
whether erythroid maturation is governed through similar anatomical, cellular 
and molecular processes as described in murine splenic stress erythropoiesis 
(Barminko, Reinholt and Baron, 2016). However, it would be interesting to 
examine bone marrow and spleen biopsies from malaria patients treated with 
ART to investigate whether a evident difference in expansion of erythroid cells is 
observable between the two tissues.  
	
6.4 Conclusion  
Taken together the findings reported in this thesis have shown that 
haematopoietic tissue is an important niche for perpetuating malaria 
transmission as well as disease recrudescence in the face of drug pressure, both 
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of which have implications for effective drug treatment and/or transmission 
control of human infection.  	
6.5 Further work 
There are a number of further experimental routes that my established work 
could support. These can be broken down into three groups: investigating the 
infected immature erythroid cell dynamics; characterising the new parasite line; 
using my model for novel antimalarial screens and examining the evolution of 
drug resistance. 
 
Further characterisation of the infected erythroid cells: 
• Combining my flow-based approach with the  PbGFPCON/RFPGAM  parasite 
line would allow for the purification of infected and uninfected immature 
erythroid cells. These could be used in workflow designed to investigate 
whether the parasite alters or arrest the maturation of the host cell and if 
the parasite itself is altered in its gene expression profile as a result of 
colonising increasingly immature (nucleated) cells of the erythroid 
lineage. Any alterations in parasite transcriptome in relation to 
parasitised host cell immaturity should be taken into account in the 
development of anti-malarials to ensure that parasites within both the 
circulation and the tissue resident niche are targeted.   
 
Further characterisation of the PbGFPCON/RFPGAM parasite line: 
• The early onset of the RFP gametocyte specific promoter (8hrs post 
invasion) would allow for the purification of early gametocytes. These can 
then be used in a work flow designed to investigate early gametocyte 
deformability and the transcriptional profile of both male and female 
gametocytes. 
 
A model for novel antimalarial screening and the evolution of drug resistance:  
• By combining the flow-based approach for detecting immature erythroid 
cells with the PbGFPCON/RFPGAM  parasite line developed in this study, a 
model to directly test new antimalarials for their effects on erythropoiesis 
and parasite persistence might be developed. This approach might also be 
exploited to examine whether this niche offers conditions that might 
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promote the selection of drug-resistant parasites or enhance parasite 
transmission.	
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7. Appendix  
8.1. Supplementary material: Chapter 3  	 	 	
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Figure 7.1.1 CD71 is an unreliable marker for resolving different erythroid populations during P. berghei infection. Spleen and peripherial blood 
representative FACS plots.  
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Figure 7.1.2 CD44 vs FS-A gating. Spleen and peripherial blood representative FACS plots.  
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Figure 7.1.3 Peripheral blood parasiteamia (left) and spleen weight on day 7 post 
infection (right).n= 9. ±SD.   
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Figure 7.1.4 Peripheral blood parasiteamia (left) and spleen weight on day 7 post 
infection (right) NIH mice. N= 9. ± SD. Significant difference between groups or 
samples is indicated with asterisks, denoting as follows: * p < 0.05, ** p < 0.01, *** p 
< 0.001, **** p < 0.0001. 	
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7.2 Supplementary material: Chapter 4 						 											 							 									 											
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Figure 7.2.1 A. Gel showing amplified RFP fragment. Fragment is 650bp in size. B. 
linearization of pG403 plasmid with SacII. 2.5kb band corresponds to the excised Amp 
resistance gene. The larger band is the vector band bone to transfect into parasite 
genome.    
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Figure 8.2.2 The Introduction of the RFPGAM cassette does not effect 
gametocyteamia. ±SD 
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Figure 8.2.3 Representative FACS plots. Top row PbGFPCON/RFPGAM, middle row characterized line 
820tbb, bottom row characterized line 507 clon1. 820tbb line contains GFP and RFP  fluorophore 
which are observable from 12hrs post invasion and 22hrs post invasion, respectively . This line was 
therefore a timing control. 507 clone 1 is the parental line to PbGFPCON/RFPGAM. This line was a RFP- 
gating control.  
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Figure 8.2.4 Gametocytaemia of synchronized PbGFPcon/RFPGAM in vitro culture.  As P. 
berghei cannot re invade in vitro the gametocyteamia is reflective of the dynamics of the 
florescent proxy. Hours post invasion on the x-axis. Error bars are ± SD.   
Figure 8.2.5 Parasitaemia of peripheral blood and tissue extracted Ter119+CD44low cells from 
NIH on day 7 post infection with parasite line 507 clone 1.  
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BALB/C	A.	
B.	
Figure	8.2.6		A	&C.	p	values	generated	from	ANOVA	multiple	comparisons	of	the	tissue	resident	erythroid	cell	parasitaemia		B&D.	p	values	generated	from	ANOVA	multiple	comparisons	of	the	tissue	resident	erythroid	cell	parasite	whole	cell	numbers.			
NIH	
C.		
D.		
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Figure	8.2.7		A	&	B.	p	values	generated	from	ANOVA	multiple	comparisons	of	the	whole	cell	numbers	of	gametocytes	in	the	tissue	resident	erythroid	cells.	C&D.	p	values	generated	from	ANOVA	multiple	comparisons	of	the	whole	cell	numbers	of	asexual	parasites	in	the	tissue	resident	erythroid	cells.			
A.	
B.	
NIH	
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NIH	D.	
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Figure 8.2.8 Gametocytaemia of erythroblastsa and splenic early reticulocytes 
across a 7 day infection. The bars represent the data from the organs and the dotted 
lines infer continuous growth. A. BALB/ c mice. All time points n=9; day 7 n=8. B. NIH 
mice. All time points n =6. Error bars ± SEM. Significant difference between splenic early 
reticulocytes and peripheral blood samples is indicated with asterisks, denoting as follows: 
* p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001. Significance generated from a one 
way ANOVA comparison. Significance represents comparison between the splenic early 
reticulocytes and peripheral blood.  
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Days	pi	 Contribution	of	EB	to	ER	parasites	%	(±	SD)	
Day2	 0	
Day3	 0	
Day4	 0.07	±	0.1	
Day5	 1.11	±	2.73	
Day6	 87.49	±	213	
Day7	 91	±	112	
Days	pi	
Contribution	of	EB	to	
ER	gametocytes	%	(±	
SD)	
Day2	 0	
Day3	 0	
Day4	 0	
Day5	 0	
Day6	 11	±	21	
Day7	 34	±	45	
	
Figure 8.2.9 Percentage contribution of bone marrow EB parasites to the bone marrow 
ER parasites population 24 hours later. Plotted on the graph are the mean ± SD whole cell 
numbers of GFP+RFP- splenic early reticulocytes (ER) and the mean ± SD whole cells 
numbers of GFP+RFP- splenic intermediate and mature erythroblasts (EB). Tables show the 
percentage contribution the parasitised splenic intermediate and mature erythroblasts make to 
the parasitized splenic early reticulocytes population at the ensuing time point ± SD. A. BALB/c 
mice. All time points n=9; day 7 n=8. B. NIH mice. All time points n=6.	
A. BALB/c 
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Days	pi	 Contribution	of	EB	to	ER	gametocytes	%	(±	SD)	
Day2	 0	
Day3	 0	
Day4	 0	
Day5	 0	
Day6	 1	±	2	
Day7	 6	±	11	
	
Figure 8.2.10 Percentage contribution of splenic EB gametocytes to the 
splenic ER gametocyte population 24 hours later. Tables show the percentage 
contribution the RFP+ splenic intermediate and mature erythroblasts make to the 
RFP+ splenic early reticulocytes population at the ensuing time point ± SD. A. 
BALB/c mice. All time points n=9; day 7 n=8. B. NIH mice. All time points n=6.		
B. NIH 
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8.2. Supplementary material: Chapter 5 		 																												 							 						 			
40mg/kg	BM	EB	20mg/kg	BM	EB	
20mg/kg	BM	ER	Uninfected	BM	ER	
Uninfected		BM	EB	
GFP 
40mg/kg	BM	ER	
Ter119
 
Figure 8.3.1 Representative FACS plots showing bone marrow early reticulocytes from 
the uninfected vehicle control, 20 mg/kg ART dosed group and the 40 mg/kg ART dosed 
group.  
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Figure 7.3.2 ART treatment does not increase gametocytogenesis within erythroblasts 
of BALB/c mice. Whole cell numbers of gametocytes within the splenic erythroblast 
population of infected BALB/c mice treated with ART. 		
	
Appendix 8.3.3  
On day 6 pi the average parasitaemia of mice in the 20 mg/kg dosing group was 
0.02%. When taking into account that the average BALB/c mouse contains 1ml of 
blood with 6 x106 erythroid cells/µl, it can be extrapolated that the mice on average 
contained 1200000 parasites on day 6. P. berghei has a x 10 replication rate/ 24 hrs 
(Janse, 2014), as such, it can be extrapolated that on day 4 the mice would need to 
contain 12000 asexual parasites. On average the mice contained 853 ± 700 asexual 
parasites in the splenic early reticulocytes on day 4 (Figure 5.5C).  
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